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Abstract"
This thesis is concerned with the synthesis of allenic compounds and their gold-catalyzed 
isomerization reactions. Its general aim is the development of new reaction methodologies 
within these topics and the work has been published in two separate articles. After an 
introductory chapter (covering relevant literature upto 2010) three separate projects are 
discussed: 
1. Development of tandem enzyme/gold-catalyzed reaction where lipase-catalyzed 
kinetic resolution of g-allenic acetates [R12CCCH(CHR2OAc)] (R1,R2 = alkyl) leads 
to the formation of g-hydroxyallenes with 86-99% ee and this transformation is 
followed by the cycloisomerization of the g-hydroxyallenes to the corresponding 2,5-
dihydrofurans in a one-pot reaction. It is found that the two transformations work well 
in one pot except in the case where R2 is branched, which are not hydrolysed. 
 
2. A new approach is developed for the synthesis of allenyl acetates 
[Ar(R1)CCCH(O2CR2)] (R1 = alkyl, R2 = Me, Ph, t-Bu) using cuprate-mediated SN2’ 
nucleophilic substitution to propargylic dicarboxylates. The reaction was successfull 
with a range of substrates (11 examples). Investigation on a catalytic variant for the 
synthesis of the above allenyl acetates. Nickel-catalyzed SN2’ nucleophilic 
substitution to propargylic dicarboxylates gives the highest selectivity of the desired 
allenic products but the transformation is not very high-yielding. Attempts towards an 
asymmetric reaction are thwarted by low enantioselectivities (<22% ee). 
 
3. Comparing the reactivity of propargylic acetates and allenyl acetates (prepared in 
Sections 2-3) in the gold-catalyzed synthesis of indenes. It was discovered that the 
allenyl acetates prepared earlier yield indenes with up to quantitative yields and high 
chemoselectivity, whereas propargylic acetates with terminal a alkyne group only 
yielded a mixture of cyclization and elimination products. 
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1 Introduction" to" allene" chemistry" and" gold-catalyzed" organic"
transformations"
This thesis focuses on the synthesis of allenic compounds and on gold-catalyzed 
transformations of allenic and propargylic compounds. This introductory chapter gives an 
overview on the two topics (literature upto 2010) without going into extensive detail. Allene 
synthesis, and the versatility of allenes as building blocks in organic synthesis, is discussed and 
illustrated with examples from natural products and their synthesis. Gold catalysis is then 
discussed with some recent examples. The background for the topic of each following chapter 
(Chapters 2-5) will be introduced in detail in the beginning of each chapter. 
1.1 Allenes in organic chemistry 
The cumulative double-bond structure of allenes is often present in nature. There are over 150 
reported natural products with allene structure [1], many of which have interesting biological 
properties. Some examples of allenic natural products that have recently been synthesized are 
given in Scheme 1. 
 
Scheme 1 
In 2006, Ondeyka et al. isolated phomallenic acids A-C from the fermentation broth of Phoma 
sp [2]. From the phomallenic acid family, phomallenic acid C 1 has shown the highest activity 
as type FASII inhibitor (MICs in the range of 0.77-3.9 たg/ml against Staphylococcus aureus 
(MRSA) and Haemophilus influenzae) [3] and might be a selective agent against infection 
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diseases. Total synthesis of phomallenic acid C was first reported by Wu and co-workers in 
2007 [4]. This was followed by synthetic approaches from two other groups: Watanabe in 2008 
[5] and 2009 [6] and Shishido 2008 [7]. 
Marasins are a group of natural products having considerable bioactivity against numerous 
bacteria including Mycobacterium turberculosis. (aR)-(-)-Marasin 2 was isolated from 
Marasimus ramealis in 1959 and Cortillenus berceleyanus in 1966 [8] and its first total 
synthesis was accomplished in 1988 by Graaf and co-workers who also tested the bioactivity of 
marasin against Staphylococcus aureus [9]. Graaf obtained the product (aR)-(-)-marasin with 
very low, 0.5% ee. There are recent examples of the synthesis of (aR)-(-)-marasin via 
biosynthetic route by Hodge 2005 [10] as well as a very recent example from Wu 2010 [11] 
which allows the synthesis of the natural product with 75% ee. 
Scorodonin 3 was isolated from Marasmius scorodonius and it has inhibiting effects on the 
growth of bacteria, yeasts and filamentous fungi [12]. Its first total synthesis with 63% ee for 
the final product was accomplished by Wu and co-workers in 2010 [13]. The first 
enantioselective synthesis of nemotin was also reported in 2010 by Wu and co-workers [14]. 
Nemotin 4 was isolated in 1950 by Robbins [15] and the structure completely determined by 
Leeming in 1955 [16]. 
Panacene 5 was isolated in 1977 from a sea hare [17]. Racemic panacene was first synthesized 
by Feldman in 1982 [18] and in 2006 Boukouvalas and Snieckus reported the first 
enantioselective total synthesis [19].  
Poison arrow frogs of South America have toxic allenic products in their skin for defence. In 
1970 Witkop and co-workers collected a series of skin extracts from Colombian frogs of 
family Dendrobates histrionicus and reported the structures of new spiroalcaloids containing 
acetylenic and allenic substitutents [20]. These compounds can be highly toxic, but some of 
them also show inhibiting activity to the nicotinic acetylcholine receptor with (-)-
histrionicotoxin 6 being the most potent inhibitor within the histrionicotoxins family [21]. The 
first total synthesis of (-)-histrionicotoxin was reported by Holmes in 2008 [22]. 
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The several recent syntheses of allenic natural products prove that these compounds are of 
great interest to the modern organic chemist. Allenic compounds are interesting not only for 
the synthetic challenges that they present but also for their potential biological activities.  
Allenic compounds are present in nature but allenes are also valuable building blocks and in 
organic synthesis. The importance of allenes in organic synthesis is based on the unique 
reactive properties of cumulative double bonds. Allenes can undergo various cycloaddition 
reactions both intra- and intermolecularly. Allenic compounds also perform well in various 
cycloisomerizations, as well as coupling reactions. Allenes also possess the property of axial 
chirality that can be transferred to a new chiral center in many reactions of allenic compounds 
[1a].  
Reich and co-workers have studied the synthesis and reactivity of siloxyvinylallenes 9. They 
reported a total synthesis of cis-dehydydrofukinone 12 in 1986 [23]. The key step in this 
synthesis was a Diels-Alder cyclization of enone-allene 10 in the presence of a Lewis acid to 
give cycloadduct 11 which can be further modified to the natural product 12 (Scheme 2).  
 
Scheme 2 
Another example of an allenic moiety as an intermediate in total synthesis is from Wender and 
co-workers from 1999 [24]. They carried out the total synthesis of (+)-dictamnol 14 by using a 
rhodium-catalyzed [5+2]-cycloaddition reaction of allenylvinylcyclopropane 13 to yield the 
product 14 in high diastereoselectivity (Scheme 3). 
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Scheme 3 
In the following discussion on allene synthesis, as well as in Chapter 2, additional examples of 
allenes as starting materials in the synthesis of complex structures are presented.  
1.1.1 Synthetic methods towards allenic compounds 
In the thousands of publications on allene synthesis, there are a plethora of synthetic methods 
to access these compounds [25]. Two methods are discussed in detail here, which are also used 
in this thesis. These are the use of stoichiometric organometallic reagents, focusing on 
reactions with cuprates and aluminium hydrides; secondly the use of transition metal catalysis 
in allene synthesis will be discussed. 
1.1.1.1 Use of stoichiometric organometallic reagents in synthesis of allenes 
Metal-mediated allene synthesis can be summarized in to three fundamental methodologies; 
SN2’ nucleophilic substitution to propargylic electrophiles 15, 1,4-addition to enynes 17 and 
1,6-addition to acceptor-substituted enynes 19 (Scheme 4). Often in these reactions the 
organometallic reagent used is an organocopper reagent as many combinations of 
organocopper reagents and leaving groups result in clean conversions to the allene product. 
 
Scheme 4 
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The first example of organocopper-mediated allene synthesis was reported by Rona and Crabbé 
in 1968 [26]. They used a lithium dialkylcuprate in the synthesis of allenes 22 from propargylic 
acetates 21 (Scheme 5).  
 
Scheme 5 
Since the pioneering work of Rona and Crabbé several methods have been developed including 
changes both in the propargylic electrophile and the cuprate reagent. The propargylic system 
often carries a carboxylate [26], an epoxide [27], an ether or acetal [28] or a halide [29] as a 
leaving group but the substrate can also be a propargylic tosylate [30] or even aziridine [31]. 
The organocopper reagents have also evolved to various functionalized cuprates derived from 
organolithium [32], Grignard [33] and organozinc [34] reagents. 
Organocopper-mediated allene synthesis has found its applications in total synthesis of natural 
or bioactive products. 7-Vinylidenecephem sulphones 24 and 25 were prepared by 
organocopper-mediated SN2’ nucleophilic substitution of propargylic triflates [35]. Two types 
of copper reagents were employed; copper(I) bromide and the cyanocuprate (t-Bu)2CuCNLi2, 
both yielded the corresponding allenic products with 100% stereospecificity via an anti SN2’ 
displacement of the leaving group (Scheme 6). Bromoallene 25 can be reduced with zinc-
copper couple to the terminally unsubstituted allene 26. 
 
Scheme 6 
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Although there are many other methods for metal-mediated allene synthesis [1a] we will 
concentrate here on methods using aluminium hydrides as this method has been used in this 
thesis.  
Aluminium hydrides, such as lithium aluminium hydride and diisobutylaluminium hydride 
(DIBAH) can transform various propargylic electrophiles to the corresponding allenes. The use 
of aluminium hydrides has proved particularly useful in the synthesis of g-hydroxyallenes [36]. 
The reductive substitution of lithium aluminium hydride to mono-THP ether of bispropargylic 
alcohols 27 yields g-hydroxyallenes 28 with high selectivity and yield (Scheme 7). 
 
Scheme 7 
The aluminium hydride mediated allene synthesis has also found applications in total synthesis 
as in the synthesis of peridinin 31, a carotenoid isolated from planctonic algae dinoflagellates 
[37]. In the total synthesis, the allenic building block of the natural product is synthesized by 
reacting a propargylic epoxide 29 with diisobutylaluminium hydride to give g-hydroxyallene 
30 (Scheme 8). 
 
Scheme 8 
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1.1.1.2 Transition metal -catalyzed synthesis of allenes 
There are also reports of using catalytic amounts of transition metals in the synthesis of allenes. 
In this approach the starting material is also often a propargylic electrophile dating from the 
seminal work of Vermeer from 1974 who synthesized g-hydroxyallenes 33 from propargylic 
epoxides 32 with Grignard reagents in presence of 10 mol% of copper(I) iodide (Scheme 9) 
[27]. In 1976 Pasto successfully synthesized allenes 35 from propargylic chlorides 34 with 
Grignard reagent and iron(III) chloride as catalyst (Scheme 9) [38]. 
 
Scheme 9 
After the first reports on iron- and copper-catalyzed allene formations other transition metals 
have also been found efficient in allene synthesis. Probably the most frequently used transition 
metal catalysts in this approach are palladium catalysts. In 1980 Jeffery-Luong and 
Linstrumelle applied palladium(II) chloride with phosphine ligands to an SN2’ nucleophilic 
substitution of a Grignard reagent to propargylic electrophile 36 (Scheme 10) [39]. Since then 
various palladium catalysts as well as different organometallic reagents have been successfully 
used [25]. 
 
Scheme 10 
The mechanism of the palladium-catalyzed SN2’ nucleophilic substitution is shown in Scheme 
11 [40]. A (j-allenyl)palladium(II) species 39 forms in an oxidative addition with the 
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propargylic substrate 38. This complex can then react with a carbon nucleophile, such as 
organomagnesium, -zinc or –boron reagents via transmetallation. Reductive elimination yields 
the allenic product 41 and the [Pd(0)] catalyst.  The mechanism resembles that of a cross-
coupling reaction, except that the propargylic substrates rearrange to allenyls in the oxidative 
addition step (Scheme 11). 
 
Scheme 11 
Copper and nickel catalysts have also been used to catalyze the synthesis of allenes. The first 
examples of nickel-catalyzed allene synthesis are from 1985 [41] when Michelotti studied the 
reactions of propargylic alcohols 42 with Grignard reagents in the presence of nickel catalysts 
(Scheme 12). 
 
Scheme 12 
Copper  catalysis  was  one  of  the  first  methods  used  in  allene  synthesis  (Scheme  9)  but  is  of  
current interest as well. Woodward and Krause reported a new synthesis for g-hydroxyallenes 
in 2009. The copper-catalyzed SN2’ reaction was used to form the allenic products 45 from 
propargylic dioxolanones 44 [42]. The reaction yields g-hydroxyallenes with high 
regioselectivity (Scheme 13). 
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Scheme 13 
In some cases the regioselectivity in the SN2’ vs SN2 reaction is dependent on the transition 
metal used. A good example of this is Kobayashi’s report from 1995 (Scheme 14) [43]. In the 
SN2’ reaction of silanes with propargylic halides 46 the desired regioselectivity towards SN2’ 
nucleophilic substitution (product 48) is obtained with a nickel catalyst while copper catalysts 
tested yielded mostly SN2-product 47. 
H
Cl
HSiCl3
cat. M, amine H
SiCl3 SiCl3
H
major product
M= CuCl
major product
M= NiL2
O O
OEt
46 47 48
L:
 
Scheme 14 
1.1.2 Asymmetric synthesis of allenic compounds 
Enantioselective synthesis of allenes is a topic that is of current interest to many research 
groups. There are several methods to obtain enantiomerically enriched allenes and the most 
common are listed here. Probably the most used method is to use center-to-axis chirality 
transfer starting from enantiomerically enriched propargylic alcohols. This approach is popular 
due to the easily available starting materials. The SN2’ reaction can proceed via anti- or syn- 
selectivity. With organocopper reagents anti-SN2’ reaction is often favored [44]. There are also 
examples of using a catalytic amount of a copper salt with a Grignard reagent to obtain syn-
selectivity [45] (Scheme 15). 
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Scheme 15 
Besides the use of different copper reagents, several other methods have been reported that use 
the center-to-axis chirality transfer from propargylic alcohol derivatives to allenes. These 
include intramolecular rearrangements [46], palladium-catalyzed reactions [47], reductions of 
propargylic alcohol derivatives with lithium hydrides to the corresponding allenes [48] and 
many others. 
Enantiomerically enriched or pure allenes can also be prepared via direct asymmetric synthesis. 
First success in catalytic direct asymmetric allene synthesis was achieved by Elsevier and co-
workers in 1989 [49]. They reported a coupling reaction of a racemic allenyl-metal compound 
54 with iodobenzene in the presence of a palladium catalyst and a chiral ligand (Scheme 16). 
The best ee obtained for allenes 55 with this method was 25%. 
 
Scheme 16 
Recently (2009) guanidine-catalyzed isomerization of alkynoates 56 to the corresponding 
allenoates 57 was reported by Huang and Tan [50]. The reaction takes place via a base 
catalyzed 1,3-proton shift. The resulting allenoates 57 are obtained with high yields and in 
most cases with over 90% ee (Scheme 17). 
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Scheme 17 
Classical kinetic resolution has been applied to the preparation of enantiomerically enriched 
allenes by several research groups very recently. In two reports from Bäckvall in 2009-2010 
Porcine pancreatic lipase (PPL) -catalyzed kinetic resolution [51], and lipase/palladium-
catalyzed dynamic kinetic resolution were used to prepare compounds (R)-60 and (R)-62 [52] 
(Scheme 18). By kinetic resolution is meant a process, where a racemic material reacts with a 
chiral catalyst and the two enantiomers having unequal rates of the reaction results to 
resolution of the enantiomers. Dynamic kinetic resolution can be achieved by adding a second 
catalyst, which is able to racemize the starting material. 
 
Scheme 18 
Bäckvall has also reported some examples of cinchonidine mediated kinetic resolution of 
axially chiral allenic acids in 2008 [53]. Additionally, in 2010 Gong reported the use of 
biphosphoric acid in the kinetic resolution of axially chiral allenic acids [54]. There is also a 
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report on the optimization of the enantioselectivity of a lipase from Pseudomonas aeruginosa 
towards allenic compounds [55]. 
1.2 Gold catalysis in organic synthesis 
The use of gold catalysts in organic synthesis has seen a tremendous rise in the 21st century. 
Gold catalysts are generally considered as safe and simple to use and the resultant reactions are 
normally easy to perform. Often gold-catalyzed reactions can be performed under very mild 
reaction conditions with reasonably short reaction times. Gold catalysts often show excellent 
chemoselectivity towards unsaturated C-C ヾ systems, leaving other functional groups 
untouched.  
Most gold catalysts exist in two oxidation states: Au(I) and Au(III). Gold catalysts, as platinum 
catalysts, do not undergo traditional redox catalytic cycles of oxidative addition and reductive 
elimination like many other transition metal catalysts.  Instead, gold catalysts tend to stay in 
one oxidation state through the reaction. The first gold catalysts were simple halide salts such 
as AuCl3. The catalyst activity can be enhanced by creating cationic gold-species, which can be 
stabilized with phosphine or N-heterocyclic carbene ligands [56]. Often a silver co-catalyst is 
used to create the cationic gold-complex in situ [57]. 
Many gold-catalyzed reactions have to be performed in organic solvents. Some gold salts, 
however, also perform well also in aqueous solutions. The gold acid HAuCl4 and NaAuCl4 [58] 
are  active  in  water  under  air.  Ionic  liquids  have  also  been  used  as  solvents  with  the  gold  
catalysts Bu4N[AuCl4] [59] and AuBr3 [60]. 
1.2.1 Gold-catalyzed organic transformations 
The ヾ-electrophilicity of gold catalysts is their most important property when used as catalysts 
in organic chemistry. Gold catalysts have even been named as ヾ-acids [57] due to their affinity 
to bind to C-C multiple bonds. The activation of a ヾ-ligand (alkene A, allene B or alkyne C) 
renders the ヾ system electrophilic and thus activates the ヾ system towards a nucleophilic attack 
(Scheme 19). 
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Scheme 19: Activation of unsaturated C-C ヾ-systems with cationic gold-complexes. 
The nucleophile in the reaction can be delivered in an intramolecular or intermolecular manner. 
Both carbon and heteroatom nucleophiles have been extensively used [61]. The reaction 
mechanisms of such reactions have been reviewed recently [62].  
Alkenes, allenes and alkynes have all been used as substrates for gold-activated nucleophilic 
attack (Scheme 20). Gold catalysts can activate substitution of phenols 63 to unactivated 
alkenes 64 [63], catalyze the cycloisomerization of g-hydroxyallenes 66 to 2,3-dihydrofurans 
67 [64] and promote the cyclosomerization of  homopropargylic alcohols 68 to 
tetrahydrofuranol ethers 69 [65]. Allenes and alkynes are more reactive substrates due to their 
sp-hybrid carbon atoms which render them more electrophilic than similarly substituted 
alkenes allowing the reactions to be performed at room temperature.  
 
Scheme 20 
In Chapters 2 and 5 gold-catalyzed reactions of allenes will be discussed in detail. Reactions of 
gold catalysts with some alkynes are discussed in Chapter 5. In this Chapter are presented 
representative examples of alkyne ヾ
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Besides alcohols, other oxygen nucleophiles have been used in gold-activated reactions. 
Alkynes can be activated towards intramolecular nucleophilic attack of epoxides 70 [66], 
carboxylic acids 72 [67], amides 74 [68] and ketones 76 [69] forming substituted furans 71 and 
77, lactones 73 and oxazoles 75 (Scheme 21). With different oxygen nucleophiles the reactions 
are often performed at room temperature. 
 
Scheme 21 
Nitrogen-based nucleophiles can also be used, recent examples using alkyne substrates are 
presented in Scheme 22. Gold-catalyzed hydroamination has been known since 1987 [70]. 
Scheme 22 presents a recent intermolecular version of this reaction which yields imines 80 
from alkynes 78 and amines 79 [71]. Imidates 81 can also be used in hydroamination [72] to 
form 4,5-dihydrooxazoles 83 and 5,6-dihydro-1,3-oxazines 82 under very mild reaction 
conditions. Even pyridine compounds 84 work well as nucleophiles forming N-fused 
heterocycles 85 [73] under gold- and silver-catalysis. Azides 86 display a gold-catalyzed 
Schmidt reaction giving pyrroles 87 with elimination of N2 [74]. 
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Scheme 22 
Among sulphur-nucleophiles, acetylenic thioethers 88 react cleanly forming 2,3-substituted 
benzothiophnes 89 with excellent yields [75] (Scheme 23). Other thiols have been used in the 
hydrothiolation of conjugated olefins [76] as well as in the cycloisomerization of g-thioallenes 
[77] which will be discussed further in Chapter 2. 
 
Scheme 23 
24 
 
Besides heteroatom nucleophiles, there are a plethora of examples of different carbon 
nucleophiles which react with gold-activated alkynes (Scheme 24). Enol ethers 90 react with 
alkynes to form bicyclic compounds 91 [78]. Different く-ketoester–nucleophiles 92 also work 
well in similar reactions [79]. Gold catalysts also perform well in Friedel-Crafs–type chemistry 
where different aromatic species, such as substituted furans 94, react with gold-activated 
alkynes 95 or other ヾ-systems [80], although this reaction can have problems of selectivity as 
in some cases double-addition occur (as in Scheme 24). 
 
Scheme 24 
The examples above are only representative examples from the recent literature and simple 
reactions were deliberately selected. There are also many tandem reactions that often have 
several nucleophiles present in the reaction mixture [61]. The development of asymmetric 
gold-catalyzed reactions has thrived in recent years and new chiral gold-ligand -complexes are 
being developed and tested in catalysis more and more [81]. This area of gold catalysis has 
been intentionally excluded from this introduction as there are no examples of reactions of this 
type in this thesis. 
Gold-catalyzed reactions allow simple starting materials to be turned into complex products 
under mild conditions and thence have found their applications also in natural product 
synthesis. The synthesis of (-)-rhazinilam 99 was reported by Nelson in 2006 [82]. One of the 
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key steps in the total synthesis was a gold-catalyzed intramolecular hydroarylation of allene 97 
with the pyrrole ring (Scheme 25). 
 
Scheme 25 
Another example of the use of gold catalysts in the total synthesis of bioactive natural products 
is the synthesis of (+)-Rubiginone B2 102, which belongs to the family of angucyclinone 
antibiotics [83]. The key step in the total synthesis of (+)-Rubiginone B2 was a gold-catalyzed 
[4+2] benzannulation forming two rings of the product in one step (Scheme 26). 
 
Scheme 26 
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1.3 Aims of the thesis 
As described in the introduction, allenic compounds are of interest to organic chemist due to 
the challenges presented by their synthesis but also for their ability to act as versatile building 
blocks in organic synthesis. The aim of this thesis was to study both the synthesis and usability 
of some allenic compounds with following projects: 
1. Development of gold/enzyme –catalyzed transformations of g-allenic acetates.  
Before this thesis work there has been no examples in the literature of gold catalysis working 
in one-pot manner with a lipase. The possibility for this kind of reactivity is tested to prove that 
such reaction can exist. There would be several applications for a synthetic method where gold 
catalysis can be combined with chiral induction from a lipase. 
2. Development of new methodologies towards the synthesis of allenyl carboxylates.  
Allenyl acetates are a group of compounds not widely present in the chemical literature and 
there are limited ways to access these compounds. New methods to access allenyl acetates will 
be  studied  as  there  are  a  number  of  compounds  that  cannot  be  accessed  by  the  literature  
methods. Allenyl acetates are highly reactive compounds and can prove to have interesting 
properties as substrates in cyclization –or transition metal-catalyzed reactions.  
3. The reactivity of allenyl acetates will be tested in the presence of gold catalysts. 
Allenyl acetates are studied as starting materials for the synthesis of indenes. The reactivity of 
allenyl acetates synthesized in this thesis work will be compared to that of propargylic acetates. 
 "
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2 Tandem"enzyme/ gold"–catalysis;"from"racemic"ゎ-allenic"acetates"
to"enantiomerically"enriched"2,5-dihydrofurans"in"one"pot"
2.1 Background and introduction  
Allenes carrying a heteroatom in the g- or く-position are likely to undergo cyclization to 
heterocycles in the presence of a gold catalyst. This type of reaction has been studied 
extensively over the past decade. The first examples of this type of reactivity were reported by 
Marshall in 1992 using a silver catalyst and in 2000 Hashmi tested gold catalysts in a similar 
reaction [84]. They accomplished the cycloisomerization of g-allenyl ketone 103 to substituted 
furans 104 (Scheme 27). This reaction also yielded two different dimeric products 105 and 106 
but subsequently the reaction was optimized by Che to yield only furans 104 [85]. Other 
groups have also contributed to the expanding scope of this reaction [86]. 
 
Scheme 27: Cycloisomerization of g-allenyl ketone by Hashmi [84]. 
The synthesis of furans has a drawback in that the product is achiral. This reduces the potential 
applications of the reaction in natural product synthesis. In 2001 Krause reported a synthesis of 
2,5-dihydrofurans 67 starting from g-hydroxyallenes 66 [64][87]. Earlier similar reactions had 
been catalyzed by HCl gas in chloroform [88], by Amberlyst resins [89] or silver catalysts [90]. 
The acid-catalyzed methods have limitations in their scope as some substrates are acid-labile 
and undergo elimination reactions. Gold catalysts are mild electrophiles which removes the 
possibility of elimination reactions and allows these reactions to be performed at room 
temperature. The cycloisomerization of g-hydroxyallenes 66 (Scheme 28) in presence of a 
AuCl3 furnishes tri-and tetrasubstituted dihydrofurans 67 with complete axis-to-center chirality 
transfer  (the  chirality  is  transferred  from  the  axis  of  the  allene  to  a  new  chiral  center  in  the  
product) in case of alkyl- and alkenyl-substituted g-hydroxyallenes. 
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Scheme 28 
Coordination of the carbophilic gold catalyst to the allenic double bond affords ヾ-complex 107, 
which undergoes 5-endo-cyclization to the zwitterionic j-gold species. Protodeauration leads 
to the dihydrofurans 67 and regenerates the gold catalyst. As the gold catalyst does not 
epimerize the allenic bond the reaction normally proceeds with full stereocontrol (Scheme 29). 
 
Scheme 29 
However, when the allene carries a phenyl or electron-rich aromatic substituent, the allene 109 
or product 2,5-dihydrofuran 112 can epimerize in the course of the reaction (Scheme 30) [91]. 
The epimerization probably proceeds via a benzylic cation intermediate 110 or 113. This can 
be prevented by using additives in the reaction or using a coordinating solvent such as THF, or 
lowering the reaction temperature to –30 °C. The cycloisomerization of g-hydroxyallenes has 
been optimized further so that only 0.05 mol% of the catalyst is actually necessary for full 
conversions [92].  
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Scheme 30 
Similar methodology has been developed for various allenic moieties carrying a heteroatom at 
the g- or く-position (Scheme 31). く-Hydroxyallenes 115 undergo 6-endo-cyclization under 
gold-catalyzed conditions giving dihydropyrans 116 as products [93]. This reaction is slow 
without additives but in the presence of NIS the reaction speeds up tremendously [94]. This 
effect is probably caused by a very rapid iododeauration of a j-gold intermediate by NIS. 
Aminoallenes 117 give pyrrolines 118 under similar reaction conditions [95]. Even thioallenes 
119 give 2,5-dihydrothiophenes 120 in the presence of a gold catalyst [77][96] although 
sulfides are known to coordinate strongly to gold this does not apparently inhibit the reaction 
[97]. 
 
Scheme 31 
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The tendency of allenes with heteroatoms in the g- or く-position to undergo 
cycloisomerizations with axis-to-center chirality transfer in the presence of gold catalysts has 
been extensively used in the synthesis of natural products (Scheme 32). The cycloisomerization 
of g-hydroxyallenes has been used in the synthesis of furanomycin derivatives 121 [98], in the 
total synthesis of (-)-isocyclocapitelline 123 and (-)-isochrysotricine 122 [92] as well as in the 
synthesis of ionomycin calcium complex 124 [99]. Cycloisomerization of く-hydroxyallenes to 
dihydropyrans has been exploited in the synthesis of (R,R,R)- and (3R,5S,9R)-bejarols 125 
[100]. 
 
Scheme 32 
2.1.1 Lipase-catalyzed kinetic resolution 
Lipase-catalyzed kinetic resolution is an efficient tool to access chiral secondary esters and 
alcohols. When a secondary ester 126 has two substituents R1 and R2, of which R1 is medium 
sized or small and R2 is large, an appropriate lipase can hydrolyze only the (R) -enantiomer of 
this ester (Route A, Scheme 33). The same happens in the esterification of a secondary alcohol: 
the (R) -enantiomer of the alcohol reacts whilst the (S) -enantiomer remains unchanged (Route 
C, Scheme 33) [101].  
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Scheme 33 
The selectivity of a certain lipase towards the reactive enantiomer of the substrate is described 
by the selectivity factor. When a racemic starting material (enantiomers R and S) reacts with 
chiral catalyst B* the products R’ and S’ form with reaction rates kR and kS (Equation 1). 
Equation 1 
迎 喋茅蝦 迎嫗 
鯨 喋茅蝦 鯨旺 
The selectivity factor S can be derived from the ratio of the two reaction rates kR and kS. When 
the reaction rates are presented as functions of ee and conversion (C), the selectivity factor can 
be derived as in Equation 2, which is relatively easy to calculate as the ee and conversion can 
be obtained from experimental data (such as GC or HPLC data). The calculation of the 
selectivity factor was proposed by Kagan and Fiaud in 1988 [102].  
Equation 2 
鯨 = 倦迎倦鯨 = ln[1 伐 系(1 + 結結嫗)]ln"[1 伐 系(な 伐 結結嫗)]  
In Equation 2, ee’ is the enantiomeric excess of the product and this is calculated by Equation 
3. 
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Equation 3 
結結嫗 = ([迎嫗] 伐 [鯨嫗])( [迎嫗] + [鯨嫗]) 
g-Hydroxyallenes are desirable starting materials in organic synthesis. This group of organic 
compounds is also special for the reason that they can have axial chirality, as well as a chiral 
center next to the allenic moiety. Ma reported the kinetic resolution of g-hydroxyallenes 128 
with Lipase B from Candida Antarctica (Novozym-435) [103]. They presented twelve 
examples of this reaction with very high yields and ee values (Scheme 34). 
 
Scheme 34 
2.2 Enzyme/gold-catalyzed tandem reactions  
The objective of this project was to develop a reaction that combines enzymatic kinetic 
resolution and gold-catalyzed cycloisomerization in one pot (Scheme 35). In the ideal case, 
racemic g-allenic acetate 130 can be resolved with a lipase to form g-hydroxyallene (R)-131 
with high enantiomeric excess. The forming g-hydroxyallene (R)-131 could be cyclized in the 
same reaction pot in the presence of a gold catalyst to form 2,5-dihydrofuran (R)-132. The 
methodology would permit the transformation of racemic g-allenic acetate 130 to 
enantiomerically enriched 2,5-dihydrofuran (R)-132 in one pot. 
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Scheme 35 
There are two approaches to this methodology: (i) a method with simultaneous addition of the 
enzyme and gold  precatalyst;  both  are  added to  the  reaction  mixture  in  the  beginning of  the  
reaction (Scheme 36, pathway 1). For this method to work the reaction must be started with the 
allenic acetate rac-130 which is hydrolyzed in the course of the reaction to yield 
enantioenriched alcohol (R)-131 which will directly react to the corresponding 2,5-
dihydrofuran (R)-132. (ii) A ‘first lipase then gold catalyst’ sequence where the gold catalyst is 
added only when half of the starting material has reacted (Scheme 36, pathway 2). If this 
method is used, the reaction can also start with racemic g-hydroxyallene rac-131. 
 
Scheme 36 
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There is an additional competing reaction with g-allenic esters in the presence of a gold 
catalyst (Scheme 37). Gagosz and co-workers reported in 2007 an isomerization reaction of g-
allenic esters 133 to 1,3-butadien-2-ol esters 134 [104]. With selected gold catalyst 135 the 
reaction proceeds to completion within five minutes with substrates 133 with unsaturated R1 
and R2 substituents. A similar rearrangement has also been reported for allylic acetates [105]. 
 
 
Scheme 37 
2.2.1 Synthesis of racemic g-allenic acetates 
The practical work was started by synthesizing several racemic g-allenic acetates. The 
synthesis of racemic g-allenic acetate 140a was started from propargylic alcohol 136a (Scheme 
38). The alcohol was first protected as the tetrahydropyranyl ether to give 137a. Deprotonation 
of the terminal alkyne followed by the addition of acetaldehyde gave propargylic alcohol 138a. 
Compound 138a was  then  subjected  to  LiAlH4 reduction giving the SN2’ nucleophilic 
substitution product 139a. This three-step reaction route gives racemic g-hydroxyallenes 139 in 
moderate to high yields (30-76%). This route is convenient as intermediates 137 and 138 do 
not need to be purified. Alcohol 139a is then esterified to g-allenic ester 140a. 
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Scheme 38 
Nine different g-allenic acetates were prepared by varying the size of R1 and  R2 groups. All 
these substrates carry a chiral center g to the acetate group and have no axial chirality (Table 
1).  
Table 1. 
 
139/140 R1 R2 Yield (%)a 139 
(over 3 steps) 
Yield (%)a 140 
a (CH2)5 Me 39 68 
b (CH2)5 n-Pr 50 80 
c Me Me 60 68 
d Me n-Pr 38 50 
e Me n-Oct 76 92 
f Me c-Hex 61 85 
g (CH2)5 c-Hex 58 86 
h (CH2)4 n-Pr 60 81 
i (CH2)5 (CH2)2Ph 50 83 
a) Isolated yield. 
2.2.2 Optimization of lipase-catalyzed kinetic resolution 
Screening of lipases for the kinetic resolution was undertaken by hydrolyzing ester 140a in 
phosphate buffer. The nine lipases in Table 2 are from a lipase basic kit from Sigma Aldrich 
and were used as received. Conversion and ee of the hydrolysis was followed with gas 
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chromatography using a chiral column FS-Lipodex-G octakis(2,3-di-O-pentyl-6-O-methyl)-け-
cyclodextrin which separates the product alcohol 139a to its two enantiomers. Unfortunately, 
ester 140a is not separated with this gas chromatography column. All of the lipases in Table 2 
were selective toward the same enantiomer of the product alcohol. As no internal standard was 
used in these reactions, the GC yield given might have an error or some percentage. This can 
be seen in entry d as the yield is too high for the high enantiomeric excess. 
Table 2. Lipase screening for 140a 
 
Entry Lipase Reaction 
time (h) 
GC yield (%)a 
139a  
ee (%) 
(R)-139a  
a Lipase from Aspergillus 16 9 18 
b Lipase from Candida antarctica 16 54 40 
c Lipase from Candida cylindracea 16 99 - 
d Lipase from Mucor miehei 16 
23 
38 
57 
95 
94 
e Lipase from Pseudomonas  
cepacia 
16 
23 
31 
35 
94 
94 
f Lipase from Pseudomonas 
fluorecens 
16 
23 
27 
34 
99 
93 
g Lipase from Rhizopus arrhizus 16 6 - 
h Lipase from Rhizopus niveus 16 - - 
i Lipase from Hog pancreas 16 15 50 
a) GC yield. Reaction conditions: Acetate 140a (5 mg) was stirred vigorously in phosphate 
buffer (1 ml) and enzyme (5 mg) was added. Aliquots of the reaction mixtures were extracted 
with Et2O and the organic layer was used in gas chromatography analysis. 
 
With acetate 140a three lipases gave >90% enantioselectivities and usable conversions to 
alcohol 139a (entries d, e and f). Next the three most promising lipases: lipases from Mucor 
miehei, Pseudomonas cepacia and Pseudomonas fluorecens were studied further with other 
substrates. 
With 140b, the lipase from Mucor miehei, that had been the most active catalyst with 140a was 
now completely inactive (Table 3, entry a). The seemingly small two-carbon change in the R2 
sidechain was enough to inactivate the enzyme. With lipases from Pseudomonas cepacia and 
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Pseudomonas fluorecens the hydrolysis was considerably slower as compared to 140a; 40 hour 
reaction time was needed for 8-11% conversion (entries b and c). 
Table 3. Lipase screening for 41b 
 
Entry Lipase Reaction 
time (h) 
GC yield (%)a 
(R)-139b  
ee (%) 
(R)-139b 
a Lipase from Mucor miehei 40 - - 
b Lipase from Pseudomonas cepacia 40 11 86 
c Lipase from Pseudomonas 
fluorecens 
40 8 92 
a) GC yield. Reaction conditions: Acetate 140b (5 mg) was stirred vigorously in phosphate 
buffer (1 ml) and enzyme (5 mg) was added. 
 
One more substrate, 140d, was screened with the three lipases to see how the size of R1 affects 
the activity of the enzyme. As expected with similar propyl-chain as with 140b, the lipase from 
Mucor miehei gave again very low conversion (Table 4 entry a). The lipase from Pseudomonas 
fluorecens only gave 8% conversion for the alcohol 139d. However, with 40 hour reaction time 
the lipase from Pseudomonas cepacia gave 40% conversion with very high ee (97%) to the 
alcohol 139d (Table 4 entry b). 
Table 4. Lipase screening for 140d 
 
Entry Lipase Reaction 
time (h) 
GC yield (%)a 
(R)-139d  
ee (%) 
(R)-139d  
a Lipase from Mucor miehei 40 3 - 
b Lipase from Pseudomonas cepacia 40 40 97 
c Lipase from Pseudomonas 
fluorecens 
40 8 92 
a) GC yield. Reaction conditions: Acetate 140d (5 mg) was stirred vigorously in phosphate 
buffer (1 ml) and enzyme (5 mg) was added. 
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From the initial screening (Tables 2-4) two lipases, Pseudomonas cepacia and Pseudomonas 
fluorecens were  chosen for  further  study.  Although the  initial  screening was  carried  out  with  
lipases from Sigma Aldrich the following reactions were carried out with lipases produced by 
Amano Enzymes [106]. Lipases used will be named according to their Amano product names: 
AK Amano (lipase from Pseudomonas fluorecens)  and  PS  Amano  SD  (lipase  from  
Burcholderia cepacia). Although the lipases from Burcholderia cepacia and Pseudomonas 
cepacia are named differently, they stem from the same biological source and thus have similar 
selectivities [107].  
2.2.2.1 Attempts on alcoholysis and esterification 
The alcoholysis of 140a with  lipases  AK  Amano  and  PS  Amano  SD  was  tried.  However,  
although the reaction works well in water it did not work when alcohol was used as a solvent. 
Several different alcohol-organic solvent mixtures were tested as well as alcohol/water-ionic 
liquid mixtures, but the conversions maximized at 7% of alcohol 139a after one week reaction 
time [108].  
The esterification of alcohol 139a was attempted with lipase PS Amano SD. Esterification with 
vinyl acetate as solvent gave the desired (R)-acetate 140a as product but the reaction was very 
slow. The enantioselectivity was not as good as with the hydrolysis. When 57% of the alcohol 
has reacted to the corresponding acetate 140a, the ee of the remaining alcohol 139a was only 
85%. This reaction pathway was not studied further. 
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Table 5. Esterification of 139a with PS Amano SD and vinyl acetate 
 
Sample Time GC yield (%)a 
(R)-140a  
ee (%) 
(S)-139a  
a 1 h 4 - 
b 4 h 6 - 
c 23 h 24 - 
d 2 days 35 37 
e 7 days 57 85 
a) GC yield. To rac-139 (5 mg) in 0.25 ml of vinyl acetate was added lipase PS Amano SD 
with vigorous stirring. Samples for GC analysis were diluted with Et2O and filtrated through 
Celite. 
 
2.2.3 Synthesis of racemic 2,5-dihydrofurans 
To be able follow the tandem-reactions with gas chromatography a racemic sample of each 
cycloisomerization product was needed as a reference. The synthesis of racemic 2,5-
dihydrofurans 141 was optimized with g-hydroxyallene 139a (Table 6). 
Table 6. 
 
Entry Catalyst Cat. 
(mol%) 
Solvent Time Yield (%)a 
141a 
a HAuCl4 5 H2O:THF (100:1) 1 h 46 
b NaAuCl4 5 H2O:THF (100:1) 45 min 54 
c AuCl3 3 CH2Cl2 28 h 63 
d AuBr3 3 CH2Cl2 17 h 54 
e AuBr3 2 [bmim][PF6] 48 h 39 
f (IPr)AuCl/AgOTf 5 CH2Cl2 1 h 95 
g (PPh3)AuCl/AgOTf 5 CH2Cl2 24 h 60 
a) Isolated yield. 
 
The reactions in Table 6 were run until the starting material had disappeared. However, the 
reaction did not yield the desired product selectively in every case. The most efficient catalyst 
for the cycloisomerization was a gold(I)-carbene complex Au(IPr)Cl with silver(I)-triflate as 
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co-catalyst. Within one hour reaction time this catalyst system yielded 2,5-dihydrofuran 141a 
with a 95% isolated yield (Table 6, entry f). Reference compounds 141a-j (Table 7) were all 
prepared with this methodology. The starting material for 141j had been prepared by another 
group member [109]. Compound 141c was too volatile to be fully analyzed but on TLC the 
reaction went to full conversion. 
Table 7. 
 
141 R1 R2 Yield (%)a 141 
a (CH2)5 Me 95 
b (CH2)5 n-Pr 47 
c Me Me 100b 
d Me n-Pr 100b 
e Me n-Oct 98 
f Me c-Hex 96 
g (CH2)5 c-Hex 98 
h (CH2)4 n-Pr 90 
i (CH2)5 (CH2)2Ph 67 
j (CH2)5 i-Bu 87 
a) Isolated yield, b) Full conversion on TLC but the product was too volatile to isolate with 
reproducible yields. 
2.2.4 Optimization of the tandem reaction 
As the lipase catalyzed kinetic resolution gave promising results in aqueous solutions (Tables 
2-4) and some reactivity towards the 2,5-dihydrofuran product was obtained with water-soluble 
gold catalysts (Table 6, entries a and b), it was decided at this point that some initial tests with 
the tandem catalysis should be carried out. It was decided that the simultaneous addition of 
gold- and lipase catalysts was most interesting to try first. 
Optimization of the tandem reaction was carried out with substrates 140a and 140b. Initially, 
the two lipases PS Amano SD and AK Amano were used in the optimization but PS Amano 
SD showed higher selectivity towards the substrates 140a and 140b. In Table 6 there are two 
gold catalysts that are water soluble. These are the chloroauric derivatives HAuCl4 and 
NaAuCl4
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product. However, they could be used in aqueous solution and it was easy to prepare stock 
solutions of these water-soluble catalysts. From the two catalysts chloroauric acid HAuCl4 
gave slightly higher conversions to 141a in the first tandem reaction attempts so this catalyst 
was chosen for further optimization. Tetrahydrofuran was used as co-solvent as it improves the 
solubility of the substrate to the aqueous reaction mixture. 
In the presence of 10 mg of the lipase (with 10 mg of starting material 140a) and 1 mol% 
HAuCl4, substrate 140a afforded 2,5-dihydrofuran 141a with high enantiomeric excess (>90%) 
but only <30% conversion after 48 hours at room temperature (Table 8, entry a). Increasing the 
temperature to +50 °C gave a similar result after 24 hours but some unidentified byproducts 
also formed in the reaction mixture (entry b). When the amount of lipase was increased to 100 
mg, conversion to 141a reached 50% but the stereoselectivity suffered (entry c). No reaction at 
all took place when 10 mol% of gold catalyst was used (entry d) which means that the ratio of 
enzyme to gold precatalyst strongly affects the conversion of the acetate 140a to alcohol 139a. 
Table 8. Effect of the amount of gold catalyst and temperature for conversion to 141a 
 
Entry Lipase (mg) HAuCl4 
(mol%) 
t (h) GC yield (%)a 
(R)-141a 
ee (%) 
(R)-141a 
a 10 1 48 25-30 90-95 
b 10 1 24 b 25-30 90-95 
c 100 1 24 45-50 55-60 
d 10 10 24 0 - 
a) GC yield b) Reaction temperature: +50 °C. Reaction conditions: 140a (10 mg) in 2 mL of 
phosphate  buffer  (pH  7)  and  50  たL  of  THF  was  treated  with  PS  Amano  SD  (30000  U)  and  
aqueous HAuCl4 solution at room temperature. 
 
As the reactions in Table 8 were tested several times, the reaction did not always yield exactly 
the same GC yield and ee for the product 141a.  This  is  the  reason  for  the  percentage  unit  
difference given in Table 8 for the results (for example entry a GC yield 25-30%). For the next 
reactions the amount of gold precatalyst was decreased to 0.5 mol% and these reaction 
conditions were tested with different amounts of the enzyme. With 10 mg of lipase (Table 9, 
entry a) a high ee of 96% was obtained for 141a but only at 27% conversion. Larger amounts 
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of the lipase (entries b and c) resulted to higher conversions but lower ee values of 141a. 
However, this was not observed for the slightly bulkier propyl-substituted 140b which gave 
high conversion 45% with 94% ee to the 2,5-dihydrofuran 141b (entry d). 
Table 9. Optimizing the amount of lipase for 140a and 140b 
 
Entry 140 Lipase 
(mg) 
HAuCl4 
(mol%) 
Time 
(h) 
GC yield (%)a 
(R)-141 
ee (%) 
(R)-141 
a 140a 10 0.5 24 27 96 
b 140a 50 0.5 48 35 87 
c 140a 100 0.5 48 46 63 
d 140b 100 0.5 48 45 94 
a) GC yield. Reaction conditions: 140 (10 mg) in 2 mL of phosphate buffer (pH 7) and 50 たL 
of THF was treated with PS Amano SD (30000 U) and aqueous HAuCl4 solution at room 
temperature. 
 
2.2.5 Scope and limitations of the tandem reaction  
Having discovered that the enzyme and gold precatalyst do not compromise each other as long 
as the amount of gold catalyst is kept low, the tandem reaction was tested with g-allenic 
acetates 140a-j (Table 10). The reaction works well with substrates that have straight alkyl 
chains as R2 (entries 1, 2, 3, 4 and 7). However when R2 is branched either at the g or く carbon, 
the reaction gives very low, or no conversion at all. A phenyl substituent further away from the 
ester (entry 8) gives low, 4% conversion of 141i. If the branching is closer to the acetate, such 
as a cyclohexyl group (entries 5 and 6) or an i-butyl (entry 9), no reaction occurs. The lipase is 
very sensitive to any steric hindrance in R2. 
The reaction is more tolerant towards R1 substituents, both five- and six-membered rings are 
well tolerated as in 140a, 140b and 140h which all give good ee values, 88-95%, and yields to 
141 (entries 1, 2 and 7). Acyclic R1 groups are also well tolerated as seen with 140d and 140e 
and these substrates give the highest enantioselectivities, up to 99%, for 141 (entries 3 and 4). 
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Table 10. 
 
Entry           rac-140          (R)-141 
yield (%) / ee (%) 
          (S)-140 
yield (%) / ee (%) 
1 
 
 
 
 
 140a R1= (CH2)5, R2= Me 141a yield 28%a ee 86% 140a yield 31%a ee 93% 
 
2 
 
 
 
 
 
 
 
 140b R1= (CH2)5, R2= nPr 141b yield 45%a ee 95% 140b yield 40%a ee 
>95% 
3 
 
 
 
 
 140d R1= Me, R2= n-Pr 141d yield 46%b ee 99% 140d yield - ee - 
4 
 
 
 
 
 
 
 140e R1= Me, R2= n-Oct 141e yield 50%a ee 98% 140e yield 36%a ee 95% 
5 
 
 
 
 
 140f R1= Me, R2= c-Hex no reaction no reaction 
6 
 
 
 
 140g R1= (CH2)5,  
R2= c-Hex 
no reaction no reaction 
7 
 
 
 
 
 140h R1= (CH2)4, R2= n-
Pr 
141h yield 38%a ee 88% 140h yield 33%a ee 
>95% 
8 
 
 
 
 
 140i R1= (CH2)5 
R2= (CH2)2Ph 
141i yield 4%b ee - 140i yield - ee - 
9 
 
 
 
 140j R1= (CH2)5, R2= i-Bu no reaction no reaction 
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a) isolated yield b) GC conversion 
Reaction conditions for test reaction: 140 (10 mg) in 2 mL of phosphate buffer (pH 7) and 50 
たL of THF was treated with PS Amano SD (30000 U) and aqueous HAuCl4 solution (0.5 
mol%) at room temperature for 24-48h. 
Reaction conditions for isolated yield: 140 (0.5 mmol) in 15 mL of phosphate buffer (pH 7) 
and 0.1 mL of THF was treated with PS Amano SD (30000 U) and aqueous HAuCl4 solution 
(0.5 mol%) at room temperature for 48 h. 
 
The ee of the remaining acetate (S)-140 was  determined  in  each  case  by  hydrolyzing  the  
acetate 140 in methanol with potassium carbonate and analyzing the product (S)-alcohol 139 
with gas chromatography (Scheme 39). 
 
Scheme 39 
Some of the spirocyclic products 141 had interesting odour-properties as many of them had 
distinctive and strong sweetish smells. This behavior is known for spirocyclic ethers which are 
used in perfume industry and the property is likely to stem from the osmophoric oxygen atom 
in the 2,5-dihydrofuran ring [110]. 
2.2.6 Summary 
This project was the first example of an enzyme/gold-catalyzed tandem reaction. Some of this 
work was published in 2009 [111]. It was shown that the two catalysts tolerate each other well. 
The reaction works well for a set of racemic g-allenic esters yielding the enantiomerically 
enriched (R)-2,5-dihydofurans 141 with 28-50% yield and 86-99% ee and the remaining 
enantiomerically enriched (S)-acetates 140 with 31-40% yield and 93-95% ee.  However,  the  
drawback is that the lipase used, PS Amano SD, is highly sensitive to any steric hindrance on 
the racemic acetate and this sets limitations to the scope of the reaction. 
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3 SN2’"approach"to"the"synthesis"of"allenyl"acetates"
3.1 Introduction to the synthesis of allenyl acetates 
The first report in the literature of allenyl acetates is from 1959 [112]. Saucy and co-workers 
prepared aldehyde 145 from the propargylic acetate 142, by rearranging it to the corresponding 
allenyl acetate 143 and then hydrolyzing the acetate to enol 144 that spontaneously enolizes to 
the corresponding aldehyde 145 (Scheme 40). Quite harsh conditions were used for the acetate 
rearrangement: the reaction mixture was heated to 90 °C for 1.5 h with acetic acid as solvent. 
 
Scheme 40 
Verny and Vessière studied propargylic transpositions and reported two allenyl acetates in 
1969 [113]. They discovered two different methods that led them to the allenyl acetate moiety. 
Firstly ethyl 2-acetoxybut-3-ynoate 146 rearranges to the corresponding allene 147 in aqueous 
potassium carbonate solution. This then undergoes a [2+2] cylization spontaneously at room 
temperature to give the dimer of the allene with a cyclobutane structure 148 (Scheme 41). 
 
Scheme 41 
Verny and Vessière also tried an silver(I)acetate-catalyzed rearrangement of propargylic 
acetates 149. This silver-promoted rearrangement gave allenyl acetate 150 as product. This 
method later became the most frequently used reaction route to allenyl acetates (Scheme 42). 
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Scheme 42 
The silver-catalyzed rearrangement of propargylic acetates has been widely used in the 
synthesis of allenyl acetates. In 1973 [114] Cookson used silver perchlorate in the synthesis of 
one allenyl acetate, and the same year Schmid [115] undertook an extensive investigation on 
the mechanism and kinetics of the reaction. These studies were followed by a reaction scope 
study by Schiavelli [116] in 1977. In this report six allenyl acetates were made but Schiavelli 
mentions that a phenyl group as a substituent in the R1 or  R2 position is not tolerated (Scheme 
43). 
 
Scheme 43 
There is one report of a copper-catalyzed rearrangement of propargylic acetates by Parsons in 
1980 [117] (Scheme 44). This is a chemoselective diene/allene synthesis from propargylic 
acetates 154 controlled by catalyst choise. In Parson’s work there are only fully saturated 
substituents at the R1 and R2 positions.  
 
Scheme 44 
In 2000 Lipton and co-workers [118] reported a novel synthesis of allenyl acetates 157 
(Scheme 45). They performed the allenyl acetate synthesis by treating acetylenic ketones 156 
with cuprate reagents and trapping the resultant enolates with acetic anhydride. The enyne-
allene core underwent a cyclization after lithiation to give substituted indanones 159. 
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Scheme 45 
Uemura and co-workers (2003) reacted propargylic carboxylates 161 under ruthenium-
catalyzed conditions with alkenes 162 with the object of making cyclopropanes 163. Whilst 
testing different transition metals as catalysts they made some allenyl acetates 160 as well 
[119]. Surprisingly, the rhodium catalyst promoted allene formation was very efficient 
(Scheme 46). 
 
Scheme 46 
Although in Uemura’s report platinum catalysis did not provide any allenyl acetate under the 
reaction conditions, Malacria indicated in 2004 [120] that a PtCl2-catalyzed tandem [3,3]-
rearrangement of enyne acetate 164 could lead to the formation of intermediate allenyl acetate 
165 (Scheme 47). 
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Scheme 47 
There are limited examples of AgBF4- and AgClO4-catalyzed rearrangements of propargylic 
acetates bearing an aromatic substituent. One example of such a rearrangement from Zhang 
[121] and three compounds from Nolan [122] are known, both from 2006 (Scheme 48). Zhang 
and co-workers were investigating the gold-catalyzed rearrangement of propargylic acetate 168 
to g-alkylidene or benzylidene-く-diketones 170 while Nolan and co-workers studied gold-
catalyzed intramolecular hydroarylation that gives mixtures of indenes 173 and 174 from 
allenes 172.  
 
Scheme 48 
The objective of our own project was to study the synthesis of allenyl acetates. Structure 175 in 
Scheme 49 is an allenyl acetate where R4 is  a  proton  and  either  R1 or  R3 is an unsaturated 
substituent. These were of particular interest as such compounds are completely absent in the 
chemical literature. There are examples of R1 as  an  sp2 substituent,  but  in  these  cases  R4 is 
always a saturated alkyl group. On the other hand there are also examples of R4 being a proton 
but again there is no unsaturation in R1 or R2.  
49 
 
 
Scheme 49  
3.2 Testing literature methods in the synthesis of allenyl acetates 
As summarized in the introduction, allenyl acetates are often obtained as rearrangement 
products from propargylic acetates. The viability of the literature rearrangements was first 
tested with all-saturated 1-ethynylcyclohexyl acetate 176a (Table 11). Often a mixture of 
allene 177a and diene 178a was obtained from this reaction (Entries a-d and f). Diene product 
178a can arise from the allene 177a via a 1,3-proton shift. The two products 177a and 178a 
could not be separated by flash column chromatography so their ratio was determined by 1H 
NMR spectroscopy. Only AgBF4 gave allene 177a as the sole product (entry g). Another 
silver(I) catalyst, AgOTf, gave a good selectivity to the corresponding diene 178a (entry d); the 
reactivity of AgOTf might also be due to the presence of free acid in the reagent bottle as the 
condition of the catalyst was not studied. Gold catalysts always yielded mixtures of the two 
products, though the favored product with gold catalysts was allene 177 (entries a-c). 
Table 11 
 
Entry Catalyst Cat. (mol%) Time Yield (%)a 177a:178a 
a  AuCl3 (5) 15 min 60  92:8 
b Au(PPh3)Cl: AgBF4 (5:5) 10 min 77  95:5 
c Au(IPr)Cl: AgBF4 (5:5) 10 min 64  92:8 
d AgOTf (10) 3 h 73  11:89 
e AgOAc (10) 24 h - - 
f AgNO3 (10) 24 h 47  49:51 
g AgBF4 (10) 4 h 94  100:0 
a) Isolated yield. Screening conditions: To 176a (1 mmol, 0.16 g, 100 mol%) in 5 ml of freshly 
distilled CH2Cl2 was added catalyst at room temperature. Reaction was quenched after time 
indicated by filtration through celite and product was purified with flash column 
chromatography. 
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The limitations and scope of the silver-catalyzed rearrangement were studied with AgBF4 as 
catalyst (table 12). The rearrangement of 176 to allenyl acetate 177 works well only for 
substrates with fully saturated sidechains R1 and  R2 (entries  a-c).  With  an  alkene  g to  the  
acetate, the acetate group prefers to undergo a [3,3]-rearrangement to the alkene (entry d) 
forming enyne products (E/Z) -179. When an aromatic substituent is placed as R2 (entry e) no 
products can be isolated at all but a very complex reaction mixture forms in short reaction time. 
Table 12 
 
Substrate 176 a-e Time Yield and product (%)a 
a 
 
4 h 
 
94% 177a 
b 
 
1 h 
 
71% 177b 
 
c 
 
1 h 
 
 64% 177c 
 
d 
 
2 h 
 
 
68% 1:1 mixture 
enynes E/Z -179 
e 
 
 
5 min 
 
 
starting material consumed,  
no isolable products 
a) Isolated yield. Experimental procedure: To acetylene 176 (1 mmol, 100 mol%) in 5 ml of 
freshly distilled CH2Cl2 was added AgBF4 (10 mol%) at room temperature. Reactions were 
quenched after time indicated by filtration through Celite and the product was purified with 
flash column chromatography. 
 
 
As the rearrangement with AgBF4 failed with aromatic substrate 176e it was tested with other 
literature methods (Table 13). Allenyl acetates have been prepared with gold- and copper 
catalysts [117,119]. However, with 176e these methods did not yield the desired allenic 
products but  copper(I)-chloride gave an addition product 180 as only isolable product (entry a) 
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and the gold catalyst Au(IPr)Cl gave indene 181 as  the  only  isolable  product  (entry  b).  The  
reaction of entry a is known, this was first reported in 1975 [123]. 
Table 13 
 
Entry Catalyst and reaction conditions Yield and product (%)a 
a CuCl (10 mol%)   
benzene, reflux, 30 min 
30% 180 
 
 b Au(IPr)Cl (5 mol%) 
CH2Cl2, r.t. 5 min 
 
                           38% 181 
a) Isolated yield. Experimental procedure is described in detail in the Experimental Section.  
 
 
Out of curiosity the CuCl-catalyzed reaction (entry a Table 13) was also tried with two other 
propargylic acetates 176a and 176f, but no addition product similar to 180 could be isolated. In 
fact only starting material was isolated after a 30 min-2 hour reflux in both cases (Scheme 50). 
OAc
AcO
CuCl (10 mol%)
benzene, reflux
No reaction
176a
176f
OR
 
Scheme 50 
As a conclusion literature methods were tested in the synthesis of allenyl acetates (Scheme 49) 
but they failed to deliver the desired reactivity for the allenyl acetate 175 when R1 or R2 is an 
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sp2 unit. It was concluded that it would be necessary to develop new methodology for the 
synthesis of allenyl acetates. 
3.3 Allenyl acetates from propargylic diacetates 
A new method was envisioned for the preparation of allenyl acetates. SN2’ nucleophilic 
substitution of propargylic electrophiles is a common way to obtain allenes and the substrate 
can be a propargylic acetate where the acetate acts as a leaving group [26]. The only change 
that should be made to this reaction would be to use a propargylic diacetate 182 instead of a 
monoacetate (Scheme 51). SN2’ nucleophilic substitution of diacetate 182 should give allenyl 
acetate 183 as product. 
 
Scheme 51  
3.3.1 Synthesis of propargylic diacetates 
At the inception of this project there were only two examples in the literature of propargylic 
diacetates. One example from 1978 [124] by Wille and Schwab is 185 (Scheme 52). They 
started from propargylic aldehyde 184 and added acetic anhydride in the presence of a catalytic 
amount of sulphuric acid. No solvent was used in this reaction. 
 
Scheme 52 
The second example was from 1999 [125] when Havelková and co-workers, while making 
trialdehydes, obtained one propargylic gem-diacetate 187 as byproduct (Scheme 53). In this 
case the diacetate was also made starting from a propargylic aldehyde 186 but this time ZnBr2 
was used to catalyze the reaction. Havelková also mentions in the report that the diacetate 187 
was a remarkably stable compound. 
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Scheme 53 
In each publication only one propargylic diacetate was reported. However, there are a number 
of examples of other diacetates in the literature. These are always made from the corresponding 
aldehydes with Lewis or Brønstedt acid catalysis [126].  
3.3.1.1 Synthesis of propargylic aldehydes 
Propargylic aldehydes 186 were prepared as starting materials for the synthesis of propargylic 
diacetates. There are several ways to make these compounds. In the beginning of this project a 
two-step, one-purification synthetic route was used (Scheme 54). First, a terminal acetylene 
188a was deprotonated with n-BuLi followed by addition of paraformaldehyde, which gave 
propargylic alcohol 189a as product. The crude product alcohol could be oxidized to the 
corresponding aldehyde 186a with manganese dioxide. A large excess of manganese oxide (15 
equivalents) was needed for complete conversion but the reagent could be used several times 
after  drying  it  in  the  oven  (80  °C)  overnight.  The  same  manganese  oxide  was  used  up  to  5  
times without loss of activity. 
 
Scheme 54 
There is, however, an easier route from Larsen and co-workers to make propargylic aldehydes 
that takes only one reaction step from terminal acetylene and often gives very high conversion 
to the product (Scheme 55) [127]. In this reaction route the deprotonation of terminal acetylene 
188a is followed by addition of dimethylformamide which is then hydrolysed with KH2PO4 to 
give directly the propargylic aldehyde 186a. According to the authors it is important to do the 
hydrolysis in inverse order. The reaction mixture has to be added to a solution of aqueous 
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KH2PO4 and not vice versa, so that the leaving group (lithiated dimethylamine LiNMe2, 
proposed by the authors) does not react with the desired product.  
 
Scheme 55 
Using these two methods eight propargylic aldehydes 186 with  different  unsaturated  R1 
substituents were synthesized (Table 14). 
Table 14 
 
189/186 R1 189 Yield (%)a 186 Yield (%)a 
via method 1 
186 Yield (%)a 
via method 2 
a Ph 90 95 97 
b 4-MeC6H4 71 82 - 
c 3-MeC6H4 99 70 - 
d 4-MeOC6H4 71 79 - 
e 1-cyclohexene 66 56 - 
f (CH2)2Ph 63 77 - 
g phenanthrenyl 64 66 - 
h 4-t-BuC6H4 - - 95 
a) Isolated yield. 
3.3.1.2 Optimization of diacetate synthesis 
Literature methods for the preparation of diacetates from aldehydes often use Lewis acids or 
Brønstedt acids as catalysts. Quite early on it was discovered that if an excess of acetic 
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anhydride was used in the reaction it co-eluted with the product diacetate during column 
chromatography so a goal was set of using only one equivalent of the anhydride. After testing 
six different catalysts (Table 15) iron(III)-chloride gave the best yield for the diesterification. 
With 10 mol% of FeCl3 an isolated yield of 83% of the diacetate product 187a was obtained 
(entry d). In Table 15 also smaller amounts of iron(III)-chloride could be used successfully 
(entries g and h) but typically on larger scale (>1 g) the reaction needs 10 mol% of the catalyst 
to give high conversion to the product. Heating up the reaction mixture (entry i) had no 
remarkable effect on the conversion. 
Table 15 
 
Entry Catalyst GC yield of 187a (%) 
(isolated) 
a AlBr3 (10 mol%) 0 
b AlCl3 (10 mol%) 46 
c Al(OiPr)3 (10 mol%) 0 
d FeCl3 (10 mol%) 85 (83) 
e SnCl2 (10 mol%) 0 
f H2SO4 (10 mol%) 3 
g FeCl3 (2 mol%) 56 
h FeCl3 (5 mol%) 91 
i FeCl3 (10 mol%) reflux 88 
Screening conditions: Catalyst (2-10 mol%) was dissolved in CH2Cl2 (2 ml) at room 
temperature and aldehyde 186a (50 mg, 0.38 mmol, 100 mol%) was added in 0.25 ml of 
CH2Cl2 followed by acetic anhydride (36 µl, 0.38 mmol, 100 mol%). After 1 h the reaction was 
quenched with saturated aqueous NaHCO3 and an aliquot of dried organic phase was used for 
GC analysis. 
 
3.3.1.3 Scope of diacetate synthesis 
The scope and limitations of the diacetate synthesis were studied (Table 16). In total, ten 
different diacetates 187 were synthesized. Among different R1 substituents only the p-
methoxyphenyl group gave a clearly lower yield in the reaction. The reason for this might be 
due to electronic deactivation arising from the electron-donating methoxy group in the para-
position (entry d). Anhydrides of pivalic and benzoic acids were tested in the reaction as well 
(entries i and j); they both gave the desired dicarboxylate, only in lower yield than when acetic 
anhydride was used.  
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Table 16 
 
Entry R1 R2 Time (h) Yield 187a-j (%)a  (brsm) (%)b 
a Ph Me 1 83            (97) 
b 4-MeC6H4 Me 2 63               (89) 
c 3-MeC6H4 Me 3 72                       
d 4-MeOC6H4 Me 24 26               (54) 
e 1-cyclohexene Me 24 49               (70) 
f (CH2)2Ph Me 5 62               (79) 
g phenanthrenyl Me 18 51               (77) 
h 4-t-BuC6H4 Me 20 60 (76) 
i Ph tBu 0.5 46                       
j Ph Ph 6 20                       
a) Isolated yield. b) Isolated yield based on recovered starting material. 
 
3.3.2 SN2’ nucleophilic substitution of propargylic diacetates with a cuprate 
SN2’ nucleophilic substitution was first tested with propargylic diacetate 187a. Initial reactions 
were tried with a Gilman cuprate [128] as an alkylation reagent. The reagent was prepared 
from both copper(I)-iodide and copper(I)-cyanide (Table 17, entries a and b) but both gave 
only traces of the desired allene 190a. Next magnesium cuprates were screened with LiBr 
included as an additive. With methyl Grignard the results were not very promising as the yields 
were around 30% (entries c and d). However, when the Grignard reagent was changed to 
ethylmagnesium bromide (entry f), 52% of allene 190b was  obtained.  The  solvent  had  a  big  
role with the ethyl Grignard reaction, as in Et2O the yield was only 35% of 190b (entry e). The 
best results were obtained when the amount of cuprate used was reduced by half to 2.5 
equivalents and this was applied to the LiBr additive as well (entries g and h). Smaller amounts 
of the cuprate led to low conversions. Reducing the temperature to –10 °C gave 88% yield of 
the desired allene 190b (entry h). 
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Table 17 
 
Entry Alkylation 
reagent (equiv) 
CuX 
(equiv) 
Additive 
(equiv) 
Solvent T (°C) yield (%)a 
190 a or b 
a MeLi (3.2) CuI (1.6) - Et2O –78b traces 
b MeLi (5.3) CuCN (5.4) - Et2O –78b traces 
c MeMgBr (2.4) CuI (2.5) LiBr (2.5) THF 0 30 
d MeMgBr (2.4) CuCN (2.5) LiBr (5.0) THF 0 24 
e EtMgBr (4.8) CuI (5.0) LiBr (5.0) Et2O 0 35 
f EtMgBr (4.9) CuI (5.0) LiBr (5.0) THF 0 52 
g EtMgBr (2.4) CuI (2.5) LiBr (2.5) THF 0 72 
h EtMgBr (2.4)c CuI (2.5) LiBr (2.5) THF –10 88 
a) Isolated yield. b) Reaction started at 0 °C and cooled down to –78 ºC before addition of 
starting material. c) Grignard reagent as 1 M solution MTBE instead of 3 M solution in Et2O as 
in the other attempts with EtMgBr. 
 
As a control experiment the SN2’ reaction was tested once without the copper reagent. When 
ethylmagnesium bromide was reacted with propargylic diacetate 187a, no allenyl acetate 190b 
formed but a mixture of other products was obtained. 
3.3.2.1 Scope of SN2’ reaction 
The scope and limitations of the cuprate-mediated SN2’ reaction were studied. Firstly, different 
Grignard reagents were tested (Table 18, entries a-c and l-n). The reaction works well with 
unbranched saturated alkyl Grignards (entries a-c) although methyl Grignard gives lower yield 
(30%, entry a). Unfortunately, branched (entry l) or unsaturated (entries m and n) Grignard 
reagents do not give any of allene 190.  The  reason  for  this  behaviour  could  lie  in  the  steric  
hindrance caused by branched Grignard reagents containing isopropyl or phenyl group. Even 
when the reaction mixture was warmed to ambient temperature only starting material was 
recovered. Seven different R1 substituents were tested with ethylmagnesium bromide and they 
all gave moderate to good yields (entries b and f-k). Pivalate and benzoate carboxylates were 
also well tolerated (entries d and e). 
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Table 18 
 
Entry R1 R2 Grignard (R3) Yield 190a-n (%) a  
a Ph Me MeMgBr 30               
b Ph Me EtMgBr 88               
c Ph Me n-BuMgCl 65               
d Ph tBu EtMgBr 78               
e Ph Ph EtMgBr 74               
f 4-MeC6H4 Me EtMgBr 81               
g 3-MeC6H4 Me EtMgBr 46                
h 1-cyclohexene Me EtMgBr 67               
i (CH2)2Ph Me EtMgBr 51                
j phenanthrenyl Me EtMgBr 51               
k 4-t-BuC6H4 Me EtMgBr 53 
l Ph Me i-PrMgCl - 
m Ph Me PhMgCl - 
n Ph Me H2C=CHMgCl - 
a) Isolated yield. 
 
The reactions in Table 18 were mostly carried out on a 200-500 mg scale. The best yields for 
the SN2’ reactions were obtained when the reaction was scaled up to 1-1.5 grams. Scale-up of 
the reactions was somewhat compromised by the instability of the compounds 190 a-k. Even 
when the allenyl acetates were prepared to be used in further reactions it made no sense to 
prepare them in large amounts. At room temperature the allenyl acetates 190 started to 
decompose in matter of hours and even in the freezer in a couple of days. The allenyl acetates 
190 did not decompose to one identifiable compound but gave a very complex decomposition 
mixture. 
3.3.3 Lipase-catalyzed kinetic resolution of allenyl acetates 
The synthesis and kinetic resolution of axially chiral allenes was discussed in Chapter 1. There 
are methods to enzymatically resolve allenic acids with Porcine pancreatic lipase [51,52]. 
Lipases from Pseudomonas fluorecens and Burcholderia cepacia were tested initially with 
substrate 190b. The lipase from Burcholderia cepacia (will be from now on referred to as PS 
Amano SD) gave high ee values already in the initial tests. In Table 19 is described the short 
optimization of the reaction. The reaction was first tried with 100 mg of enzyme vs 100 mg of 
starting material rac-190b (entry 1 in table 19) but only 70% ee was obtained with 31% yield 
59 
 
of allenyl acetate (S)-190b. With a larger amount of the enzyme (400 mg vs 100 mg allenic 
acetate) an ee of 85% was obtained in 1.5 hours and an ee of 88% in 2 hours reaction time for 
the allenyl acetate (S)-190b (entries b and c). A small amount of THF was used in the reactions 
to facilitate the substrate to dissolve. The hydrolysis product, alcohol 191, tautomerizes to the 
corresponding aldehyde 192. 
Table 19  
 
 
Entry Time PSb  ee (%) 
(S)-(+)-190b 
Yield (%)a 
 (S)-(+)-190b 
Yield (%)a  
E/Z-192 
a 3 h 15 min 100 mg 70 31 35 
b 1 h 30 min 400 mg 85 45 54 
c 2 h 400 mg 88 32 65 
a) isolated yield. b) Lipase PS Amano SD, amout of lipase per 100 mg of substrate rac-190b. 
 
The kinetic resolution with PS Amano SD was tested altogether with four different allenyl 
acetates (Table 20). Changing the acetate group on allene 190 to pivalate or benzoate stops the 
reaction completely (entries c and d), as the active site of the enzyme is too small for such large 
carboxylates. What was surprising, however, is that changing the R1 group of the allenyl 
acetate 190 from phenyl to p-tolyl caused a dramatic descent in the ee of the allenyl acetate (S)-
190 (entry b). This reaction seems to be very sensitive to substitution on R1 of 190. 
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Table 20 
 
Entry R1 R2 Yield 190 (%)a ee 190 (%) Aldehyde (%)a 
a Ph Me 32    ((S)-190b) 88      (190b) 65         (192)             
b p-tolyl Me 25    ((S)-190f) 45      (190f) 56         (193)             
c Ph tBu - - - 
d Ph Ph - - - 
a) isolated yield.  
3.4 Towards a catalytic method for the synthesis of allenyl acetates 
It was proved that allenyl acetates can be synthesized from propargylic diacetates using a 
cuprate reagent derived from copper(I)-iodide and Grignard reagents. For good conversions the 
reaction needed 2.5 equivalents of the cuprate. It was appealing to attempt to develop the 
reaction further towards a catalytic variant. Using a catalytic amount of a transition metal 
catalyst  would  be  first  of  all  more  economical,  but  also  it  would  have  the  advantage  that  
asymmetric ligands could be tested in the reaction to induce chirality to the product allene.  
3.5 Attempts with copper-catalyzed SN2’ reaction 
The search for a catalytic SN2’ reaction was started with copper catalysts as there are several 
examples of this type of tranformation in the literature [42,45]. Different catalysts, solvents, 
and ligands were tested. Additionally different alkylation reagents (AlR3, ZnR2 and RMgBr) 
were tested in the copper-catalyzed reaction, but only Grignard reagents gave the desired 
product 190 (Scheme 56). 
 
Scheme 56 
From the beginning it was clear that the biggest problem in this reaction was its 
chemoselectivity. The reactions were followed with gas chromatography and many byproducts 
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were visible in the GC data of the crude reaction mixtures. To get a better insight into the 
reaction some of these, when using ethyl-Grignard reagent, were isolated and analyzed giving 
the identities described in Figure 1. There is no complete set of analytical data for any of the 
byproducts as they could not be isolated cleanly, but these are the structures deduced from 
NMR data.  
 
Figure 1 
The reaction of diacetate 187 can proceed via SN1  or  SN2’ nucleophilic substitution giving 
compounds 194 or 190. The reactive complex 198 formed from the copper catalyst and ethyl-
Grignard reagent can react to form a copper hydride 199 via"く-elimination. The copper hydride 
could further reduce both 190b and 194 yielding terminally unsubstituted allene 195 and 
alcohol 197. Propargylic acetate 194 could also react again with cuprate 198 to form 
disubstituted allene 196 (Scheme 57).  
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Scheme 57 
The organocuprate-mediated SN2’ reaction in Chapter 3 to form allenyl acetates 190 from 
diacetates 187 was tested once without the copper reagent. In the presence of Grignard reagents 
it only gave a complex product mixture and no allenyl acetate 190. This might be the problem 
in the catalytic reaction as well, as there will be ‘free’ Grignard reagent in the reaction mixture 
which can react directly with diacetate 187. 
Different pre-catalysts were tested incuding: CuBr•SMe2, Cu(OAc)2, Cu(TC), CuI, CuCl, 
CuBr, CuBr2, CuCl2, [Cu(MeCH)4][BF4] and Cu(OAc)2•H2O. From these catalysts CuBr•SMe2 
showed better selectivity towards allene 190 than the rest, although the selectivity was highly 
dependent on solvent, temperature and ligand. The best ligand donors regarding conversion 
and selectivity to allene 190 seemed to be phosphines, and PCy3 was mostly used as the ligand 
in this screening. The solvent dependency gave no clear trend, but generally the best 
conversions were observed with CH2Cl2. The screening of different reaction conditions was 
followed with gas chromatography, and up to 81% GC conversions were recorded with the 
‘optimized’ conditions. When this reaction was scaled up from 50 mg to 100 mg of substrate 
187, only up to 37% isolated yields were obtained (Scheme 58). The product was isolated after 
quenching the reaction with saturated aqueous NH4Cl solution and purified with flash column 
chromatography.  
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Scheme 58 
As the reaction seemed too sensitive to be scaled up to useful quantities, this approach was 
abandoned and different transition metals were tested instead. The copper-catalyzed reaction 
was tested some 250 times varying the ligand, catalyst, solvent and temperature as carousel and 
automated GC techniques allowed fast screening of reaction conditions. Additionally, 30 chiral 
ligands were tested with this reaction but the allenic acetates 190 obtained were always 
racemic. 
3.6 Nickel-catalyzed SN2’ reaction 
As the copper-catalyzed approach gave no desired results, additional transition metal pre-
catalysts were tested in the synthesis of allenyl acetates 190. Six different transition metals 
including iron-, ruthenium-, rhodium-, iridium-, nickel- and palladium-catalysts were tried 
(Table 21). All of these catalysts were tested first both with AlMe3 and ZnEt2. Only the 
reactions with ZnEt2 are presented in Table 21 as AlMe3 did not give any conversion to the 
desired product 190. All of the catalysts were tested both with and without a ligand, and 
Feringa’s phosphoramidite ligand 200 [129] was chosen for the screening because a large 
number of successful asymmetric syntheses has been developed with it [130]. From these test 
reactions nickel catalyst Ni(acac)2 gave the highest conversions to the desired product 190 both 
with  and  without  a  ligand  (entries  e  and  k).  No  ee was obtained with the phosphoramidite 
ligand 200 in any case. 
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Table 21 
 
Entry Catalyst (2 mol%) Ligand (4 mol%) GC yield (%) 190b 
a FeCl3 - - 
b Ru(MeCN)2COD - - 
c [RhCl(COD)]2 - 4 
d [IrCl(COD)]2 - - 
e Ni(acac)2 - 27 
f Pd2(dba)3 - 3 
g FeCl3 L* - 
h Ru(MeCN)2COD L* - 
i [RhCl(COD)]2 L* 2 
j [IrCl(COD)]2 L* - 
k Ni(acac)2 L* 16 
l Pd2(dba)3 L* - 
Screening conditions: At room temperature catalyst (0.04 mmol, 2 mol%) and ligand (4.0 mg, 
0.08 mmol, 4 mol%) were charged in carousel tube under argon and 5 ml of Et2O was added. 
After 10 min diacetate 187a (50  mg,  0.21  mmol,  100  mol%)  was  added  in  1  ml  of   Et2O 
followed by dropwise addition of ZnEt2 (1M in hexanes, 0.38 ml, 0.38 mmol, 1.8 equiv). The 
reaction was quenched with saturated aqueous NH4Cl and the organic phase was dried over 
MgSO4 and used for GC analysis. 
 
The nickel catalyst Ni(acac)2 clearly  showed highest  conversions,  up  to  27% (entry  e)  in  the  
first screening. Optimization was continued with this nickel-catalyzed system.  
3.6.1 Background on nickel-catalyzed synthesis of allenes 
There are reports of both Grignard reagents and zinc reagents being used with nickel catalysts 
in allene synthesis. It is also known that the chemoselectivity of SN2 vs SN2’ can depend on the 
transition metal used in case of copper and nickel catalysts [43]. 
Luh reported in 1996 [131] and 1997 [132] a synthesis of allenes from propargylic 
dithioacetals 201 with nickel catalyst and Grignard reagent. In this reaction the Grignard is 
coupled twice (Scheme 59). Different R groups could be substituted on the allene moiety when 
the first substitution was done with a cuprate and the reaction quenched with an electrophile. 
The second substitution was done on the C-S bond with a nickel reagent yielding allenes 205 
(Scheme 60). 
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Scheme 59 
 
Scheme 60 
Kambe reported the three-component coupling of enynes 206 with alkyl halides and zinc 
reagents under nickel-catalyzed conditions (Scheme 61) [133]. The authors propose a 
formation of an alkyl-radical from alkyl halides by single electron transfer from the nickelate 
complex. The resulting alkyl radical reacts with the enyne 206 yielding a vinyl radical 
intermediate, which can react with Ni-R2 to give the allenic product 207 after a reductive 
elimination. 
 
Scheme 61 
There are also some examples of intramolecular couplings to form allenes under nickel 
catalysis. Liang reported the synthesis of allenyl-indenes 209 in 2008 by Michael-addition type 
intramolecular nucleophilic substitution to a nickel-activated alkyne. Following elimination of 
an ether group yields the allenyl-indene product 209 with moderate to good yields (Scheme 62) 
[134]. 
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Scheme 62  
Liang expanded his allenyl-indene synthesis to three-component couplings by adding a 
nitrogen nucleophile 211 to the reaction (Scheme 63) [135]. This reaction works with both 
palladium catalysts and with nickel catalysts. Nickel-catalyzed reactions were performed under 
air, whereas the palladium-catalyzed reactions needed argon atmosphere. This tandem reaction 
gives allenyl-indenes 212 with high degree of substitution. The proposed reaction mechanism 
involves a Michael addition of the amine to the Michael acceptor and following attack of the 
malonate-type carbon nucleophile to the transition metal activated alkyne.  
 
Scheme 63 
There are also some examples of the synthesis of chiral allenic compounds using nickel 
catalysis. In 2000 Tillack and co-workers reported a hydrosilylation of butadiynes 213 to chiral 
allenes 215 with rhodium and nickel catalysts in the presence of chiral phosphine ligands. The 
drawback of this reaction is a low enantioselectivity. With a rhodium catalyst the allene 
product was obtained with up to 27% ee while a nickel catalyst gave only 11% ee (Scheme 64) 
[136]. 
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Scheme 64 
In 2008 Sarandeses and co-workers published an enantioselective synthesis of benzyl-
substituted alkynes via nickel-catalyzed cross-coupling reactions of trialkynylindium reagents 
with racemic secondary benzyl bromides. When studying the scope of this reaction, 
trialkynylindium derivative of ethyl propiolate 217 surprisingly afforded an allene product 218 
with 30% yield and 77% ee (Scheme 65) [137]. This was the only example of allene synthesis 
in the report. 
 
Scheme 65 
3.6.2 Optimization of nickel-catalyzed SN2’ reaction 
The optimization of nickel-catalyzed SN2’ reaction was started by testing different nickel 
catalysts without ligands (Table 22, entries a-h) and Ni(acac)2 showed the highest activity in 
the reaction. Some simple ligands were tested with this catalyst (Table 22, entries i-l). 
Phosphine and phosphate ligands lowered the activity of the catalyst whereas the diamine 
ligand TMEDA 219 improved the conversion from 37% (without a ligand) to 46% (entries a 
and l). The presence of an amine ligand seemed to accelerate the reaction. 
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Table 22 
 
Entry Catalyst (5 mol%) Ligand (7 mol%) GC yield 190b (%)  
(isolated) 
a Ni(acac)2  37 (38 in 4 h) 
b Ni(acac)2•2H2O  35 
c NiCl2•6H2O  - 
d Ni(acac)F6•H2O  26 
e Ni(PPh3)2Cl2  - 
f NiCl2 anhydr  11 
g Ni(SO3)• 6H2O  - 
h Ni(PPh3)2Br2  1 
i Ni(acac)2 PCy3 2  
j Ni(acac)2 PPh3 3  
k Ni(acac)2 P(OBu)3 2  
l Ni(acac)2 219 (TMEDA) 46  
Screening conditions: At room temperature the nickel catalyst (5 mol%) and ligand (7 mol%) 
were charged in a Schlenck tube with 5 ml of Et2O. After 10 min diacetate 187a (50 mg, 0.21 
mmol, 100 mol%) was added in 1 ml of Et2O followed by addition of ZnEt2 (1M in hexanes, 
0.42 ml, 0.42 mmol, 200 mol%). After 1h the reaction was quenched with saturated aqueous 
NH4Cl solution and an aliquot of dried organic phase was used in GC analysis. 
 
Five solvents were compared with Ni(acac)2 and ligand 219. From the five, the reaction in 
diethyl ether gave the best conversion to the allene 190b (Table 23, entry a). 
Table 23 
Ni(acac)2 (2 mol%)
L 219 (4 mol%)
ZnEt2 (2 equiv)
r.t. 1 h
Ph
OAc
OAc Ph
Et
OAc
187a 190b
 
Entry Ni(acac)2 (mol%) L 219 (mol%) Solvent GC yield 190b (%) 
a 5 7 Et2O 46 
b 5 7 THF 14 
c 5 7 2-Me-THF 26 
d 5 7 CH2Cl2 - 
e 5 7 toluene 25 
Screening conditions: At room temperature the nickel catalyst (3.1 mg, 0.01 mmol, 5 mol%) 
and ligand (2.2 ul, 0.014 mmol, 7 mol%) were charged in carousel tube and 5 ml of solvent 
was added. After 5-10 min diacetate 187a (50 mg, 0.21 mmol, 100 mol%) was added in 1 ml 
of solvent followed by dropwise addition of ZnEt2 (1M in hexanes 0.42 ml, 0.42 mmol, 200 
mol%). The reaction was quenched with saturated aqueous NH4Cl and organic phase was dried 
with MgSO4 and used in GC analysis. 
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After the discovery of ligand-acceleration with nitrogen donor ligands some more ligands were 
tested. Several reaction conditions were tested with ligands 220-223. When 5-7 equivalents of 
ZnR2 were used higher yields of 190a-b were attained. 
Table 24 
 
Entry Ni(acac)2  
(mol%) 
Ligand 
(mol%) 
T (°C) Time (h) ZnR2 
(equiv) 
Yield 190a/b 
(%)a 
a 5  220 (7) +4 °C 3 h ZnEt2 (7) 64        
b 5  220 (7) +4 °C 4 h  ZnEt2 (5) 62  
c 5  220 (7) +4 °C 22 h  ZnMe2 (5) 10  
 
d 5  221 (7) +4 °C 2 h ZnEt2 (7) 54  
e 10  221 (15) +4 °C 0.5 h ZnEt2 (7) 60  
f 5  221 (7) –5 °C 2.5 h ZnEt2 (7) 48  
 
g 5  222 (7) +4 °C 22 h ZnEt2 (5) 58  
h 5  223 (7) +4 °C 1 h ZnEt2 (5) 47  
a) Isolated yield. General conditions: Ni(acac)2 (5-10 mol%) and ligand (7-15 mol%) were 
charged in Schlenk tube and 10 ml of Et2O was added. The reaction was cooled to the 
temperature required. After 5 min substrate 187a and ZnR2 were added. 
 
With racemic NOBIN 220 the reaction yielded allenyl acetate 190b with over 60% isolated 
yields. Some different addition methods were tested with 220. Diacetate 187a was added first 
to the reaction mixture followed by rapid addition of 5 equiv. of zinc reagent and 2 equiv. of 
zinc reagent was added after 1 hour reaction time (entry a). Zinc reagent was added before 
diacetate, which was added slowly over 1 hour (entry b). Both addition methods give very 
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similar isolated yields, 64% and 62% respectively. ZnMe2 gives very low yields of the allene 
product (entry c). 
With ligand 221 were tested different methods for adding the zinc reagent. In both entries d 
and e, ZnEt2 was  added only  after  the  diacetate.  Adding ZnEt2 portion-wise over 1 hour had 
little effect (entry d) compared to adding it all at once (entry e). With fast addition of 
diethylzinc the yield of the allene product is somewhat higher (60% vs 54%) after 30 minutes 
reaction time. When the reaction is cooled down to –5 °C the yield drops to 48% (entry f). 
From the tests in entries a-e was it  concluded that it  is best to add all the zinc reagent in the 
beginning and then slowly add the diacetate substrate. With simple 2-aminophenol as ligand 
(222) the yield 58% (entry g) is quite close to the 64% yield obtained with ligand 220 (entry a). 
Reaction with proline 223 gives the allenyl acetate 190b with 47% isolated yield (entry h). 
3.6.3 Testing different substrates on nickel-catalyzed SN2’ reaction 
The nickel-catalyzed SN2’ reaction was tested with four other substrates (Table 25). As in 
Table 24 there was not one ligand dramatically better than the others, 2-aminophenol 222 was 
used as ligand with a selection of substrates. With p-tolyl-substitutent (entry a) reaction with 
ligand 222 gave  a  yield  of  53%  and  the  reaction  with  (CH2)2Ph substituent reached 50% 
isolated yield (entry d). However when m-tolyl or 1-cyclohexene substituents were tested the 
yields clearly dropped (entries b and c). The reaction times in entries c and d are shorter than 
those in entries a and b. It was discovered that the allene product is formed in the beginning of 
the reaction but soon there starts to form other products as well (particularly in case of entry c). 
If the reaction is left on for longer times in the end none of the allenyl acetate can be isolated 
but it seems that the product starts to react further and only a complex product-mixture is 
obtained. 
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Table 25 
 
Entry R1  Time  Yield 190 (%)a         (brsm %)b 
a p-tolyl 
 
3 h 
 
53  (190f)              (93)       
b m-tolyl 
 
3 h 
 
27  (190g)             (79)       
c 1-cyclohexene 
 
1.5 h 
 
38  (190h)             (82)       
d (CH2)2Ph  1 h  50  (190i)              (99)       
a)  Isolated yield. b) Isolated yield based on recovered starting material. 
3.6.4 Attempts towards catalytic asymmetric SN2’ reaction  
Some chiral ligands were tested in the SN2’ reaction. Amino-alcohol ligands were of particular 
interest as they seemed to accelerate the reaction most. Unfortunately enantiopure NOBIN 
(220) was not available at the time as it is an expensive ligand to buy. Chiral ligands in Table 
24 did not yield any ee to the product allene 190b so few others were tested (Scheme 66). The 
ligands in Scheme 74 are commercially available or made by previous group members. 
 
72 
 
 
Scheme 66 
Thiocarbamate ligand (R)-225 gave 10% ee of enantiomer (R)-190b. With the corresponding 
(S)-ligand (S)-225 8% ee to enantiomer (S)-190b was  observed.  Here  the  assignment  of  the  
allenyl acetate 190b enantiomers is based on the assignment made with kinetic resolution 
results in Chapter 3. The (R)-ligand gives the opposite enantiomer of 190b and (S)-ligand gives 
the same enantiomer of 190b as in the kinetic resolution with lipase from Burcholderia 
cepacia. 
Thiocarbamate ligands are not commercially available, but they are also not difficult to make 
[138]. Thiocarbamate ligands can be accessed from BINOL 227 and thiocarbamoyl chlorides 
in the presence of a base. The choice in commercially available thiocarbamoyl chlorides is 
limited, but two different chlorides 229 and 229 are available (Scheme 67). The synthesis of 
two new ligands 230 and 231 is described in Scheme 67. The one-pot synthesis yielded ligand 
230 with 39% yield and ligand 231 with very low, 2% yield. 
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Scheme 67 
Unfortunately, the newly made ligands 230 and 231 showed no stereoselectivity at all in the 
nickel-catalyzed SN2’ reaction. The ligands with the only enantioselectivity remain (R)- and 
(S)-225. 
In an attempt to improve the ee values the reaction temperature was lowered to –10 °C but this 
gave similar ee (8%) and conversion (49%) to the allenyl acetate 190b as  earlier  at  +4  °C  
(entry a, Table 26). When the reaction temperature was lowered to –70 °C a higher ee of 22% 
was observed for the allenyl acetate but conversion dropped to 31% (entry b). In entries c and d 
the catalyst/ligand mixture was left stirring at room temperature before cooling the reaction 
down for the addition of diacetate 187a and the zinc reagent. This modified reaction was tested 
with 5 mol% and with 10 mol% of catalyst (entries d and c respectively) but in both cases the 
ee and conversion of allene product 190b was lower than without the pre-stirring.  
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Table 26 
 
Entry Ni(acac)2 
(mol%) 
(R)-225 
(mol%) 
Temperature 
(°C)  
Time 
(h) 
GC yield (%) 
190b   
ee  190b 
(%) 
a 5 7 –10 4  49 8 
b 5 7 –70 4  31 22 
c 10 14 –70a 4  6 7 
d 5 7 –70a 4  14 7 
General conditions: Ni(acac)2 (5-10 mol%) and ligand (7-15 mol%) were charged in Schlenk 
tube and 10 ml of Et2O was added. The reaction was cooled to the temperature required. After 
5 min substrate 187a and ZnR2 were added. a)The ligand and catalyst were stirred at room 
temperature for 30 min before the reaction was cooled down to the temperature indicated in the 
table. 
 
Other alkylation reagents were also tested. Aluminium reagents AlMe3 and AlEt3 as well as 
Grignard reagent EtMgBr were tested in this reaction but none of them gave any conversion to 
the desired product. As a control experiment the reaction was also tested with ligand (R)-225 
without the nickel catalyst, but no reaction occurred. 
3.7 Other reactions with the substrates and methodology developed this chapter 
3.7.1 Propargylic diacetamide and propargylic bis-methoxyether in SN2’ nucleophilic 
substitution 
Inspired by the easy synthesis of propargylic diacetates diacetamide 232 was also prepared. 
There are plenty of examples in the literature for this type of diacetamides (although none of 
them propargylic) and the synthesis is often started from the corresponding aldehyde [139]. 
This reaction was attempted a couple of times with different reaction times, temperatures and 
catalysts but the best result, 57% yield of 232, was obtained simply with sulphuric acid as 
catalyst and reaction time of 18 h (Scheme 68). 
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Scheme 68 
Diacetamide 232 was subjected to the cuprate-mediated SN2’ reaction to see whether an amido-
allene could be made. The reaction was carried out under the optimized conditions for a 
propargylic diacetate (Scheme 69). However, none of the desired product formed. 
 
Scheme 69 
Propargylic acetal 233 was prepared to be tested in the cuprate-mediated SN2’ reaction. Bis-
methoxyether 233 was synthesized from propargylic aldehyde 186a using one equivalent of 
trimethoxymethane and a catalytic amount of p-toluenesulphonic acid [140]. Heating the 
reaction mixture at 60 °C for 4 hours gave propargylic acetal 233 in 50% yield after 
purification by distillation (Scheme 70). 
 
Scheme 70 
Cuprate mediated SN2’ reaction with acetal 233 was attempted. However, only the starting 
material was recovered and no allene was formed (Scheme 71). 
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Scheme 71 
The nickel-catalyzed SN2’ reaction was tested also with a propargylic acetal 233. However, 
attempts to react this substrate with ZnEt2 in presence of a nickel catalyst resulted in a complex 
mixture from which no desired product could be isolated (Scheme 72). 
 
Scheme 72 
3.7.2 Propargylic diacetates in Meyer-Schuster rearrangement 
Some reactions were also carried out with the propargylic diacetates 187. The the most 
succesful was a Meyer-Schuster rearrangement [141]. In 1922 Meyer and Schuster reported an 
acid-catalyzed rearrangement of propargylic alcohol 234 to enone 235 (Scheme 73). 
 
Scheme 73 
A gold-catalyzed Meyer-Schuster rearrangement was developed in 2007 by both Nolan [142] 
and Zhang [143]. The two groups have studied the reaction quite thoroughly including 
computational studies and extensive studies on the scope of the reaction. Both groups started 
the synthesis of enones 237 from propargylic acetates 236 (Scheme 74). 
 
77 
 
R3 R
2
OAc
Au(PPh3)NTf2
2-butanone
R1
R1
R2
R3
O
13 examples
83-98% yield
236 237
 
Scheme 74 
The reactivity of propargylic diacetate 187a was tested under gold-catalyzed conditions with 
Au(IPr)Cl/AgOTf as catalyst system and enone 238 was obtained with high selectivity but only 
moderate 30% isolated yield (Scheme 75). This reaction was carried out in non-distilled 
CH2Cl2 which is not an optimal solvent as the reaction needs some water. Nolan [142] debated 
that the reaction proceeds via an addition of water to the gold-activated alkyne, and as the 
acetate acts as leaving group the resulting hydroxyallene tautomerizes to the product enone. 
The reaction could be optimized by using wet solvents that would probably enhance the 
reaction rate and conversion. 
 
Scheme 75 
The reaction was tested once with a deuterated diacetate d-187a to see if any of the deuterium 
would be integrated into the final product. This was not the case and product d-238 only 
contains protons on the alkene moiety (Scheme 76). 
 
Scheme 76 
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The Meyer-Schuster reaction for propargylic gem-diacetates has not been previously reported 
in the literature. This short study extends the scope in the literature. However, this reaction was 
not considered to be interesting enough on its own, and no further optimization or scope study 
was carried out. 
3.7.3 Summary 
Two new methods were developed for the synthesis of allenyl acetates. The first method 
developed uses a cuprate-mediated SN2’ nucleophilic substitution. The new methodology 
permits the synthesis of allenyl acetates with an aromatic substituent at C3 of the allenic 
compound and could be successfully applied to a family of substrates. The organocuprate-
mediated reaction was reliable, several commercially available Grignard reagents could be 
used, and it was also easy to scale up to gram quantities without any loss in the yield. 
Secondly, advances were made towards a catalytic SN2’ reaction. An advantage of a catalytic 
version of this reaction could be the atom-economy of the transformation or asymmetric 
synthesis of the allenic products. However, in this case the nickel-catalyzed reaction proved 
unreliable and atom-economy cannot be claimed as 5-7 equivalents of zinc-reagent were 
needed for moderate yields. The synthesis of enantiomerically enriched allenic products did not 
work very well with this catalytic reaction as only up to 22% ee values were observed. Some of 
the work in Chapter 3 was published in 2010 [144]. 
 
 "
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4 Gold-catalyzed" synthesis" of" indenes" from" allenyl" acetates" and"
propargylic"acetates"
4.1 Introduction to gold-catalyzed reactions of propargylic carboxylates 
Propargylic carboxylates are highly versatile starting materials in gold-catalyzed reactions and 
their reactivity in the presence of a gold catalysts has been studied extensively [145]. A 
plethora of different rearrangement- and cyclization products can be obtained from propargylic 
carboxylates because of the ability of the carboxylate group to migrate on the gold-activated 
alkyne. The mechanistic explanation of the reactions often starts with 1,2- or 1,3 migration of 
the  carboxylate  (pathways  1  and  2  in  Scheme  77),  which  leads  to  the  formation  of  highly  
reactive intermediates; allenyl carboxylates (V) and gold carbenoids (III).  
 
Scheme 77 Activation of propargylic carboxylate with a cationic gold-complex. 
As the gold carbenoid (III) and allenyl carboxylate (V) can also transform into each other, the 
cycle forms a ‘golden carousel’ [146]. DFT calculations of the energy barriers show that the 
transformation of propargylic carboxylate (I) via two consecutive 1,2-shifts to (V) would be 
more preferential than one 1,3-shift. The highest energy transition state on the pathway from 
(I) via two consecutive 1,2-shifts to (V) is lower in energy than the highest energy transition 
state from (I) to (V) via direct 1,3-shift. However, in the computational study the differences in 
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the  energy  barriers  were  so  small  that  using  different  substrates  or  catalysts  could  affect  the  
favored reaction route and thus the two reaction pathways are competitive. 
There are some clear cases in the literature where the reactivity of a propargylic carboxylate 
can be explained by a preference toward 1,2- or 1,3-shifts. These two migrations present 5-exo- 
and 6-endo-dig modes of the nucleophilic attack of the carbonyl group to the activated alkyne. 
Internal alkynes often favor the 6-endo-dig cyclization as in the synthesis of alkenyl enol 
acetates 243 from trimethylsilylmethyl-substituted propargylic carboxylates 239 (Scheme 78) 
where the reaction mechanism can be explained via the formation of allenyl carboxylate 
intermediate 240 [147]. 
 
Scheme 78 
Another example of favored 6-endo-dig cyclization is the synthesis of bicyclo[3.1.0]hexanes 
248 from 5-en-2-yn-1-yl acetates 244 (Scheme 79) [148]. The mechanism for this reaction can 
also be explained with the formation of allenic intermediate 245 followed by the attack of the 
intramolecular alkene on the gold-activated allene and consecutive cyclization of the cationic 
intrermediate 246. 
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Scheme 79 
More complex structures can be accessed when an internal nucleophile is added to the substrate 
structure. For example, the nucleophile can be an indole as in Scheme 80 [149]. As before, 
propargylic carboxylate 250 transforms to an allenic intermediate 251, which in turn is 
activated by the gold catalyst and this results in oxonium species 252. The oxonium species 
can cyclize to the 3-position of the indole group and when this is followed by intramolecular 
trapping of the resulting iminium species 253 the cyclobutane ring 254 is formed. 
 
Scheme 80 
In some cases the favored reaction route goes via 1,2-migration of the carboxylate group. 
Echavarren and co-workers studied a nucleophilic substitution of carbon nucleophiles with 
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different propargylic carboxylates 255 with a terminal alkyne [150]. They discovered that the 
substitution can go via the allenic intermediate 256 or via gold carbenoid intermediate 259 
depending on the substitution pattern of substrate 255 (Scheme 81). The conclusion was that 
terminal propargylic carboxylates with less hindered carboxylate groups (small R1 and R2) are 
more likely to undergo 1,3-migration and the propargylic carboxylates with large R1 and  R2 
groups would be more likely to choose 1,2- migration pathway. The authors also admitted that 
the factors that influence the regioselectivity in this reaction are not yet completely understood. 
 
Scheme 81 
To conclude (Schemes 78-81) there are some empirical rules for the preference of propargylic 
carboxylates to undergo 1,2- or 1,3 migrations. Internal alkynes often favor the 1,3-route which 
leads to allenyl acetate-type reactivity whereas terminal or electron-poor alkynes favor the 1,2-
route that leads to gold carbenoid-type reactivity [145a]. There are exceptions to these rules 
and the reactivity of the propargylic carboxylate can be reversed by tuning the substitution and 
catalyst used.  
Zhang and co-workers reported a synthesis of (1Z,3E)-2-pivaloxy-1,2-dienes 265 from 
propargylic pivalates 261 (R3 = t-Bu) where the regioselectivity is completely the reverse of 
the general rules (Scheme 82) [151]. The propargylic pivalates 261 used in the synthesis had 
electronically unbiased internal alkynes and in earlier work of Zhang very similar substrates 
had been used in Meyer-Schuster type rearrangements with Au(PPh3)NTf2 as catalyst and 
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propargylic acetate as substrate (1.3-migration, Scheme 82) [141, 142, 143]. The preference to 
5-exo-dig cyclization was attained by using IPrAuNTf2 as catalyst and a bulky pivalate as 
starting material. 
 
Scheme 82  
As a conclusion the reactivity of propargylic carboxylates in the presence of gold catalysts 
often involves allenic intermediates. Propargylic and allenic carboxylates are even often 
considered as ‘equivalent’ in gold-catalyzed conditions because often both will give similar 
final products.  
4.2 Introduction to the synthesis of indenes 
Indenes are widely used building blocks in organic chemistry. Indenes are used in the search 
for new pharmaceuticals, for example new anti-inflammatory agents [152] antidepressives 
[153] and compounds with psychological activity [154]. Indenes also find their place in 
materials science as starting materials for new conducting polymers [155] and liquid crystals 
[156]. Indene-containing structures are often used as ligands in transition metal chemistry. 
Examples of ruthenium [157], rhodium [158] and zirconium [159] complexes with indenyl 
ligands are commonly encountered. 
4.2.1.1 General methods in indene synthesis 
There are various ways to synthesize indenes and some of these are briefly reviewed below. 
These examples do not cover all the methodology available but will provide a small insight to 
the literature methods. 
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4.2.1.2 Platinum-catalyzed indene synthesis 
Platinum catalysis has been used to prepare various indenes [160]. Both t-propargyl 
carboxylates and sec-propargyl carboxylates have been successfully used as starting materials. 
Sarpong and co-workers [160a] carried out a synthesis of indenes 267 starting from tertiary 
propargylic carboxylates 266 carrying a carboxylate function at C1 position. They obtained 
only one isomer of the product indene 267 (Scheme 83). The reaction conditions are quite 
harsh as high temperatures and long reaction times are required. 
 
Scheme 83 
Ohe  and  co-workers  published  a  similar  synthesis  of  indenes  starting  from  secondary  and  
tertiary acetates 268 and 270 carrying terminal alkynes [160b]. Ohe also used PtCl2 as catalyst. 
The reaction was selective with secondary acetates towards indenes 269 with mostly moderate 
yields. However, when tertiary acetates were used, the product indene was always obtained as 
a mixture of two isomers 271 and 272 (Scheme 84). In Ohe’s methodology long reaction times 
are also required to obtain the indene product. 
 
Scheme 84 
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4.2.1.3 Ruthenium-catalyzed indene synthesis 
Ruthenium catalysts can yield indenes from propargylic acetates [119]. Only one example of 
this reaction is published. Using the ruthenium catalyst there were no byproducts from 273 
reported and only indene 274 is formed selectively (Scheme 85). 
 
Scheme 85 
4.2.1.4 Rhodium-catalyzed indene synthesis 
Rhodium catalysts have also been applied to indene synthesis [161]. For example, coupling 
between ketimine 275 and internal alkyne 276 led to [3+2] annulations giving amino-
substituted indene 277 with high yield and selectivity (Scheme 86). 
 
Scheme 86 
4.2.1.5 Non-transition metal-catalyzed synthesis of indenes 
An electrophilic cyclization of 2-substituted ethynylmalonates 278 to indenes 279 has been 
reported in the presence of stoichiometric iodine and base [162] (Scheme 87). Diaryl propargyl 
alcohols 280 have been cyclized to indenes 281 with Et3SiH and catalytic iodine [163] 
(Scheme 87). 
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Scheme 87 
Indenes have also been synthesized in the presence of Brønstedt acids [164]. Using tenfold 
amount of methanesulphonic acid yielded cyclododecano[b]indenes 283 with moderate to high 
yields from g-benzylcyclododecanones 282 (Scheme 88). 
 
Scheme 88 
A Lewis acid-catalyzed Friedel-Crafts reaction has also been used in indene synthesis [165]. 
An example of this method is the synthesis of 3-iodoindenes 285 from iodinated allylic 
alcohols 284 with BF3•Et2O as catalyst or reagent (Scheme 89). There are also other examples 
where Lewis acids have been used in indene synthesis [166]. 
 
Scheme 89 
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4.2.1.6 Gold-catalyzed indene synthesis 
Gold catalysis has also found its place in indene synthesis. Nolan and co-workers reported in 
2006 a cycloisomerisation of propargylic acetates 171 and allenyl acetates 172 to the 
corresponding indenes 173 and 174 (Scheme 90) [122][167]. They often obtained high yields 
and chemoselectivity to indene 173 but indene 174 was  formed  as  minor  product  in  some  
cases. With allenes 172 every example gave a mixture of products. The allenyl acetates 172 
were prepared by silver-catalyzed rearrangement and they gave very similar product pattern as 
propargylic acetate 171. In this approach the allenyl acetate and the propargylic acetate could 
be called ‘equivalent’ in the reaction conditions as both give similar products and yields in the 
gold-catalyzed reaction. The reaction conditions are very mild as the tranformation proceeds at 
room temperature and with short reaction times. 
 
Scheme 90  
Zhang and co-workers have also developed a gold-catalyzed indene synthesis. They published 
a synthesis of indenes 287 with 3 fused rings [168] (Scheme 91). A propargylic cyclopropane 
286 rearranges to give indene structure 287 as product. 
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Scheme 91 
Reaction of propargylic sulphides 288 with gold catalysts has also been reported [169] 
(Scheme 92). In this case indenes 289 and 290 are always prepared as a mixture. Instead of the 
oxygen of an carboxylate group it is the lone pair on sulfur that attacks the gold-activated 
alkyne forming a three-membered ring intermediate, which then opens to a gold carbenoid 
species. The authors made a large study and the product preference depends on the substituents 
R1, R2 and R3. 
 
Scheme 92 
In conclusion indenes can be synthesized from various starting materials and by several 
catalytic methods. In many cases the prefered starting material for these indene synthesis is a 
propargylic carboxylate or a propargylic alcohol. When comparing the different methods it can 
also be concluded that the gold-catalyzed indene synthesis often represents the mildest and 
fastest methodology, as elevated temperatures are rarely needed. The negative side in gold-
catalyzed indene synthesis is that it often yields product mixtures and there are clearly some 
problems with chemoselectivity. The same issues apply to platinum catalysis. The mechanistic 
proposals in the publications related above often explain the problems in the chemoselectivity 
as due to competing 1,2- and 1,3- migrations of the propargylic carboxylates, as there is not 
always one clear preference which one of the two mechanisms is favored in the reaction. It 
would be desirable to develop a mild gold-catalyzed synthesis of indenes that is selective 
towards one indene product. 
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4.3 Allenyl acetates and propargylic acetates in gold-catalyzed indene synthesis 
In Chapter was described the synthesis of allenyl acetates 190. If these allenyl acetates are 
compared with their ‘equivalent’ propargylic acetates the conclusion would be that under gold-
catalyzed conditions the allenyl acetate 190 can arise from propargylic acetate 291 (Scheme 
93). Propargylic acetates with a terminal alkyne can also react via 1,2-acyloxy migration to 
give gold carbenoids (III)’ but, according to Nolan’s ‘golden carousel,’ [146] also this could 
be in equilibrium with the allenyl acetate 190.  
 
Scheme 93 
The reactivity of allenyl acetates 190 under gold-catalyzed conditions is discussed in this 
chapter and their reactivity compared to that of propargylic acetates 291. The reaction 
mechanism for both substrates is discussed in detail. 
4.3.1 Indene synthesis with allenyl acetates: optimization and scope 
The reactivity of allenyl acetate 190a towards gold catalysts was tested with the expectation of 
obtaining a mixture of indene products. Initial attempts with AuCl3 and AuCl(PPh3) were 
thwarted by the formation of complex reaction mixtures but gold-carbene complex Au(IPr)Cl 
(293) with a AgOTf co-catalyst immediately gave a very high yield of 3-ethyl-1H-inden-1-yl 
acetate 292a (Table 27). Silver catalyst alone yielded a diene 294 as only isolable product 
(entry d). 
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Table 27 
 
Entry Catalyst  Time 
(min) 
Solventa Yield (%) 292a  
a AuCl3 (2 mol%) 20 CH2Cl2 12b 
b (PPh3)AuCl/AgOTf (2/2 mol%)  20 CH2Cl2 50b 
c (IPr)AuCl/AgOTf (2/2 mol%) 10  CH2Cl2 99c 
 
 
d 
 
 
AgOTf (5 mol%) 
 
 
30  
 
 
CH2Cl2  
  
37%  (E/Z- 294)c,d 
e (IPr)AuCl (2 mol%) 45  CH2Cl2 starting material 
recovered 
a) Reactions preformed in CH2Cl2 as 0.1 mmol/ml solution of allene 190b. b) NMR yield. c) 
Isolated yield. d) Only isolable product. 
 
 
A small study of the scope of the gold-catalyzed reaction was carried out. As no byproducts 
form with the Au(IPr)Cl/AgOTf catalyst system up to quantitative yields of indenes 292 are 
attained. Pivalate and benzoate esters are tolerated providing high yields (Table 28 entries d 
and e). When the reaction was scaled up (> 0.5 gram scale), only 1 mol% of the catalyst was 
enough to provide up to quantitative isolated yields of 292. The cycloisomerization was tested 
with one non-aromatic allene 190h (entry i) but this gave no desired product.  
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Table 28  
 
Entry R1 R2 R3 Yield (%)a 292a-h 
a H  Me Et 99b 
b H  Me Me 69 
c H Me n-Bu 92 
d H Ph Et 82 
e H t-Bu Et 96 
f 4-t-Bu Me Et 
 
97 
g 4-Me Me Et 
 
70 
h 3-Me Me Et 
 
 92% combined yield 
 
i 
 
1-cyclohexene 
 
Me 
 
Et 
 
- 
a) Isolated yield. b) 1 mol% of catalyst used (>0.5 g scale).  
 
 
The reaction of allenyl acetates 190 with Au(IPr)Cl catalyst is very selective as only one 
indene  product  forms  in  the  reaction.  The  reaction  is  also  very  fast  and  often  over  in  1-2  
minutes and only due to the slowness of TLC-reaction monitoring the reaction times are 
assigned over 5 minutes. The selectivity of the reaction is likely due to the unhindered C1-H"g 
to the acetate group. As the gold catalyst favors this unhindered C1-C2 bond  there  is  no  
competition between the two allenic bonds to be activated towards the carbocyclization 
(Scheme 94). The mechanism of this cyclization is discussed in detail later in the chapter. 
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Scheme 94 
4.3.2 Constitutional isomers of two propargylic acetates 
To study the reactivity of propargylic acetates some of these compounds were prepared. The 
ethyl-substituted propargylic acetate 298a was synthesized starting from propiophenone 295. 
The addition of lithiated trimethylsilylacetylene resulted in TMS-substituted propargylic 
alcohol 296 which was desilylated to give 3-phenylpent-1-yn-3-ol 297 with 64% yield over 
two steps. Alcohol 297 could be transformed to the corresponding acetate 298a (Scheme 95). 
 
Scheme 95 
Attempts were made to prepare i-Pr substituted and Ar-OMe substituted acetates 298b and 
298c. However, the last step on the synthetic route (Scheme 95) proved problematic with these 
substrates, so the two compounds were never obtained in good yield or purity (Scheme 96). 
 
Scheme 96 
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The gold-catalyzed reaction of propargylic acetate 176e has been described already in Chapter 
3 (Table 13), where attempts were made to synthesize allenyl acetates with literature methods 
(Scheme 97). This reaction gave 1-methyl-1H-inden-2-yl acetate 181 with 38% yield. Despite 
the low yield 181 was the only product that could be isolated from the complex reaction 
mixture. 
 
Scheme 97  
A similar test reaction was carried out with the ethyl-substituted propargylic acetate 298a 
(Scheme 98). This substrate also gives 1-Et-1-H-inden-2-yl acetate 299a as the major product 
(39%) but also some of the 3-Et-1-H-inden-1-yl acetate 292a (11%), which is the only product 
obtained from allenyl acetate 190b. A considerable amount, 25% of the substrate, is consumed 
to enyne product 300 arising from elimination of the acetate, which shows that the gold 
catalyst has also some oxophilic Lewis acid character. 
 
Scheme 98  
It was difficult to reproduce the isolated yields from the reaction in Scheme 98. The major 
products, indene 299a and enyne 300, were always isolable with approximately the same ratio. 
However, it seemed that the indene 292a was somehow consumed if the reaction was left 
running for longer times. This problem was studied further and observed that the indene 292a 
forms an elimination product 301 in the reaction mixture (Scheme 99). This behavior was 
never seen with the indene synthesis starting from allenyl acetates 190, probably because of 
short reaction times. If the reaction was left running at room temperature, after 2 hours none of 
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indene 292a was present in the reaction. The elimination could be followed with NMR 
experiments the results of which are described in detail in the experimental section. 
 
Scheme 99 
Propargylic acetate 304 is a constitutional isomer of 298a (Scheme 100). The acetate 304 was 
synthesized so that the reactivity of the two propargylic acetates in the presence of gold 
catalysts could be compared. The synthesis was started from benzaldehyde 302 and 1-butyne. 
Gaseous 1-butyne had to be first condensed in a Schlenck tube at –78 °C before deprotonation 
with n-BuLi and following addition of benzaldehyde 302. This reaction route yielded 
propargylic alcohol 303 with 92% yield and following transformation to acetate 304 was nearly 
quantitative.  
 
Scheme 100 
When the propargylic acetate 304 was reacted with Au(IPr)Cl, allenyl acetate 307 was the 
major product (57% yield) after 15 min reaction time (Scheme 101). At longer reaction times 
(4 hours), indene 306 was isolated with 54% yield. With propargylic acetate 304 the reaction 
clearly proceeds via allenic acetate 307. A considerable amount of Meyer-Schuster enone 305 
also forms in both cases [141, 142, 143]. 
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Scheme 101 
4.3.3 Reaction mechanisms for the formation of indenes 
4.3.3.1 Reaction mechanism for the cycloisomerization of allenyl acetate 190b 
Chapter 3 described the synthesis of enantiomerically enriched allenenyl acetate (S)-(+)-190b 
by lipase-catalyzed kinetic resolution and this was now used to access enantiomerically 
enriched samples of the allene. Gold-catalyzed cycloisomerization of 190b is a fast reaction at 
room temperature but when the reaction mixture is cooled down to 0 °C the reaction slows 
down enough that it can be followed by gas chromatography. Samples were taken from the 
reaction mixture and filtered through Celite to remove the catalyst and the samples were used 
for gas chromatography analysis. Chiral gas chromatography column octakis(2,6-di-O-methyl-
3-O-pentyl)-け-cyclodextrin separates both 190b and 292a to their enantiomers. 
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Figure 2 
 
Figure 3 
The gas chromatography data (Figures 2 and 3) show that the allene (+)-190b is racemized in 
the course of the reaction. After 20 minutes reaction time only racemic allene 190b is left. 
There must be a planar intermediate 308 in equilibrium with the allene 190b. Intermediate 308 
can cyclize via electrophilic aromatic substitution (SEAr); racemic indene 292a is obtained as 
product (Scheme 102). 
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Scheme 102  
At first the objective was only to follow the chirality transfer in the cycloisomerization of 
allenyl acetate 190b but these results were encouraging as a clear insight was obtained to how 
the gold-catalyzed reaction proceeds. At this point a gas chromatography program was 
optimized, which separated 1-H-allenic acetate 190b, 1-H-propargylic acetate 298a and 
indenes 292a and 299a to their enantiomers. 
 
Figure 4: GC retention times of 292a (tr ~ 50.86/51.01 min), 190b (tr ~ 52.68/53.02 min), 298a 
(tr ~ 44.06/44.29 min), 299a (tr ~ 49.12/49.41 min), 300 (tr ~ 32.28 min) and 294 (tr ~ 
47.84/50.38 min) on GC column octakis(2,6-di-O-methyl-3-O-pentyl)-け-cyclodextrin. 
Compounds 304 (tr ~46.75/47.13 min), 307 (tr ~ 49.29/49.83 min) and 306 (tr ~ 43.80 min) can 
be separated from the rest. All chiral compounds except for 306 are separated to their 
enantiomers. 
 
The reaction with 190b was run again on this program, this time the reaction temperature was 
set to -10 °C. The results are similar to those obtained earlier (Figure 2). The reaction proceeds 
cleanly without the formation of any of the propargylic acetate 198a. None of the compounds 
in Figure 4, except for 190a and 292a, are seen in the course of the reaction. 
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Figure 5 
4.3.3.2 Reaction mechanism for the cycloisomerization of propargylic acetate 298a 
The mechanism of gold-catalyzed cycloisomerization of propargylic acetate 298a is proposed 
in Scheme 103. The reaction can take three courses. The first option is the 1,2-migration of the 
acetate group (route B) which leads to the major product 299a via gold carbenoid complex 
(IIIa). Secondly, the gold catalyst can act as oxophilic Lewis acid (Route A) which leads to the 
elimination of the acetate group and to product 300. Thirdly, the propargylic acetate 299a can 
rearrange to the allenic acetate 190b which will quickly cyclize to minor indene product 292a 
(Route C). 
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Scheme 103 
To further confirm the reaction mechanism in Scheme 103 deuterium-labelled propargylic 
acetate d-298a was prepared (Scheme 104). 3-Phenylpent-1-yn-3-ol 297 was deprotonated with 
n-BuLi and the reaction was quenched with deuterium oxide to give d-297 with 99% yield after 
aqueous workup (d-purity 99%). Propargylic acetate d-298a was obtained with 89% yield and 
81% d-purity. 
 
Scheme 104 
The d-labeled propargylic acetate d-298a was  subjected  to  gold  catalysis  and  it  gave  indene  
products d-299a and d-292a as expected (Scheme 105). Deuterium-label test supports the 
proposed reaction mechanism as it maps to the expected H-atom positions in Scheme 103.  
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Scheme 105 
4.3.3.3 Some unclear mechanistic results with propargylic acetate 298a 
Enantiomerically enriched acetate 298a can be accessed by kinetic resolution with Lipase A 
from Candida Antarctica (Scheme 106). Acetate (S)-298a is obtained with 48% yield and 57% 
ee and alcohol (R)-297a with 32% yield and 92% ee. 
 
Scheme 106 
When the gold-catalyzed cycloisomerization reaction of (S)-298a was cooled to –10 °C it could 
be monitored with the same method as the cycloisomerization of alleneacetate 190b (Figure 6). 
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Figure 6  
The following conclusions can be drawn from Figure 6. The elimination product 300 forms 
right in the beginning of the reaction along with some 190b. Any allene 190b formed rapidly 
cyclizes to indene 292a. There is also an unknown chiral compound visible in the reaction 
mixture. The unknown compound elutes as two peaks with retention time (tr ~ 48.41/ 48.56 
min).  It  is  formed  with  partial  transfer  of  chirality  (best  seen  at  90  sec,  Figure  6).  As  the  
unknown  compound  vanishes  towards  the  end  of  the  reaction  it  was  at  first  assigned  as  an  
intermediate in the reaction pathway. As significant quantities (>10 mol-%) of this compound 
can be detected by both NMR and gas chromatography, it cannot be a gold-bound species such 
as (IIa) or (VII) (Scheme 107) as normally presented as intermediates of 1,2-acyloxy 
migration (route B, Scheme 107). Additionally, such intermediates are very unlikely to survive 
GC analysis. The unknown compound was too reactive to be isolated, so only partial 1H and 
13C NMR data could be obtained on the reaction mixture. These data are tentatively assigned to 
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the cyclopropene acetate 309 (Scheme 107). The cyclopropene acetate 309 is expected to arise 
from 298a with transfer of chirality. 
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Scheme 107 
The unknown compound (assigned as 309) could not be isolated to allow a full set of analytical 
data to be attained. Some information of the structure could be gathered from NMR data of 
crude reaction mixtures. As the compound could not be isolated and purified, it is not certain 
whether the compound forms in the reaction mixture or on Celite as the reaction must be 
quenched before GC analysis. It must also be mentioned that this compound is decomposed if 
it gets in touch with silica gel. The gold-catalyzed reaction is so fast that the GC samples could 
not be run without quenching the reaction first. Attempts were made to subject the intermediate 
to the gold-catalyzed reaction conditions, but it did not clearly react to any of the known 
isolable products. It could be that this unknown compound forms on Celite from one of the 
reactive intermediates and this is the reason it is no more visible in the end of the reaction. 
Due to the rarity of cyclopropene acetates in the primary literature we attempted the 
preparation of an analogue of the proposed structure 309.  Commercially available 2,3-
diphenylcycloprop-2-enone 310 was treated first with an ethyl cuprate and the resulting enolate 
103 
 
311 reacted with Ac2O (Scheme 108). 3-Ethyl-2,3-diphenylcycloprop-1-enyl acetate 312 was 
attained in low (9%) isolated yield. 
 
Scheme 108 
The 13C  NMR  data  of  312 was compared to those of 309 (Scheme 109). There are some 
similarities to these two compounds. However, as the complete analytic data of 309 could not 
be obtained this structure remains tentative. 
 
Scheme 109 
4.3.4 Summary 
A thorough study of the reactivity of allenyl acetates 190 and propargylic acetates 298 in the 
presence of gold catalyst has been presented. It was discovered that allenyl acetates 190 are 
excellent substrates for the synthesis of indenes 292 as the reaction with Au(IPr)Cl/AgOTf 
proceeds with complete chemoselectivity. It was also discovered that although often allenyl 
acetates and propargylic acetates having the same substitution pattern are ‘equivalent’ in gold-
catalyzed reactions, this is not the case with allenes 190 as they yield different products than 
their ‘equivalent’ propargylic acetates 298. 
 "
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5 Conclusion"and"future"work"
Although this thesis was composed of three separate projects, the common aim was to develop 
new synthetically useful reaction methodologies towards the preparation and transformations 
of allenic compounds. The most important findings of this work can be summarized as follows:  
‚ Some g-allenic acetates are excellent substrates for lipase-catalyzed kinetic resolution 
yielding g-hydroxyallenes in high enantioselectivities. The g-hydroxyallenes can be 
transformed into 2,5-dihydrofurans with a gold catalyst in the same reaction pot. This 
tandem transformation worked well with five substrates yielding 2,5-dihydrofurans 
with 28-50% yield and 86-99% ee and the remaining g-allenic acetates with 31-40% 
yield and 93-95% ee (Scheme 110). It was also discovered that bulky substituents next 
to the acetate group is detrimental to this transformation as the active site on the lipase 
(lipase from Burcholderia cepacia) is too small. 
 
Scheme 110 
‚ Allenyl acetates can be synthesized via a cuprate-mediated SN2’ substitution reaction. 
This method gives access to allenyl acetates with substitution pattern that cannot be 
accessed with literature methods. Altogether eleven allenyl acetates were synthesized 
with this method with 30-88% yields (Scheme 111). 
 
Scheme 111 
105 
 
‚ In attempts to develop a catalytic variant of the SN2’ nucleophilic substitution it was 
discovered that a nickel-catalyzed SN2’ reaction with amino-alcohol ligand and zinc 
alkylation reagent gives the highest chemoselectivity of the desired allenyl acetate 
product. However, the reaction yields allenyl acetates with only up to 64% yields. By 
using chiral ligands up to an 22% ee was  obtained  for  the  allenic  product  (Scheme  
112). 
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Scheme 112 
‚ Allenyl acetates under gold-catalyzed reaction conditions can yield indenes with up to 
quantitative yields and excellent chemoselectivity. Altogether eight indenes were 
prepared with 69-99% yield (Scheme 113). Propargylic acetates with terminal alkyne 
did not undergo selective cycloisomerization but yielded only product mixtures. 
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AuCl(IPr) 2 mol%
AgOTf 2 mol%
CH2Cl2, 5-10 min
190 292
R1 R1
8 examples
69-99% yield
 
Scheme 113 
Particularly the third point has potential for further study as the nickel-catalyzed SN2’ 
substitution reaction has potential for an asymmetric transformation. A full library of BINAM-
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based or thiocarbamate ligands with bulky substituents (Scheme 114) should be synthesized 
and tested in this reaction. Although this work was beyond the scope of this thesis, the 
groundwork has been presented here. 
 
Scheme 114 
Further reactions could also be developed with the allenyl acetates. The allenyl acetates 
synthesized in this work might have interesting applications for instance in Diels-Alder type 
cyclization reactions (Scheme 115).  
 
Scheme 115 
Reissig reported Diels-Alder-type cyclizations of allenic ethers 317 in 2002 [170] with oximes 
318 resulting to interesting heterocycles 319 (Scheme 116). 
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Scheme 116 
There are also known [3+2] cyclizations performed with allenic ethers 320 and aldehydes 322 
[171] (Scheme 117). This type of transformation might also be interesting to try with allenic 
acetates prepared within this thesis work. 
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Scheme 117 
What might be also interesting to try are couplings of the allenic acetate. There are plenty of 
examples of couplings of aromatic or allylic esters 324 and 326 with boronic acids under 
nickel-catalyzed conditions [172] (Scheme 118). This type of reaction has, however, not been 
reported for an allenic carboxylate. 
 
Scheme 118 
In conclusion, the projects presented in this thesis work towards efficient methods to 
synthesize allenic compounds, and their use in gold-catalyzed transformations, and resulted in 
the development of several new reaction methodologies. The work also gave access to several 
new compounds. The work presented in this thesis will act as a base for new inspiring ideas 
and several research projects could arise from the work started in this thesis.  
 
"
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6 Experimental"data"
6.1 General remarks 
All reactions involving air sensitive materials were carried out under argon atmosphere using 
standard Schlenk techniques. Reagents and catalysts were purchased reagent grade and used 
without further purification. Aldehydes were distilled prior to use. Diethyl ether and 
tetrahydrofuran were distilled under argon from Na-benzophenone and dichloromethane was 
distilled from CaH2. All other chemicals were purchased from commercial sources and used as 
received. Column chromatography was carried out with Acros silica gel 60 and petroleum 
ether used in column chromatography had boiling range 40 °C-60 °C. 1H and 13C NMR spectra 
were recorded with Bruker DRX 400, DRX 500, DPX400 or AV400 spectrometers at room 
temperature with CDCl3 as solvent, and signals are assigned as singlet (s),  doublet (d), triplet 
(t), quartet (q), quintet, sextet and septet. Chemical shifts were determined relative to the 
residual solvent peaks (CDCl3: h=7.26 for protons, h=77.1 for carbon atoms). J values are 
given in Hertz. Infrared spectra were recorded using Bruker Tensor 27 spectrometer. Specific 
rotations were measured using Perkin Elmer 341 or ADP440 polarimeter BS at ambient 
conditions and are given in 10-1 deg cm2 g-1; c is in g per 100 cm3 of solvent. Mass spectra were 
obtained on Bruker  Daltonics  micro  TOF (ESI),  Bruker  Daltonics  APEX 4 ECR FTMS (EI)  
and VG Autospec (EI). Elemental analyses were performed using a Fisons Instruments EA 
1108 CHN elemental analyser. Gas Chromatographers used were Varian 420 or CE 
Instruments GC 8000 and columns used was octakis(2,6-di-O-methyl-3-O-pentyl)-け-
cyclodextrin and octakis(2,3-di-O-pentyl-6-O-methyl)-け-cyclodextrin. 
6.2 Tandem Enzyme/Gold –catalyzed reactions 
4-Cyclohexylidenebut-3-en-2-ol: general procedure for g-hydroxyallenes 139 (139a)  
 
A solution of 1-ethynylcyclohexanol (2.5 g, 20 mmol, 100 mol%) and DHP (2.75 ml, 30 mmol, 
150 mol%) in dry CH2Cl2 (10 ml) was cooled to 0 ºC and p-TsOH (0.038 g, 0.2 mmol, 1 
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mol%) was added. The reaction was quickly warmed to rt and then cooled to 挑78 ºC. To the 
reaction mixture was first added THF (10 ml) followed by dropwise addition of n-BuLi (2.5 M, 
8 ml, 20 mmol, 100 mol%). After 30 min stirring (typically the reaction mixture warmed to 
about 挑40 ºC during this time) acetaldehyde (1.3 ml, 22 mmol, 110 mol%) was added and 
reaction allowed to warm slowly to rt. The reaction was quenched with saturated NH4Cl 
solution and the aqueous phase was extracted three times with Et2O. The combined organics 
were washed with saturated aqueous NaCl solution and dried with Na2SO4 and concentrated in 
vacuo to provide the intermediate for the next step. 
To a slurry of LiAlH4 (1.5 g, 40 mmol, 200 mol%) in Et2O (50 ml) was added dropwise a 
solution of previous crude product dissolved in Et2O (20 ml). The reaction mixture was 
refluxed for 2 h and then the reaction was quenched with water at 0 ºC. The reaction mixture 
was filtered through a pad of Celite which was washed with Et2O (3 x 30 ml). The reaction 
solvents were evaporated and the residue purified by flash column chromatography (30:1-10:1 
cyclohexane:EtOAc) to give the product as a clear oil (1.18 g, 7.74 mmol, 39% over 3 steps). 
Rf = 0.36 (4:1 cyclohexane: EtOAc); 1H NMR (400 MHz, CDCl3): hH 5.16-5.14 (m, 1H), 4.30-
4.26 (m, 1H), 2.15-2.11 (m, 4H), 1.64 (s, 1H, OH), 1.60-1.50 (m, 6H), 1.27 (d, 3H, J = 6.5 Hz); 
13C NMR (101 MHz, CDCl3):  hC 196.0, 106.5, 95.1, 66.4, 31.8, 27.6, 26.2, 23.6; IR (cm -1) 
ちmax 3595 (alcohol), 3302, 3053, 2980, 2934, 2855, 1447, 1423, 1265, 1075, 739, 705; MS m/z 
(EI), for C10H16O [M+] calc. 152.1196, found 152.1189, error 4.45 ppm; GC separation: the 
temperature program 70 ºC 5min, 70 ºC-115 ºC 2 ºC/min gave retention times for enantiomers 
of (23.79/24.31 min). 
1-Cyclohexylidenehex-1-en-3-ol (139b) 
 
1-Ethynylcyclohexanol (2.5 g, 20 mmol, 100 mol%) and butanal (1.9 ml, 22 mmol, 110 mol%) 
gave the title compound as a clear oil (2.8 g, 10 mmol, 50%); Rf = 0.42 (4:1 cyclohexane: 
EtOAc); 1H NMR (400 MHz, CDCl3): hH 5.10-5.08 (m, 1H), 4.10-4.08 (m, 1H), 2.15-2.11 (m, 
4H), 1.63-1.37 (m, 10 H), 0.93 (t, 3H, J = 7.2 Hz); 13C NMR (101 MHz, CDCl3):  hC 196.2, 
106.0, 93.6, 69.9, 39.6, 31.5 (2C diastereotopic), 27.4 (2C diastereotopic), 26.0, 18.6, 13.9; IR 
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(cm -1)  ちmax 3598, 3054, 2985, 2958, 2933, 2873, 2855; MS m/z (EI), for C12H20O [M+] calc. 
180.15109, found 180.1511, error 1.42 ppm; GC separation: the temperature program 100 ºC 
5 min, 100-130 ºC 2 ºC/min gave retention times for enantiomers of (19.24/19.44 min). 
5-Methylhexa-3,4-dien-2-ol (139c) 
 
2-Methylbut-3-yn-2-ol (2.0 ml, 20 mmol, 100 mol%) and acetaldehyde (1.3 ml, 22 mmol, 110 
mol%) gave the title compound as a slightly yellow oil (1.4 g, 12 mmol, 60%); Rf = 0.22 (4:1 
cyclohexane:EtOAc); 1H NMR (400 MHz, CDCl3): hH 5.16-5.06 (m, 1H), 4.29-4.23 (m, 1H), 
1.80 (bs, 1H), 1.7 (m, 6H, 2 x CH3 diastereotopic), 1.25 (d, 3H, J = 6.5 Hz); 13C NMR (101 
MHz, CDCl3): hC 199.4, 99.0, 95.2, 66.3, 27.0, 23.6, 20.8 (2C diastereotopic); IR (cm -1) ちmax 
3597, 3054, 2983, 2930, 2911, 2872, 2854, 1266, 738, 705; MS m/z (EI),  for  C7H12O [M+] 
calc. 112.0888, found 112.0883, error 4.37 ppm; GC separation: the temperature program 40 
ºC 5 min, 40 ºC-80 ºC 2 ºC/min gave retention times for enantiomers of (17.96/19.42 min). The 
NMR data in literature corresponds to this experimental data [173]. 
7-Methylocta-5,6-dien-4-ol (139d) 
 
2-Methylbut-3-yn-2-ol (2.0 ml, 20 mmol, 100 mol%) and butanal (2.0 ml, 22 mmol, 110 
mol%)  gave  the  title  compound  as  a  clear  oil  (1.1  g,  7.7  mmol,  38%);  Rf = 0.39 (4:1 
cyclohexane:EtOAc); 1H NMR (400 MHz, CDCl3): hH 5.05-5.08 (m, 1H), 4.11-4.06 (m, 1H), 
1.71 (2 x d, app. t, 6H, J = 3.01 Hz, 2 x CH3 diastereotopic), 1.57-1.35 (m, 5H) 0.93 (t, 3H, J = 
7.2 Hz); 13C NMR (101 MHz, CDCl3):  hC 199.8, 98.8, 93.9, 70.2, 39.8, 20.8 (2C 
diastereotopic), 18.8, 14.2; IR (cm -1)  ちmax 3427, 3055, 2963, 2936, 2874, 1729, 1382, 1266, 
739, 705; MS m/z (EI), for C9H16O [M+] calc. 140.1196, found 140.1199, error 2.21 ppm; GC 
separation: the temperature program 40 ºC 5min, 40 ºC-90 ºC 0.5 ºC/min gave retention times 
for the enantiomers of (59.71/60.57 min). 
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2-Methyltrideca-2,3-dien-5-ol (139e) 
 
2-Methylbut-3-yn-2-ol (2.0 ml, 20 mmol, 100 mol%) and nonanal (3.1 g, 22 mmol, 110 mol-
%) gave the title compound as a clear oil (3.2 g, 15 mmol, 76%); Rf = 0.45 (4:1 
cyclohexane:EtOAc); 1H NMR (400 MHz, CDCl3): hH 5.09-5.04 (m, 1H), 4.13-4.06 (m, 1H), 
1.71 (2 x d, app. t, 6H, J = 2.6 Hz, 2 x CH3 diasterotopic), 1.61 (1H, OH), 1.54-1.23 (m, 14H), 
0.87 (m, 3H); 13C NMR (101 MHz, CDCl3): hC 200.0, 98.7, 93.9, 70.4, 37.7, 32.0, 29.8 (2C), 
29.4, 25.6, 22.8, 20.8 (2C), 14.3; IR (cm -1) ちmax 3366, 2926, 2855, 2359, 1970; MS m/z (EI), 
for  C14H26O [M+] calc. 210.1978, found 210.1983, error 2.49 ppm; GC separation: the 
temperature program 40 ºC 5 min, 40 ºC-100 ºC 0.5 ºC/min gave retention times for the 
enantiomers of (97.5/98.4 min). 
1-Cyclohexyl-4-methylpenta-2,3-dien-1-ol (139f) 
HO
 
2-Methylbut-3-yn-2-ol (2.0 ml, 20 mmol, 100 mol%) and cyclohexanecarbaldehyde (2.7 ml, 22 
mmol, 110 mol%) gave the title compound as a clear oil (2.2 g, 12 mmol, 61%); Rf = 0.41 (4:1 
cyclohexane:EtOAc); 1H NMR (400 MHz, CDCl3): hH 5.06-5.03 (m, 1H), 3.86-3.82 (m, 1H), 
1.86-1.74 (m, 2H), 1.71 (2 x d, app. t, 6H, J = 3.3 Hz, 2 x CH3 diasterotopic), 1.67-1.54 (m, 
2H), 1.42-1.36 (m, 1H), 1.27-0.98 (m, 6H), OH not observed; 13C NMR (101 MHz, CDCl3): hC 
200.1, 98.7, 92.3, 74.5, 44.2, 28.8, 28.4, 26.7, 26.3, 20.8; IR (cm -1)  ちmax 3600, 3054, 2985, 
2929, 2854, 2305, 1450, 1421, 1265, 895, 746, 705; MS m/z  (EI),  for  C12H20O [M+] calc. 
180.1509, found 180.1509, error 0.23 ppm; GC separation: the temperature program 80 ºC 5 
min, 80 ºC-220 ºC 5 ºC/min a single retention time of (17.32 min). 
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1-Cyclohexyl-3-cyclohexylideneprop-2-en-1-ol (139g) 
 
1-Ethynylcyclohexanol (2.6 g, 20 mmol, 100 mol%) and cyclohexanecarbaldehyde (2.7 ml, 22 
mmol, 110 mol%) gave the title compound as a very viscose clear oil (2.6 g, 12 mmol, 58%); 
Rf = 0.45 (4:1 cyclohexane:EtOAc); 1H NMR (400 MHz, CDCl3): hH 5.08-5.06 (m, 1H), 3.86-
3.82 (m, 1H), 2.15-2.11 (m, 4H), 1.86-1.53 (m, 11H), 1.42-1.39 (m, 1H), 1.26-0.99 (m, 6H); 
13C NMR (101 MHz, CDCl3):  hC 196.6, 106.2, 92.2, 74.5, 44.1, 31.7, 28.9, 28.4, 27.6, 26.7, 
26.2; IR (cm -1) ちmax 3598, 3054, 2986, 2930, 2854, 1448, 142, 1265, 895, 746, 705; MS m/z 
(EI), for C15H24O [M+] calc. 220.1822, found 220.1812, error 4.31 ppm; GC separation: the 
temperature program 90 ºC 5 min, 90 ºC-220 ºC 2 ºC/min gave a single retention time of (42.53 
min). 
1-Cyclopentylidenehex-1-en-3-ol (139h) 
 
1-Ethynylcyclopentanol (2.2 g, 20 mmol, 100 mol%) and butanal (1.9 g, 22 mmol, 110 mol%) 
gave the title compound as a light yellow oil (1.0 g, 12 mmol, 60%); Rf  =   0.36  (4:1  
cyclohexane:EtOAc); 1H NMR (400 MHz, CDCl3): hH 5.18-5.15 (m, 1H), 4.14-4.07 (m, 1H), 
2.38-2.35 (m, 5H), 1.71-1.34 (m, 8H), 0.92 (t, 3H, J = 7.3 Hz); 13C NMR (101 MHz, CDCl3): 
hC 195.1, 107.3, 96.4, 70.2, 39.8, 31.6 (2C), 27.2, 18.8, 14.2; IR (cm -1) ちmax 3398, 2958, 2871, 
2252, 1436, 1383, 1015, 909, 734, 650; MS m/z (EI), for C11H18O [M+] calc. 166.1352, found 
166.1347, error 2.99 ppm; GC separation: the temperature program 40 ºC 5 min, 40 ºC - 220 
ºC 10 ºC/min gave retention times for the enantiomers of (42.07/43.08 min). 
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1-Cyclohexylidene-5-phenylpent-1-en-3-ol (139i) 
 
1-Ethynylcyclohexanol (2.6 g, 20 mmol, 100 mol%) and hydrocinnamaldehyde (3.2 ml, 24 
mmol, 120 mol-%) gave the title compound as a clear oil (2.5 g, 10 mmol, 50%); Rf  =  0.47 
(4:1 cyclohexane:EtOAc); 1H NMR (400 MHz, CDCl3):  hH 7.31-7.28 (m, 2H), 7.23-7.18 (m, 
3H), 5.16-5.14 (m, 1H), 4.16-4.11 (m, 1H), 2.81-2.68 (m, 2H), 2.18-2.15 (m, 4H), 1.91-1.86 
(m, 2H), 1.67-1.51 (m, 6H); 13C NMR (101 MHz, CDCl3):  hC 196.6, 142.2, 128.6, 128.4, 
125.8, 106.3, 93.6, 69.6, 39.2, 31.8 (2C), 27.5, 26.1; IR (cm -1) ちmax 3362, 3062, 3026, 2930, 
2853, 2252, 1965, 1460, 1446, 1031, 971, 909, 742, 700, 650 ; MS m/z (EI), for C17H22O [M+] 
calc. 242.1665, found: 242.1675, error 4.01 ppm; GC separation: the temperature program 40 
ºC 5 min, 40 ºC - 220 ºC 10 ºC/min gave a single retention time of (25.41 min). 
4-Cyclohexylidenebut-3-en-2-yl Acetate: general procedure to g-allenic acetates 140 
(140a) 
 
To a solution of 4-cyclohexylidenebut-3-en-2-ol (139a, 2.8 g, 18.4 mmol, 100 mol%) in dry 
CH2Cl2 (450 ml) at r.t. was added DMAP (0.45 g, 3.7 mmol, 20 mol%) and NEt3 (5.1 ml, 36.8 
mmol, 200 mol%). The reaction mixture was cooled to 0 ºC and Ac2O (3.5 ml, 36.8 mmol, 200 
mol%) was added. The mixture was left to stir at r.t. overnight. The reaction mixture was 
concentrated in a rotary evaporator and the residue was purified by flash column 
chromatography (10:1 cyclohexane: EtOAc) to give the title compound as a clear oil (2.4 g, 
12.4 mmol, 68%); Rf = 0.65 (4:1 cyclohexane: EtOAc); 1H NMR (400 MHz, CDCl3): hH 5.35-
5.29 (m, 1H), 5.11-5.09 (m, 1H), 2.15-2.09 (m, 4H), 2.04 (s, 3H), 1.62-1.52 (m, 6H), 1.31 (d, 
3H, J =  6.5  Hz,  CH3 terminal); 13C NMR (101 MHz, CDCl3):  hC 198.3, 170.6, 105.7, 90.6, 
69.4, 31.4, 27.5, 26.2, 21.6, 19.9; IR (cm -1) ちmax 3055, 2983, 2933, 2892, 2855, 1732, 1447, 
1371, 1265, 1246, 1039, 739; MS m/z  (EI),  for  C12H18O2 [M+] calc. 194.1301, found 
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194.1295, error 3.01 ppm; GC separation: the temperature program 70 ºC 5min, 70 ºC-115 ºC 
2 ºC/min gave a single retention time of (26.14 min). 
1-Cyclohexylidenehex-1-en-3-yl Acetate (140b) 
 
1-Cyclohexylidenehex-1-en-3-ol (139b, 2.0 g, 11 mmol, 100 mol%) gave the title compound 
as a clear oil (2.0 g, 8.8 mmol, 80%); Rf = 0.66 (4:1 cyclohexane:EtOAc); 1H NMR (400 MHz, 
CDCl3):  hH 5.21-5.16 (m, 1H), 5.02-5.00 (m, 1H), 2.14-2.11 (m, 4H), 2.04 (s, 3H), 1.65-1.33 
(m, 10H), 0.92 (t, 3H, J = 6.8 Hz); 13C NMR (101 MHz, CDCl3): hC 198.6, 170.5, 105.0, 89.3, 
73.0, 36.3, 31.4, 27.5, 26.2, 21.6, 18.8; IR (cm -1)  ちmax 2958, 2932, 2855, 1968, 1733, 1371, 
1240, 1018, 739; MS m/z (EI), for C14H22O2 [M+] calc. 222.1614, found 222.1612, error 1.17 
ppm; GC separation: the temperature program 100 ºC 5 min, 100-130 ºC 2 ºC/min gave a 
single retention time of (20.96 min). 
5-Methylhexa-3,4-dien-2-yl Acetate (140c) 
 
5-Methylhexa-3,4-dien-2-ol (139c, 0.56 g, 5 mmol, 100 mol%) gave the title compound as a 
clear oil (0.53 g, 3.4 mmol, 68%); Rf = 0.52 (4:1 cyclohexane:EtOAc); 1H NMR (400 MHz, 
CDCl3): hH 5.31-5.29 (m, 1H), 5.08-5.06 (m, 1H), 2.03 (s, 3H), 1.69 (app. d, 6H, J = 3.0 Hz, 2 
x CH3 diastereotopic), 1.29 (d, 3H, J = 6.5 Hz); 13C NMR (101 MHz, CDCl3): hC 201.7, 170.6, 
98.4, 90.7, 69.4, 21.5, 20.4 (2C diastereotopic, 2 x CH3), 19.9; IR (cm -1)  ちmax 3054, 2986, 
2931, 1727, 1371, 1265, 1046, 739, 705; MS m/z  (EI),  for  C9H14O2 [M+] calc. 154.0988, 
found 154.0987, error 0.63 ppm; GC separation: the temperature program 40 ºC 5 min, 40 ºC-
80 ºC 2 ºC/min gave retention times for the enantiomers of (18.19/18.53 min). 
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7-Methylocta-5,6-dien-4-yl Acetate (140d) 
 
7-Methylocta-5,6-dien-4-ol (139d,  0.68  g,  5  mmol,  100 mol%) gave  the  title  compound as  a  
clear oil (0.45 g, 2.5 mmol, 50%); Rf = 0.63 (4:1 cyclohexane:EtOAc); 1H NMR (400 MHz, 
CDCl3):  hH 5.18-5.16 (m, 1H), 5.00-4-97 (m, 1H), 2.03 (s, 3H), 1.70-1.68 (m, 6H, 2 x CH3 
diastereotopic), 1.64-1.53 (m, 2H), 1.42-1.30 (m, 2H), 0.91 (t, 3H, J = 7.5 Hz); 13C NMR (101 
MHz, CDCl3):  hC 202.0, 170.6, 97.8, 89.4, 72.9, 36.4, 21.5, 20.4 (2C diastereotopic), 18.8, 
14.0; IR (cm -1) ちmax 3054, 2962, 2913, 2874, 1728, 1371, 1265, 1249, 739, 705; MS m/z (EI), 
for  C11H18O2 [M+] calc. 182.1301, found 182.1294, error 4.20 ppm; GC separation: the 
temperature program 40 ºC 5min, 40 ºC-90 ºC 0.5 ºC/min gave retention times for the 
enantiomers of (55.23/56.13 min). 
2-Methyltrideca-2,3-dien-5-yl Acetate (140e) 
 
2-Methyltrideca-2,3-dien-5-ol (139e, 1.1 g, 5 mmol, 100 mol%) gave the title compound as a 
clear oil (1.2 g, 4.6 mmol, 92%); Rf = 0.54 (4:1 cyclohexane:EtOAc); 1H NMR (400 MHz, 
CDCl3):  hH 5.17-5.15 (m, 1H), 5.00-4.97 (m, 1H), 2.04 (s, 3H), 1.70-1.68 (m, 6H, 2 x CH3 
diastereotopic), 1.64-1.50 (m, 2H), 1.33-1.26 (m, 12H), 0.88 (t, 3H, J = 7.2 Hz); 13C NMR 
(101 MHz, CDCl3):  hC 202.0, 170.6, 97.8, 89.5, 73.2, 34.3, 32.0, 29.7, 29.5 (2C), 25.5, 22.8, 
21.5, 20.4 (2C), 14.3; IR (cm -1) ちmax 3155, 2928, 2857, 2254, 1972, 1726, 1251, 912, 735, 651; 
MS m/z  (EI),  for  C16H28O2 [M+] calc. 252.2084, found 252.2096, error 4.95 ppm; GC 
separation: the temperature program 40 ºC 5 min, 40 ºC-220 ºC 10 ºC/min gave a single 
retention time of (18.83 min). 
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1-Cyclohexyl-4-methylpenta-2,3-dienyl Acetate (140f) 
AcO
 
1-Cyclohexyl-4-methylpenta-2,3-dien-1-ol (139f,  0.90  g,  5  mmol,  100  mol%)  gave  the  title  
compound as a clear oil (0.95 g, 4.3 mmol, 85%); Rf = 0.57 (4:1 cyclohexane:EtOAc); 1H 
NMR (400 MHz, CDCl3): hH 4.98-4.89 (m, 2H), 2.04 (s, 3H), 1.78-1.73 (m, 4H), 1.69 (d, 3H, J 
= 2.8 Hz, CH3 diastereotopic), 1.67 (d, 3H, J = 2.8 Hz, CH3 diastereotopic), 1.54-1.50 (m, 1H), 
1.26-0.98 (m, 6H); 13C NMR (101 MHz, CDCl3): hC 202.4, 170.6, 97.2, 87.8, 77.2, 41.8, 28.7 
(2C), 26.1 (2C), 21.4, 20.4; IR (cm -1) ちmax 3155, 2983, 2931, 2855, 2253, 1753, 1724, 1250, 
908, 732, 651; MS m/z (EI), for C14H22O2 [M+] calc. 222.1614, found 222.1613, error 0.49 
ppm; GC separation: the temperature program 80 ºC 5 min, 80 ºC-220 ºC 5 ºC/min gave a 
single retention time of (17.56 min). 
1-Cyclohexyl-3-cyclohexylideneallyl Acetate (140g) 
 
1-Cyclohexyl-3-cyclohexylideneprop-2-en-1-ol (139g, 1.1 g, 5 mmol, 100 mol%) gave the title 
compound as a viscose clear oil (1.1 g, 4.3 mmol, 86%); Rf = 0.57 (4:1 cyclohexane:EtOAc); 
1H NMR (400 MHz, CDCl3): hH 5.00-4.92 (m, 2H), 2.14-2.08 (m, 4H), 2.05 (s, 3H), 1.78-1.72 
(m, 4H), 1.64-1.49 (m, 8H), 1.26-0.99 (m, 5H); 13C NMR (101 MHz, CDCl3): hC 199.0, 170.6, 
104.5, 87.6, 41.8, 31.4, 31.3, 28.9, 28.6, 27.4, 26.6, 26.2, 26.1 (2C); IR (cm -1) ちmax 2931, 2855, 
2253, 1725, 1249, 910, 734; MS m/z (EI), for C17H26O2 [M+] calc. 262.1927, found 262.1920, 
error 2.84 ppm; GC separation: the temperature program 90 ºC 5 min, 90 ºC-220 ºC 2 ºC/min, 
gave a single retention time of (43.69 min). 
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1-Cyclopentylidenehex-1-en-3-yl Acetate (140h) 
 
1-Cyclopentylidenehex-1-en-3-ol (139h, 0.83 g, 5 mmol, 100 mol%) gave the title compound 
as  a  clear  oil  (0.84  g,  4.0  mmol,  81%);  Rf  = 0.58 (4:1 cyclohexane:EtOAc); 1H NMR (400 
MHz, CDCl3): hH 5.20-5.18 (m, 1H), 5.10-5.05 (m, 1H), 2.38-2.31 (m, 4H), 2.03 (s, 3H), 1.70-
1.64 (m, 4H), 1.62-1.51 (m, 2H), 1.38-1.29 (m, 2H), 0.90 (t, 3H, J = 7.5 Hz); 13C NMR (101 
MHz, CDCl3):  hC 197.4, 170.6, 106.3, 91.8, 73.0, 36.3, 31.3, 27.2 (2C), 21.5, 18.8, 14.0; IR 
(cm -1)  ちmax 2961, 2253, 1727, 1372, 1248, 912, 742, 651; MS m/z (EI),  for  C13H20O2 [M+] 
calc. 208.1458, found 208.1461, error 1.56 ppm; GC separation: the temperature program 40 
ºC 5 min, 40 ºC - 220 ºC 10 ºC/min gave a single retention time of (16.81 min). 
1-Cyclohexylidene-5-phenylpent-1-en-3-yl Acetate (140i) 
 
1-Cyclohexylidene-5-phenylpent-1-en-3-ol (139i, 1.2 g, 5 mmol, 100 mol%) gave the title 
compound as a clear oil (1.2 g, 4.1 mmol, 83%); Rf  = 0.59 (4:1 cyclohexane:EtOAc); 1H 
NMR (400 MHz, CDCl3):  hH 7.31-7.27 (m, 2H), 7.21-7.18 (m, 3H), 5.23 (m, 1H), 5.09-5.07 
(m, 1H), 2.73-2.65 (m, 2H), 2.21-2.10 (m, 4H), 2.06 (s, 3H), 1.68-1.49 (m, 8H); 13C NMR 
(101 MHz, CDCl3):  hC 198.7, 170.5, 141.6, 128.5 (2C), 126.0, 105.3, 89.1, 72.5, 35.8, 31.8, 
31.4, 27.4, 27.0, 26.1, 21.4; IR (cm -1) ちmax 3028, 2929, 2853, 2253, 1968, 1735, 1449, 1372, 
1245, 1021, 911, 738, 651; MS m/z (EI) for C19H24O2 [M+] calc. 284.1771, found 284.1772, 
error 0.36 ppm; GC separation: the temperature program 40 ºC 5 min, 40 ºC - 220 ºC 10 
ºC/min, gave a single retention time of (24.8 min). 
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2-Methyl-1-oxaspiro[4.5]dec-3-ene: general procedure to racemic 2,5-dihydrofurans 
(141a) 
 
To a solution of 4-cyclohexylidenebut-3-en-2-ol (139a, 76 mg, 0.5 mmol, 100 mol%) in 
CH2Cl2 (10 ml) at r.t.was added (IPr)AuCl (15 mg, 0.025 mmol, 5 mol%) and AgOTf (7 mg, 
0.025 mmol, 5 mol%). After 1h the reaction mixture was filtered through a pad of Celite, 
which was washed with Et2O (3 x 30 ml). The combined organics were concentrated in vacuo 
and purified by flash column chromatography (30:1 pentane:Et2O)  to  give  the  product  as  a  
clear oil (72 mg, 0.47 mmol, 95%); Rf  = 0.74 (4:1 cyclohexane:EtOAc); 1H NMR (400 MHz, 
CDCl3): hH 5.87 (dd, 1H, J = 6.0, 2.0 Hz), 5.70 (dd, 1H, J = 6.0, 1.2 Hz), 4.91-4.90 (m, 1H), 
1.63-1.73 (m, 2H), 1.53-1.61 (m, 4H), 1.37-1.50 (m, 4H), 1.25 (d, 3H, J = 6.5 Hz); 13C NMR 
(101 MHz, CDCl3):  hC 133.4, 130.4, 89.6, 80.5, 39.6, 39.1, 37.6, 25.6, 23.5 (2C); IR (cm -1) 
ちmax 2973, 2934, 2858, 2253, 1088 (cyclic ether), 908, 734, 650; MS m/z (EI), for C10H16O 
[M+] calc. 152.1196, found: 152.1190, error 3.44 ppm; GC separation: the temperature 
program 70 ºC 5min, 70 ºC-115 ºC 2 ºC/min gave retention times for the enantiomers of 
(7.75/8.48 min). 
2-Propyl-1-oxaspiro[4.5]dec-3-ene (141b) 
 
1-Cyclohexylidenehex-1-en-3-ol (139b, 86 mg, 0.5 mmol, 100 mol%) was suspended in 
distilled water (10 ml) and THF (0.1 ml) was added. The starting material does not dissolve 
entirely but forms small droplets in the reaction mixture. Solution of HAuCl4 (0.15 M in H2O, 
0.17 ml, 0.025 mmol, 5 mol%) was added to the reaction mixture which was left to stir at r.t. 
for 1 h. The reaction mixture was extracted with Et2O (2 x 10 ml) and the combined organics 
were dried over Na2SO4. Purification by flash column chromatography (30:1 pentane:Et2O) 
gave the title compound as a light yellow oil (42 mg, 0.23 mmol, 47%); Rf  = 0.67 (4:1 
cyclohexane:EtOAc); 1H NMR (400 MHz, CDCl3):  hH 5.90 (dd, 1H, J = 6.0, 2.0), 5.72 (dd, 
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1H, J = 6.0, 0.80 Hz), 4.81-4.78 (m, 1H), 1.76-1.64 (m, 4H), 1.60-1.49 (m, 9H), 1.48-1.37 (m, 
1H), 0.93 (t, 3H, J = 7.3 Hz); 13C NMR (101 MHz, CDCl3): hC 133.60, 129.0, 89.2, 84.5, 39.6, 
39.1, 37.7, 25.7 (2C), 23.8, 18.8, 14.4; IR (cm -1) ちmax 3053, 2934, 1448, 1265, 1110, 705; MS 
m/z (EI), for C12H20O [M+] calc. 180.1509, found: 180.1513, error 2.40 ppm; GC separation: 
the temperature program 100 ºC 5 min, 100-130 ºC 2 ºC/min gave retention times for the 
enantiomers of (8.32/8.77 min). 
2,2-Dimethyl-5-propyl-2,5-dihydrofuran (141d) 
 
7-Methylocta-5,6-dien-4-ol (139d, 70 mg, 0.5 mmol, 100 mol%) gave the product as a clear 
oil. Full conversion based on TLC, but the product was so volatile that no isolated yield could 
be recorded; Rf  = 0.59 (4:1 cyclohexane:EtOAc); 1H NMR (400 MHz, CDCl3): hH 5.68 (dd, 
1H, J = 6.0, 2.0 Hz), 5.64 (dd, 1H, J = 6.0, 1.0 Hz), 4.82-4.79 (m, 1H), 1.49 (bs, 6H), in 
between in solvents 4H multiplet,  0.92 (t,  3H, J = 7.6 Hz); 13C NMR (101 MHz, CDCl3):  hC 
135.4, 128.4, 87.1, 85.0, 39.4, 28.0, 27.1, 26.0, 18.8; IR (cm -1) ちmax 2977, 2873, 2253, 1111, 
907, 732, 651; MS m/z (EI), for C9H16O [M+] calc. 140.1196, found 140.1195, error 0.20 ppm; 
GC separation: the temperature program 40 ºC 5min, 40 ºC-90 ºC 0.5 ºC/min gave retention 
times for enantiomers of (9.74/10.42 min). 
2,2-Dimethyl-5-octyl-2,5-dihydrofuran (141e) 
 
2-Methyltrideca-2,3-dien-5-ol (139e, 0.11 g, 0.5 mmol, 100 mol%) gave the title compound as 
a yellow oil (0.10 g, 0.49 mmol, 98%); Rf  = 0.62 (4:1 cyclohexane:EtOAc); 1H NMR (400 
MHz, CDCl3): hH 5.70 (dd, 1H, J = 6.0, 2.5 Hz), 5.65 (dd, 1H, J = 6.0, 1.5 Hz), 4.81-4.78 (m, 
1H), 1.55-1.49 (m, 2H), 1.32 (s, 6H), 1.29-1.25 (m, 12H), 0.87 (t, 3H, J = 6.8 Hz); 13C NMR 
(101 MHz, CDCl3):  hC 135.4, 128.4, 87.1, 85.2, 37.1, 32.0, 30.0, 29.7, 29.4, 28.1, 25.5, 22.8, 
14.3; IR (cm -1) ちmax 2928, 2856, 2253, 1098, 911, 735; MS m/z (EI), for C14H26O [M+] calc. 
210.1978, found 210.1988, error 4.59 ppm; GC separation: the temperature program 40 ºC 5 
min, 40 ºC-100 ºC 0.5 ºC/min gave retention times for the enantiomers of (93.07/94.07 min). 
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5-Cyclohexyl-2,2-dimethyl-2,5-dihydrofuran (141f) 
 
1-Cyclohexyl-4-methylpenta-2,3-dien-1-ol (139f, 90 mg, 0.5 mmol, 100 mol%) gave the title 
compound as a clear oil (86 mg, 0.48 mmol, 96%); Rf  = 0.62 (4:1 cyclohexane:EtOAc); 1H 
NMR (400 MHz, CDCl3):  hH 5.72 (dd, 1H, J = 6.0, 2.5 Hz), 5.66 (dd, 1H, J = 6.0, 1.0 Hz), 
4.61-4.59 (m, 1H), 1.80-1.64 (m, 7H), 1.42-1.40 (m, 1H), 1.31 (s, 3H), 1.28 (s, 3H), 1.01-0.96 
(m, 3H); 13C NMR (101 MHz, CDCl3):  hC 135.8, 126.7, 89.8, 86.9, 43.5, 29.2, 28.9, 26.8, 
26.4, 26.3; IR (cm -1) ちmax 2976, 2928, 2854, 2253, 907, 732, 651; MS m/z (EI), for C12H20O 
[M+] calc. 180.1509, found 180.1509, error 0.43 ppm; GC separation: the temperature 
program 80 ºC 5 min, 80 ºC-220 ºC 5 ºC/min gave retention times for the enantiomers of 
(9.35/9.60 min). 
2-Cyclohexyl-1-oxaspiro[4.5]dec-3-ene (141g) 
 
1-Cyclohexyl-3-cyclohexylideneprop-2-en-1-ol (139g, 110 mg, 0.5 mmol, 100 mol%) gave the 
title compound as a clear oil (107 mg, 0.49 mmol, 98%); Rf  = 0.70 (4:1 cyclohexane:EtOAc); 
1H NMR (400 MHz, CDCl3): hH 5.90 (dd, 1H, J = 6.0, 2.5 Hz), 5.72 (dd, 1H, J = 6.0, 1.0 Hz), 
4.57 (m, 1H), 1.82-1.62 (m, 9H), 1.59-1.39 (m, 6H), 1.26-1.10 (m, 4H), 1.02-0.93 (m, 2H); 13C 
NMR (101 MHz, CDCl3): hC 134.0, 127.3, 89.2, 88.9, 43.8, 38.5, 37.8, 29.4, 28.8, 26.8, 25.7, 
23.9, 23.7; IR (cm -1)  ちmax 2931, 2854, 2253, 1450, 1064, 907, 734, 651; MS m/z (EI), for 
C15H24O [M+] calc. 220.1822, found 220.1815, error 2.89 ppm; GC separation: the 
temperature program 90 ºC 5 min, 90 ºC-220 ºC 2 ºC/min gave retention times for the 
enantiomers of (27.25/27.61 min). 
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2-Propyl-1-oxaspiro[4.4]non-3-ene (141h) 
 
1-Cyclopentylidenehex-1-en-3-ol (139h, 83 mg, 0.5 mmol, 100 mol%) gave the title compound 
as a clear oil (75 g, 0.45 mmol, 90%); Rf  = 0.60 (4:1 cyclohexane:EtOAc); 1H NMR (400 
MHz, CDCl3): hH 5.70 (s, 2H), 4.77 (t, 1H, J = 5.8 Hz), 1.80-1.70 (m, 4H), 1.62-1.59 (m, 4H), 
1.52-1.49 (m, 2H), 1.41-1.33 (m, 2H), 0.92 (t, 3H, J = 7.3 Hz); 13C NMR (101 MHz, CDCl3): 
hC 133.4, 128.8, 97.4, 84.8, 40.2, 39.2, 38.8, 27.1, 24.8 (2C), 18.6, 14.5; IR (cm -1) ちmax 2960, 
2253, 1466, 1384, 913, 743, 651; MS m/z  (EI),  for  C11H18O [M+] calc. 166.1352, found: 
166.1354, error 1.10 ppm; GC separation: the temperature program 40 ºC 5 min, 40 ºC - 220 
ºC 10 ºC/min gave retention times for the enantiomers of (12.22/12.40 min). 
2-Phenethyl-1-oxaspiro[4.5]dec-3-ene (141i) 
 
1-Cyclohexylidene-5-phenylpent-1-en-3-ol (139i, 120 mg, 0.5 mmol, 100 mol%) gave the title 
compound as a clear oil (81 mg, 33 mmol, 67%); Rf  = 0.68 (4:1 cyclohexane:EtOAc) ; 1H 
NMR (400 MHz, CDCl3): hH 7.31-7.25 (m, 2H), 7.23-7.17 (m, 3H), 5.93 (dd, 1H, J = 6.0, 2.3 
Hz), 5.73 (dd, 1H, J = 6.0, 1.0 Hz), 4.87-4.84 (m, 1H), 2.73-2.69 (m, 2H), 1.89-1.83 (m, 2H), 
1.75-1.69 (m, 2H), 1.64-1.57 (m, 4H), 1.51-1.45 (m, 4H) ; 13C NMR (101 MHz, CDCl3):  hC 
142.6, 134.2, 128.7, 128.6, 128.4, 125.8, 89.4, 84.0, 39.1 (2C), 37.7, 31.9, 27.1, 25.7, 23.8 
(2C); IR (cm -1)  ちmax 2934, 2253, 1384, 912, 743, 651; MS m/z,  for  C16H20O [M+] calc. 
242.1671, GC-MS (EI) found peak 242, ESI found peak 241.7; GC separation: the 
temperature program 40 ºC 5 min, 40 ºC - 220 ºC 10 ºC/min gave a single retention time of 
(21.98 min). 
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2-Isobutyl-1-oxaspiro[4.5]dec-3-ene (141j) 
 
1-Cyclohexylidene-5-methylhex-1-en-3-ol (97 mg, 0.5 mmol, 100 mol%) gave the title 
compound as a clear oil (85 mg, 0.44 mmol, 87%); Rf  = 0.73 (4:1 cyclohexane:EtOAc) ; 1H 
NMR (400 MHz, CDCl3):  hH 5.88 (dd, 1H, J = 6.0, 2.5 Hz), 5.74 (dd, 1H, J = 6.0, 1.5 Hz), 
4.85-4.81 (m, 1H), 1.81-1.67 (m, 3H), 1.59-1.54 (m, 4H), 1.49-1.31 (m, 6H), 0.93 (dd, 6H, J = 
6.5, 2.5 Hz) ; 13C NMR (101 MHz, CDCl3): hC 133.4, 129.5, 89.1, 83.2, 47.2, 39.5, 37.7, 27.1, 
25.7 (2C), 23.8 (2C), 23.3 (2C); IR (cm -1) ちmax 2934, 2253, 1384, 908, 735, 651; MS m/z (EI), 
for  C13H22O [M+] calc. 194.1665, found 194.1663, error 1.23 ppm; GC separation: the 
temperature program 40 ºC 5 min, 40 ºC-220 ºC 10 ºC/min gave retention times for the 
enantiomers of (9.09/9.13 min). 
Preparation of phosphate buffer (pH = 7) 
Disodium hydrogenphosphate (Na2HPO3) (1.42 g, 10.0 mmol) was dissolved in 100 ml water. 
Sodium dihydrogenphosphate (NaH2PO4) (1.58 g, 13.1 mmol) was dissolved in 100 ml water 
in a separate flask. Disodium hydrogenphosphate solution (100 ml) and sodium 
dihydrogenphosphate solution (43.3 ml) were combined. For this solution pH paper shows pH 
7. 
General procedure for tandem gold/enzyme-catalyzed reaction on test scales 
The racemic allenic acetoxy compound (10 mg) was dissolved in 2 ml of phosphate buffer (pH 
= 7) and THF (50 たl). Lipase from Burkholderia cepacia (PS Amano SD) was added (amount 
10-100 mg) followed by an addition of HAuCl4 solution (0.012 M in water, 20 たl, 0.5 mol%) 
and the reaction was stirred at room temperature for a given time while being monitored by GC 
analysis. GC samples were taken from the reaction mixture with a Pasteur pipette (0.1 ml) and 
extracted with Et2O (0.1 ml). The organic layer was used directly for GC analysis. 
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General procedure for tandem gold/enzyme-catalyzed reaction on preparative scales 
General reaction conditions: The allenic acetoxy compound (0.5 mmol) was suspended in a 
mixture of phosphate buffer (15 ml, pH = 7) and THF (0.1 ml). The starting material does not 
dissolve entirely but forms little droplets in the reaction mixture. Lipase from Burkholdia 
cepacia (PS Amano SD) was added (160-800 mg) followed by an addition of HAuCl4 solution 
(0.012 M in water, 0.2 ml, 0.5 mol%). The reaction was stirred at r.t. until the desired 
conversion was reached by GC analysis. GC samples were taken from the reaction mixture 
with a Pasteur pipette (0.1 ml) and extracted with Et2O (0.1 ml). The organic fraction was used 
for  GC  analysis.  The  reaction  mixture  was  extracted  5  times  with  Et2O and the combined 
organics were washed with saturated NaCl solution and dried with Na2SO4 and concentrated in 
vacuo. The residue was purified by flash column chromatography (eluent 30:1 pentane: Et2O) 
to give the desired products. 
(R)-2-methyl-1-oxaspiro[4.5]dec-3-ene (R)-(141a) 
 
Racemic 4-cyclohexylidenebut-3-en-2-yl acetate (140a, 80 mg, 0.5 mmol, 100 mol%) was 
dissolved in phosphate buffer solution (15 ml) and THF (0.1 ml) was added. Lipase PS Amano 
SD (160 mg) was added with vigorous stirring and when an aggregate-free suspension was 
formed, HAuCl4 solution (0.012 M in water, 0.2 ml, 0.0025 mmol, 0.5 mol%) was added and 
reaction stirred vigorously at room temperature for 48 h. After workup and purification the 
following products were obtained: (R)-141a (21 mg, 28%); ee 86 %; [g]D = /45.2 (c = 0.38, 
CH2Cl2); (S)-140a (30 mg, 31%); ee 93 %; [g]D = /58.7 (c = 0.45, CH2Cl2). 
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(R)-2-propyl-1-oxaspiro[4.5]dec-3-ene (R)-(141b) 
 
Racemic 1-cyclohexylidenehex-1-en-3-yl acetate (140b, 110 mg, 0.5 mmol, 100 mol%) was 
dissolved in phosphate buffer solution (15 ml) and THF (0.1 ml) was added. Lipase PS Amano 
SD (700 mg) was added with vigorous stirring and when an aggregate-free suspension was 
formed, HAuCl4 solution (0.012 M in water, 0.2 ml, 0.0025 mmol, 0.5 mol%) was added and 
reaction stirred vigorously at room temperature for 48 h. After workup and purification 
following products were obtained: (R)-141b (41 mg, 45%); ee 95 %; [g ]D = /50.3 (c = 0.74, 
CH2Cl2); (S)-140b (44 mg, 40%); ee > 95 %; [g]D = /49.8 (c = 1.4, CH2Cl2). 
(R)-2,2-dimethyl-5-octyl-2,5-dihydrofuran (R)-(141e) 
 
Racemic 2-methyltrideca-2,3-dien-5-yl acetate (140e, 126 mg, 0.5 mmol, 100 mol%) was 
dissolved in phosphate buffer solution (15 ml) and THF (0.1 ml) was added. Lipase PS Amano 
SD (600 mg) was added with vigorous stirring and when an aggregate-free suspension was 
formed, HAuCl4 solution (0.012 M in water, 0.2 ml, 0.0025 mmol, 0.5 mol%) was added and 
reaction stirred vigorously at room temperature for 48 h. After workup and purification the 
following products were obtained: (R)-141e (53 mg, 50%); ee 98 %; [g ]D = /39.1 (c = 1.4, 
CH2Cl2); (S)-140e (45 mg, 36%); ee = 95 %; [g]D = /38.0 (c = 0.65, CH2Cl2). 
(R)-2-propyl-1-oxaspiro[4.4]non-3-ene (R)-(141h) 
 
Racemic 1-cyclopentylidenehex-1-en-3-yl acetate (140h, 105 mg, 0.5 mmol, 100 mol%) was 
dissolved in phosphate buffer solution (15 ml) and THF (0.1 ml) was added. Lipase PS Amano 
SD (800 mg) was added with vigorous stirring and when an aggregate-free suspension was 
formed, HAuCl4 solution (0.012 M in water, 0.2 ml, 0.0025 mmol, 0.5 mol%) was added and 
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reaction stirred vigorously at room temperature for 48 h. After workup and purification the 
following products were obtained: (R)-141h (32 mg, 38%); ee 88 %; [g ]D = /47.2 (c = 0.64, 
CH2Cl2); (S)-140h (35 mg, 33%); ee > 95 %; [g]D = /56.6 (c = 0.70, CH2Cl2). 
General procedure for determining the ee of acetates (S)-140 
Acetate (S)-140 (0.1 mmol, 100 mol%) was dissolved in methanol (1.5 ml) at r.t. and K2CO3 
(14 mg, 0.1 mmol, 100 mol%) was added. After 2 hours water (1 ml) was added to the the 
reaction mixture and the reaction mixture was extracted with Et2O (0.5 ml). The organic 
fraction was dried with Na2SO4 and used directly for gas chromatography analysis. 
6.3 SN2’ approach to the synthesis of allenyl acetates  
1-Ethynylcyclohexyl Acetate: general procedure towards propargylic acetates (176a) 
 
To 1-ethynylcyclohexanol (1.24 g, 10 mmol, 100 mol%) in CH2Cl2 (175 ml) at r.t. was added 
dimethylaminopyridine (0.24 g, 2 mmol, 20 mol%) and triethylamine (2.8 ml, 20 mmol, 200 
mol%). The reaction was cooled to 0 °C and acetic anhydride (2.0 ml, 20 mmol, 200 mol%) 
was added slowly. The mixture was stirred at room temperature overnight and then 
concentrated in a rotary evaporator. Purification of the crude product by flash column 
chromatography (10:1 petroleum ether:Et2O) gave 176a as a clear oil with quantitative yield 
(1.71 g, 10 mmol, 100%). Rf = 0.45 (9:1 petroleum ether:Et2O); 1H NMR (400 MHz, CDCl3) 
hH 2.60 (s,1H), 2.16-2.10 (m, 2H), 2.05 (s, 3H), 1.88-1.82 (m, 2H), 1.65-1.59 (m, 4H), 1.55-
1.49 (m, 1H), 1.36-1.30 (m, 1H); 13C NMR (67.9 MHz, CDCl3) hC 169.3, 83.6, 75.1, 74.2, 36.9 
(2 x CH2), 25.1, 22.5 (2 x CH2), 21.9; IR (cm -1) ちmax 3306, 2941, 1735, 1369, 1240, 1025; MS 
m/z (EI) for C8H12O (M-C2H2O) calc. 124.0883, found 124.0883, error 0.1 ppm. NMR data in 
the literature corresponds to the experimental data [174]. 
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3,5-Dimethylhex-1-yn-3-yl Acetate (176b) 
 
The starting material 3,5-dimethyl-1-hexyn-3-ol (1.47 ml, 10 mmol, 100 mol%) gave the title 
compound as a clear oil (1.52 g, 9.03 mmol, 90%). Rf  = 0.64 (9:1 petroleum ether:Et2O); 1H 
NMR (400 MHz, CDCl3) hH 2.55 (s, 1H), 2.02 (s, 3H), 2.01-1.94 (m, 1H), 1.89-1.84 (m, 1H), 
1.77-1.71 (m, 1H), 1.69 (s, 3H), 0.99 (2 x d, app. t, 6H, J = 6.8 Hz, 2 x CH3 diastereotopic); 
13C NMR (67.9 MHz, CDCl3) hC 169.3, 84.2, 75.0, 73.3, 49.4, 27.1, 24.8, 24.1, 23.7, 22.1; IR 
(cm -1) ちmax 3306, 2961, 1735, 1370, 1248; MS m/z (EI) only fragments of product found; for 
C9H13O2 [M-CH4] calc. 153.0910, found 153. 0910, error 0.20 ppm. 
3-Methylpent-1-yn-3-yl Acetate (176c) 
 
The starting material 3-methyl-1-pentyn-3-ol (1.12 ml, 10 mmol, 100 mol%) gave the title 
compound as a clear oil (1.15 g, 8.17 mmol, 82%). Rf = 0.47 (9:1 petroleum ether:Et2O); 1H 
NMR (400 MHz, CDCl3) hH 2.54 (s, 1H), 2.03 (s, 3H), 2.00-1.82 (m, 2H), 1.66 (s, 3H), 1.02 (t, 
3H, J = 7.6 Hz); 13C NMR (67.9 MHz, CDCl3) hC 169.4, 83.7, 75.3, 73.1, 34.3, 25.9, 21.9, 8.4; 
IR (cm -1)  ちmax 3306, 3010, 1736, 1370, 1250; MS m/z (EI) found [M-Me]+ C7H9O2 calc. 
125.0597, found 125.0597, error 0.20 ppm. The NMR data in the literature corresponds to the 
experimental data [175]. 
3-Methylpent-1-en-4-yn-3-yl Acetate (176d) 
 
The starting material 3-methyl-1-penten-4-yn-3-ol (0.96 g, 10 mmol, 100 mol%) gave the title 
compound as a clear oil (1.07 g, 7.77 mmol, 78%). Rf = 0.44 (9:1 petroleum ether:Et2O); 1H 
NMR (400 MHz, CDCl3) hH 5.98 (dd, 1H, J  = 17.2, 10.4 Hz), 5.58 (dd, 1H, J  = 17.2, 0.4 Hz), 
5.25 (dd, 1H, J
 
= 10.4, 0.4 Hz), 2.67 (s, 1H), 2.04 (s, 3H), 1.71 (s, 3H); 13C NMR (67.9 MHz, 
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CDCl3) hC 168.9, 138.4, 115.7, 82.1, 74.8, 74.0, 28.4, 21.8; IR (cm -1) ちmax 3306, 3009, 1741, 
1370, 1249, 1066; MS m/z (EI) found [M-Me]+ C7H7O2 calc. 123.0441, found 123.0441, error 
0.10 ppm. The NMR data in the literature corresponds to the experimental data [176]. 
2-Phenylbut-3-yn-2-yl Acetate (176e) 
 
The starting material 2-phenyl-3-butyn-2-ol (2.9 g, 20 mmol, 100 mol%) gave the title 
compound as a clear oil (4.0 g, 20 mmol, 100%). Rf = 0.62 (9:1 petroleum ether:Et2O); 1H 
NMR (400 MHz, CDCl3) hH 7.60-7.58 (m, 2H), 7.39-7.35 (m, 2H), 7.32-7.28 (m, 1H), 2.82 (s, 
1H), 2.09 (s, 3H), 1.90 (s, 3H); 13C NMR (67.9 MHz, CDCl3) hC 168.6, 142.1, 128.3, 127.9, 
124.7, 82.9, 75.5, 75.3, 32.0, 21.7; IR (cm -1) ちmax 3306, 3009, 1744, 1369, 1241, 1063; MS 
m/z (ESI) for C12H12NaO2 [M+Na] calc. 211.0730, found 211.0743, error 6.40 ppm. The NMR 
data in the literature corresponds to the experimental data [160b]. 
1,1-Diphenylprop-2-ynyl Acetate (176f) 
 
The starting material 1,1-diphenyl-2-propyn-1-ol (2.08 g, 10 mmol, 100 mol%) gave the title 
compound as a colourless solid (1.77 g, 7.1 mmol, 71%). Rf = 0.25 (20:1 petroleum 
ether:EtOAc), M.p. 77-78 °C; 1H NMR (400 MHz, CDCl3)  hH 7.56-7.53 (m, 4H), 7.37-7.27 
(m, 6H), 3.01 (s, 1H), 2.19 (s, 3H); 13C NMR (67.9 MHz, CDCl3)  hC 168.1, 142.0, 128.3, 
128.0, 126.1, 82.3, 79.0, 78.0, 21.8; IR (cm -1) ちmax 3305, 3009, 1752, 1493, 1450, 1369, 1240; 
MS m/z (ESI) for C17H14NaO2 [M+Na] calc. 273.0886, found 273.0876, error 3.80 ppm. The 
NMR in the literature corresponds to the experimental data [177]. 
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2-Cyclohexylidenevinyl Acetate: general procedure for the silver catalyzed 
rearrangement of propargylic acetates (177a) 
 
To 1-ethynylcyclohexyl acetate (0.16 g, 1.0 mmol, 100 mol%) in CH2Cl2 (5  ml)  at  r.t.  was  
added AgBF4 (19 mg, 0.1 mmol, 10 mol%). After 4 hours reaction was quenched by filtration 
through a pad of Celite and the product was concentrated on a rotary evaporator. The residue 
was purified by flash column chromatography (30:1 pentane:Et2O), which gave the title 
compound as a clear oil (0.15 g, 0.94 mmol, 94%). Rf = 0.75 (9:1 petroleum ether:Et2O); 1H 
NMR (400 MHz, CDCl3) hH 7.21 (quintet, 1H, J = 1.2 Hz), 2.24-2.20 (m, 4H), 2.12 (s, 3H), 
1.70-1.52 (m, 6H); 13C NMR (67.9 MHz, CDCl3)  hC 186.4, 168.9, 118.6, 107.8, 32.6, 27.2, 
25.8, 21.0; IR (cm -1)  ちmax 2936, 1973, 1739, 1447, 1241, 1037; MS m/z  (EI)  for  C10H14O2 
calc. 166.0988, found 166.0988, error 0.40 ppm. The NMR in literature corresponds to 
experimental data [178].  
3,5-Dimethylhexa-1,2-dienyl Acetate (177b) 
 
The starting material 3,5-dimethylhex-1-yn-3-yl acetate (0.17 g, 1.0 mmol, 100 mol%) gave 
the title compound as a clear oil (0.12 g, 0.71 mmol, 71%). Rf = 0.82 (9:1 petroleum 
ether:Et2O); 1H NMR (400 MHz, CDCl3)  hH 7.27 (m, app. sextet, 1H, J = 2.0 Hz), 2.13 (s, 
3H), 1.97-1.94 (m, 2H), 1.81-1.80 (m, 4H), 0.91 (2 x d, 6H, J
 
= 6.8 Hz, 2 x CH3 
diastereotopic); 13C NMR (67.9 MHz, CDCl3) hC 190.0, 168.9, 114.8, 109.1, 44.6, 30.9, 26.3, 
22.5, 22.3, 20.9, 20.6; IR (cm -1) ちmax 2959, 1977, 1741, 1370, 1240, 1042; MS m/z (EI) only 
fragments of product found; for C7H10O2 [M-C3H6] calc. 126.0675, found 126.0675, error 0.1 
ppm. 
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3-Methylpenta-1,2-dienyl Acetate (177c) 
 
The starting material 3-methylpent-1-yn-3-yl acetate (0.14 g, 1.0 mmol, 100 mol%) gave the 
title compound as a clear oil (0.93 g, 0.64 mmol, 64%). Rf = 0.74 (9:1 petroleum ether:Et2O); 
1H NMR (400 MHz, CDCl3) hH 7.31 (m, app. sextet, 1H, J = 2.1 Hz), 2.13 (s, 3H), 2.15-1.99 
(m, 2H), 1.84-1.83 (m, 3H), 1.03 (t, 3H, J = 7.2 Hz); 13C NMR (67.9 MHz, CDCl3) hC 188.9, 
168.8, 117.9, 110.2, 28.2, 21.0, 20.4, 11.9; IR (cm -1) ちmax 2973, 1982, 1741, 1455, 1370, 1255, 
1038; MS m/z (EI) for C8H12O2 calc. 140.0832, found 140.0832, error 0.1 ppm. The NMR in 
literature corresponds to experimental data [178]. 
(E)-2-Cyclohexenylvinyl Acetate (as earlier with AgOTf as catalyst) (178a) 
 
Starting material 1-ethynycyclohexyl acetate (0.16 g, 1.0 mmol, 100 mol%) with AgOTf (25 
mg, 0.1 mmol, 10 mol%) as catalyst gave a mixture of the title compound and 2-
cyclohexylidenevinyl acetate (allenic product) with a 1:0.12 ratio (0.12 g, 0.73 mmol, 73%) as 
a yellow oil. These two compounds could not be separated by flash column chromatography. 
Rf = 0.75 (9:1 petroleum ether:Et2O) for product mixture; Data for 178a: 1H NMR (400 MHz, 
CDCl3) hH 7.28-7.25 (m, 1H), 6.03 (d, 1H, J = 13.2 Hz), 5.71-5.69 (m, 1H), 2.13 (s, 3H), 2.12-
2.09 (m, 4H), 1.69-1.57 (m, 4H); 13C NMR (67.9 MHz, CDCl3) hC 168.2, 133.6, 132.0, 129.0, 
119.0, 25.8, 24.6, 22.3, 22.2, 20.8; IR (cm -1) ちmax 2931, 1743, 1372, 1240, MS m/z (EI) for 
C10H14O2 calc. 166.0988, found 166.0991, error 1.5 ppm. 
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(E)-and (Z)- 3-Methylpent-2-en-4-ynyl Acetate (E/Z-179) 
 
The starting material 3-methylpent-1-en-4-yn-3-yl acetate (0.14 g, 1.0 mmol, 100 mol%) gave 
a mixture of the title compounds as a yellow oil (0.07 g, 0.5 mmol, 50%). The (E)- and (Z)-
isomers could not be separated with flash column chromatography and their absolute 
configuration could not be identified by NMR spectroscopy so they were named isomer A and 
isomer  B,  ratio  of  A:B = 0.18:1  (A being the  minor  isomer)  and this  naming is  used  for  1H 
NMR. Rf = 0.50 (10:1 petroleum ether:Et2O); 1H NMR (400 MHz, CDCl3) hH 6.02-5.98 (m, 
1H)A, 5.89-5.85 (m, 1H)B, 4.78-4.76 (m, 2H)B, 4.65-4.63 (m, 2H)A, 3.20 (s, 1H)B, 2.87 (s, 
1H)A, 2.06 (s, 3+3H)A+B, 1.92-1.91 (m, 3H)B, 1.88-1.87 (m, 3H)A; 13C NMR (67.9 MHz, 
CDCl3) hC 170.9, 132.0, 131.9, 122.4, 82.9, 81.2, 76.0, 62.9, 60.4, 23.0, 20.9, 17.5; IR (cm -1) 
ちmax 3305, 3011, 1737, 1240; MS m/z (EI) for C8H10O2 calc. 138.0675, found 138.0674, error 
0.9 ppm. 
2,7-Diphenylocta-5,6-dien-3-yn-2-yl Acetate (180) 
 
The starting material 2-phenylbut-3-yn-2-yl acetate (0.37 g, 2 mmol, 100 mol%) was dissolved 
in benzene (30 ml) at r.t. and CuCl (10 mg, 0.1 mmol, 5 mol%) was added. The reaction was 
refluxed for 30 min, cooled to r.t. and filtrated through a pad of Celite and concentrated on a 
rotary evaporator. The residue was purified by flash column chromatography (20:1-10:1 
pentane:Et2O) and the title compound was obtained as a yellow oil (0.92 g, 0.29 mmol, 30%). 
Rf = 0.32 (20:1 petroleum ether:EtOAc); 1H NMR (400 MHz, CDCl3) hH 7.58-7.56 (m, 2H), 
7.43-7.24 (m, 8H), 5.85 (q, 1H, J = 2.8 Hz), 2.17 (dd, 3H, J
 
= 2.8, 1.2 Hz), 2.08 (s, 3H), 1.90 
(s, 3H); 13C NMR (67.9 Mz, CDCl3) hC 213.7, 168.6, 142.7, 135.4, 128.5, 128.3, 127.7, 127.4, 
126.2, 124.9, 103.1, 88.8, 80.0, 77.2, 76.2, 32.1, 21.8, 16.6, IR (cm -1) ちmax 3156, 3011, 2253, 
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1743, 910; MS m/z (ESI) for C22H20NaO2 [M+Na] calc. 339.1356, found 339.1357, error 0.60 
ppm. The NMR in literature corresponds to experimental data [124]. 
1-Methyl-1H-inden-2-yl Acetate (181) 
 
To 2-phenylbut-3-yn-2-yl acetate (94 mg, 0.5 mmol, 100 mol%) in CH2Cl2 (10 ml) at r.t. was 
added Au(IPr)Cl (15 mg, 0.025 mmol, 5 mol%) and AgOTf (6.4 mg, 0.025 mmol, 5 mol%). 
After 50 min the reaction mixture was filtrated through a pad of Celite and product was 
concentrated on a rotary evaporator. The residue was purified by flash column chromatography 
(30:1 pentane:Et2O) and the title compound was obtained as a clear oil (36 mg, 0.19 mmol, 
38%). Rf = 0.75 (9:1 petroleum ether:Et2O); 1H NMR (400 MHz, CDCl3)  hH 7.31-7.14 (m, 
4H), 6.62 (d, 1H, J = 1.2 Hz), 3.59 (m, 1H), 2.28 (s, 3H), 1.34 (d, 3H, J = 7.6 Hz); 13C NMR 
(67.9 MHz, CDCl3)  hC 168.0, 159.9, 141.7, 142.8, 126.8, 124.5, 122.3, 121.0, 113.1, 43.2, 
21.3, 14.8; IR (cm -1) ちmax 2971, 1764, 1600, 1463, 1370, 1199; MS m/z (ESI) for C12H12NaO2 
[M+Na] calc. 211.0730, found 211.0742, error 5.80 ppm. The title compound is identified in 
the literature, but no NMR data of this single isomer is available [160b]. 
3-Phenylpropiolaldehyde: general procedure for the synthesis of propargylic aldehydes 
186 starting from alcohols 189 (186a) 
 
To 3-phenylprop-2-yn-1-ol (189a, 1.32g, 10 mmol, 100 mol%) in CH2Cl2 (200 ml, used as 
received) was added activated MnO2* (13.0 g, 150 mmol, 15 equiv) and the reaction was 
stirred vigorously overnight at room temperature. The reaction was quenched by filtration 
through Celite and the solvents were evaporated on a rotary evaporator. If necessary, the 
residue was purified by flash column chromatography (9:1 petroleum ether:Et2O) but often the 
crude product was used in the next reaction step without further purification (1.24 g, 9.5 mmol, 
95%). 
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*The manganese oxide used in this reaction can be activated by drying it overnight in an 80 °C 
oven.  The  same  manganese  oxide  could  be  used  at  least  up  to  five  times  without  loss  of  
activity. 
3-Phenylpropiolaldehyde: general procedure starting from phenylacetylene  
 
To phenylacetylene (5.5 ml, 50 mmol, 100 mol%) in THF (125 ml) at -40 °C was added slowly 
n-BuLi (1.6 M, 31.3 ml, 50 mmol, 100 mol%) followed by anhydrous DMF (dried over 
molecular sieves: 7.75 ml, 100 mmol, 200 mol%). The reaction mixture was then poured into a 
vigorously stirred biphasic solution prepared from 10% aqueous solution of KH2PO4 (27 g of 
KH2PO4 in 270 ml H2O, 200 mmol, 400 mol%) and MTBE (250 ml) cooled to 5 °C. The layers 
were  separated  and  the  organic  layer  was  washed  with  water  (2  x  200  ml).  The  combined  
aqueous layers were then extracted with MTBE (150 ml) and all the combined organic 
fractions were dried over MgSO4, filtered and concentrated on a rotary evaporator to give 3-
phenylpropiolaldehyde as a clear oil (6.35 g, 49 mmol, 97%). The crude product was often 
used in the next reaction step without further purification but the aldehyde can be purified by 
flash column chromatography (9:1 petroleum ether:Et2O). 
Rf = 0.67 (4:1 petroleum ether:EtOAc); 1H NMR (400 MHz, CDCl3) hH 9.43 (s, 1H), 7.62-7.60 
(m, 2H), 7.49-7.48 (m, 1H), 7.43-7.39 (m, 2H); 13C NMR (67.9 MHz, CDCl3) hC 176.9, 133.4, 
131.4, 128.8, 119.5, 95.2, 88.5; IR (cm -1) ちmax 3011, 2976, 2191, 1659, 1248, 1046, 980, 877; 
MS m/z (EI) for C9H6O1 calc. 130.0419, found 130.0417, error 1.5 ppm. The NMR data in the 
literature correspond to the experimental data [179]. 
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3-p-Tolylpropiolaldehyde (186b) 
 
The starting material 3-p-tolylprop-2-yn-1-ol (189b, 1.4 g, 9.7 mmol, 100 mol%) gave the title 
compound as a yellow oil (1.2 g, 8.0 mmol, 82%) and recovered starting material (0.17 g, 1.2 
mmol, 12%). Rf = 0.83 (4:1 petroleum ether:EtOAc); 1H NMR (400 MHz, CDCl3) hH 9.41 (s, 
1H), 7.51-7.49 (m, 2H), 7.21-7.20 (m, 2H), 2.39 (s, 3H); 13C NMR (67.9 MHz, CDCl3)  hC 
176.8, 142.2, 133.3, 129.5, 116.3, 95.9, 88.4, 21.8; IR (cm -1)  ちmax 2187, 1656, 1606, 1509, 
985, 820; MS m/z (EI) for C10H8O calc. 144.0575, found 144.0570, error 1.62 ppm The NMR 
data in the literature correspond to the experimental data [180]. 
3-m-Tolylpropiolaldehyde (186c) 
 
The starting material 3-m-tolylprop-2-yn-1-ol (189c, 1.1 g, 7.4 mmol, 100 mol%) gave the title 
compound as a yellow oil (0.75 g, 5.2 mmol, 70%). Rf = 0.75 (4:1 petroleum ether:EtOAc); 1H 
NMR (400 MHz, CDCl3) hH 9.42 (s, 1H), 7.43-7.42 (m, 2H), 7.30-7.29 (m, 2H), 2.37 (s, 3H); 
13C NMR (67.9 MHz, CDCl3) hC 176.8, 138.6, 133.7, 132.2, 130.4, 128.6, 119.2, 95.2, 88.2, 
21.1; IR (cm -1) ちmax 2253, 2187, 1659, 1467, 1382, 1097, 909, 651; MS m/z (EI) for C10H8O 
calc. 144.0570, found 144.0570, error 0.10 ppm.  
3-(4-Methoxyphenyl)propiolaldehyde (186d) 
 
The starting material 3-(4-methoxyphenyl)prop-2-yn-1-ol (189d, 0.83 g, 5.1 mmol, 100 mol%) 
gave the title compound as a yellow solid (0.64 g, 4.0 mmol, 79%). Rf = 0.66 (4:1 petroleum 
ether:EtOAc); M.p. 44-45 °C; 1H NMR (400 MHz, CDCl3) hH 9.39 (s, 1H), 7.58-7.55 (m, 2H), 
6.93-6.90 (m, 2H), 3.85 (s, 3H); 13C NMR (67.9 MHz, CDCl3) hC 176.7, 162.2, 135.4, 116.5, 
114.5, 96.6, 55.5, one quaternary carbon could not be seen; IR (cm -1) ちmax 2183, 1653, 1602, 
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1510, 1256, 982, 835; MS m/z  (EI)  for  C11H12O3Na [M+MeOH+Na] calc. 215.0684, found 
215.0679, error 2.32 ppm. The NMR data in the literature correspond to the experimental data 
[180]. 
3-Cyclohexenylpropiolaldehyde (186e) 
 
The stating material 3-cyclohexenylprop-2-yn-1-ol (189e, 1.4 g, 10 mmol, 100 mol%) gave the 
title compound as a yellow oil (0.76 g, 5.6 mmol, 56%) and recovered starting material (0.41 g, 
3.0 mmol, 26%). Rf = 0.70 (4:1 petroleum ether:EtOAc); 1H NMR (400 MHz, CDCl3) hH 9.30 
(s, 1H), 6.55-6.53 (m, 1H), 2.21-2.16 (m, 4H), 1.70-1.60 (m, 4H); 13C NMR (67.9 MHz, 
CDCl3) hC 177.0, 144.1, 119.3, 97.8, 87.1, 28.1, 26.3, 21.9, 21.0; IR (cm -1) ちmax 2254, 2179, 
1655, 1467, 1383, 908, 651; MS m/z (EI), for C9H10O calc. 134.0726, found 134.0726, error 
0.10 ppm. The NMR data in the literature correspond to the experimental data [181]. 
5-Phenylpent-2-ynal (186f) 
 
The starting material 5-phenylpent-2-yn-1-ol (189f, 0.62 g, 3.9 mmol, 100 mol%) gave the title 
compound as a clear oil (0.47 g, 3.0 mmol, 77%). Rf = 0.80 (4:1 petroleum ether:EtOAc); 1H 
NMR (400 MHz, CDCl3) hH 9.16 (s, 1H), 7.34-7.31 (m, 2H), 7.27-7.22 (m, 3H), 2.92 (t, 2H, J 
= 7.2 Hz), 2.72 (t, 2H, J =  7.2  Hz)  ;  13C NMR (67.9 MHz, CDCl3)  hC 177.1, 139.4, 128.6, 
128.3, 126.7, 97.9, 82.1, 33.7, 21.2; IR (cm -1)  ちmax 2202, 1663, 1137; MS m/z (EI), for 
C11H10O1Na [M+Na] calc. 181.0629, found 181.0624, error 2.76 ppm. 
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3-(Phenanthren-9-yl)propiolaldehyde (186g) 
 
The starting material 3-(phenanthren-9-yl)prop-2-yn-1-ol (189g, 0.48 g, 2.1 mmol, 100 mol%) 
gave the title compound as a yellow solid (0.32 g, 1.4 mmol, 66%). Rf = 0.71 (4:1 petroleum 
ether:EtOAc); M.p. 94-95 °C; 1H NMR (400 MHz, CDCl3) hH 9.59 (s, 1H), 8.68-8.63 (m, 2H), 
8.39-8.37 (m, 1H), 8.19 (s, 1H), 7.88-7.86 (m, 1H), 7.74-7.69 (m, 3H), 7.63-7.61 (m, 1H); 13C 
NMR (67.9 MHz, CDCl3) hC 176.5, 136.3, 131.5, 130.4 (2C), 129.9, 129.2, 129.1, 127.6 (2C), 
127.3, 126.4, 122.9, 122.7, 115.8, 93.6, 92.6; IR (cm -1)  ちmax 3156, 2988, 2856, 2253, 2184, 
1656; MS m/z (ESI) for C17H10O1Na [M+Na] calc. 253.0624, found 253.0626, error 0.80 ppm. 
3-(4-t-Butylphenyl)propiolaldehyde (186h) 
 
The starting material 1-t-butyl-4-ethynylbenzene (4.0 g, 25 mmol, 100 mol%) gave the title 
compound as a yellow oil (4.5 g, 24 mmol, 95%). Rf = 0.59 (9:1 petroleum ether:EtOAc); 1H 
NMR (400 MHz, CDCl3) hH  9.42 (s, 1H), 7.56-7.53 (m, 2H), 7.44-7.42 (m, 2H), 1.33 (s, 9H); 
13C NMR (100.6 MHz, CDCl3) hC 177.0, 155.3, 133.4, 126.0, 116.5, 96.1, 88.6, 35.3, 31.2; IR 
(cm -1)  ちmax 3011, 2189, 1656, 1604, 986, 839; MS m/z  (ESI),  for  C13H14NaO [M+Na] calc. 
209.0937, found 209.0936, error 0.20 ppm. 
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3-Phenylprop-2-yne-1,1-diyl Diacetate: general procedure towards propargylic diacetates 
(187a) 
 
Solid FeCl3 (0.24 g, 1.5 mmol, 10 mol%) was dissolved in CH2Cl2 (150 ml) at r.t. and left to 
stir for 15 min before addition of 3-phenylpropiolaldehyde (186a, 2.1 g, 15 mmol, 100 mol%) 
in 10 ml of CH2Cl2 followed by the addition of Ac2O (1.4 ml, 15 mmol, 100 mol%). After 3 
hours the reaction was quenched with saturated aqueous NaHCO3 solution. The mixture was 
washed three times with saturated aqueous NaHCO3 solution, and the combined aqueous layers 
were re-extracted once with CH2Cl2. The combined organic fractions were washed once more 
with saturated aqueous NaHCO3 solution, then with saturated aqueous NaCl solution and dried 
over MgSO4 and concentrated in vacuo. The residue was purified by flash column 
chromatography (30:1-10:1 petroleum ether:EtOAc) to give the title compound as a yellow oil 
(2.9 g, 12.4 mmol, 83%). Some remaining aldehyde could be recovered (0.27 g, 2.1 mmol, 
14%).  Rf = 0.61 (4:1 petroleum ether:EtOAc); 1H NMR (400 MHz, CDCl3) hH 7.51-7.48 (m, 
3H), 7.38-7.31 (m, 3H), 2.15 (s, 6H); 13C NMR (67.9 MHz, CDCl3)  hC 168.1, 132.1, 129.5, 
128.3 (2C), 86.8, 81.4, 80.0, 20.7; IR (cm -1) ちmax 3010, 2976, 2895, 2240, 1826, 1767, 1372, 
1245, 1126, 1046, 956, 877; MS m/z  (ESI)  for  C13H12O4Na [M+Na] calc. 255.0628, found 
255.0624, error 1.30 ppm. The NMR data in the literature correspond to the experimental data 
[125]. 
3-p-Tolylprop-2-yne-1,1-diyl Diacetate (187b) 
 
The starting material 3-p-tolylpropiolaldehyde (186b, 0.33 g, 2.3 mmol, 100 mol%) gave the 
title compound as a yellow solid (0.35 g, 1.4 mmol, 63%) and recovered starting material 
(0.080g, 0.55 mmol, 26%). Rf = 0.43 (4:1 petroleum ether:EtOAc); M.p. 64-65 °C; 1H NMR 
(400 MHz, CDCl3) hH 7.48 (s, 1H), 7.39-7.37 (m, 2H), 7.14-7.12 (m, 2H), 2.35 (s, 3H), 2.15 (s, 
6H); 13C NMR (67.9 MHz, CDCl3) hC 168.2, 139.8, 132.0, 129.1, 117.7, 87.0, 80.8, 80.0, 21.6, 
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20.7; IR (cm -1)  ちmax 3156, 2253, 1766, 1466, 1375, 910; MS m/z  (ESI)  for  C14H14O4Na 
[M+Na] calc. 269.0784, found 269.0785, error 0.40 ppm. 
3-m-Tolylprop-2-yne-1,1-diyl Diacetate (187c) 
 
The starting material 3-m-tolylpropiolaldehyde (186c, 0.58 g, 4.1 mmol, 100 mol%) gave the 
title compound as a yellow oil (0.73 g, 2.9 mmol, 72%). Rf = 0.61 (4:1 petroleum 
ether:EtOAc); 1H NMR (400 MHz, CDCl3) hH 7.48 (s, 1H), 7.33-7.29 (m, 2H), 7.24-7.19 (m, 
2H), 2.33 (s, 3H), 2.15 (s, 6H); 13C NMR (67.9 MHz, CDCl3) hC 168.2, 138.2, 132.7, 130.4, 
129.2, 128.3, 120.6, 87.0, 81.1, 80.1, 21.2, 20.8; IR (cm -1) ちmax 2254, 1768, 1467, 1378, 1097, 
907, 651; MS m/z (ESI) for C14H14O4Na [M+Na] calc. 269.0784, found 269.0790, error 1.90 
ppm. 
3-(4-Methoxyphenyl)prop-2-yne-1,1-diyl Diacetate (187d) 
 
The starting material 3-(4-methoxyphenyl)propiolaldehyde (186d, 0.59 g, 3.7 mmol, 100 
mol%) gave the title compound as a yellow oil (0.25 g, 0.95 mmol, 26%) and recovered 
starting material (0.15 g, 1.1 mmol, 27%). Rf = 0.33 (4:1 petroleum ether:EtOAc); 1H NMR 
(400 MHz, CDCl3) hH 7.47 (s, 1H), 7.45-7.41 (m, 2H), 6.86-6.83 (m, 2H), 3.81 (s, 3H), 2.15 (s, 
6H); 13C NMR (67.9 MHz, CDCl3) hC 168.2, 160.5, 133.7, 114.0, 112.7, 86.9, 80.4, 80.1, 55.3, 
20.7; IR (cm -1) ちmax 3156, 2253, 1767, 1606, 1511, 1466, 1376, 1096, 906; MS m/z (ESI) for 
C14H14O5Na [M+Na] calc. 285.0733, found 285.0734, error 0.20 ppm. 
  
138 
 
3-Cyclohexenylprop-2-yne-1,1-diyl Diacetate (187e) 
 
The starting material 3-cyclohexenylpropiolaldehyde (186e, 0.60 g, 4.5 mmol, 100 mol%) gave 
the title compound as a colourless solid (0.52 g, 2.2 mmol, 49%) and recovered starting 
material (0.13 g, 0.93 mmol, 21%). Rf = 0.59 (4:1 petroleum ether:EtOAc); M.p. 58-69 °C; 1H 
NMR (400 MHz, CDCl3) hH 7.36 (s, 1H), 6.27-6.25 (m, 1H), 2.12 (s, 6H), 2.17-2.09 (m, 2H), 
1.63-1.55 (m, 6H); 13C NMR (67.9 MHz, CDCl3)  hC 168.2, 138.4, 118.9, 88.7, 80.1, 78.8, 
28.5, 25.7, 22.0, 21.2, 20.7; IR (cm -1) ちmax 2254, 1765, 1467, 1380, 1097, 907, 651; MS m/z 
(ESI) for C13H16O4Na [M+Na] calc. 259.0941, found 259.0946, error 2.20 ppm. 
5-Phenylpent-2-yne-1,1-diyl Diacetate (187f) 
 
The starting material 5-phenylpent-2-ynal (186f,  0.85  g,  5.4  mmol,  100 mol%) gave  the  title  
compound as a yellow oil (0.87 g, 3.3 mmol, 62%) and recovered stating material (0.14 g, 0.91 
mmol, 17%). Rf = 0.46 (4:1 petroleum ether:EtOAc); 1H NMR (400 MHz, CDCl3) hH 7.31-
7.28 (m, 2H), 7.24-7.19 (m, 4H), 2.85 (t, 2H, J = 7.9 Hz), 2.56-2.52 (m, 2H), 2.11 (s, 6H); 13C 
NMR (67.9 MHz, CDCl3)  hC 168.2, 140.0, 128.4 (2C), 126.5, 87.7, 79.8, 73.9, 34.3, 20.8, 
20.7; IR (cm -1)  ちmax 3156, 2989, 2253, 1765, 1467, 1375, 1246, 1163, 1096, 903; MS m/z 
(ESI) for C15H16O4Na [M+Na] calc. 283.0941, found 283.0944, error 1.10 ppm. 
3-(Phenanthren-9-yl)prop-2-yne-1,1-diyl Diacetate (187g) 
 
The starting material 3-(phenanthren-9-yl)propiolaldehyde (186g, 71 mg, 0.31 mmol, 100 
mol%) gave the title compound as a yellow thick oil (52 mg, 0.15 mmol, 51%) and recovered 
starting material (18 mg, 0.08 mmol, 26%). Rf = 0.53 (4:1 petroleum ether:EtOAc); 1H NMR 
(400 MHz, CDCl3) hH 8.69-8.65 (m, 2H), 8.39-8.37 (m, 1H), 8.09 (s, 1H), 7.87-7.85 (m, 1H), 
139 
 
7.72-7.68 (m, 3H), 7.68 (s, 1H), 7.66-7.60 (m, 1H), 2.22 (s, 6H); 13C NMR (67.9 MHz, CDCl3) 
hC 168.3, 133.5, 130.7 (3C), 130.0, 128.8, 128.1, 127.3 (2C), 127.1, 126.6, 122.8, 122.6, 117.2, 
85.7, 85.2, 80.2, 20.8; IR (cm -1) ちmax 3156, 2988, 2253, 1766, 1375, 901; MS m/z (ESI) for 
C21H16O4Na [M+Na] calc. 355.0941, found 355.0927, error 3.80 ppm. 
3-(4-t-Butylphenyl)prop-2-yne-1,1-diyl Diacetate (187 h) 
 
The starting material 3-(4-t-butylphenyl)propiolaldehyde (186h, 4.5 g, 24 mmol, 100 mol%) 
gave the title compound as a dark oil (1.1 g, 3.7 mmol, 16%) and starting material (2.7 g, 14 
mmol, 60%). Rf = 0.17 (9:1 petroleum ether:Et2O); 1H NMR (400 MHz, CDCl3) hH 7.48 (s, 
1H), 7.43-7.42 (m, 2H), 7.35-7.33 (m, 2H), 2.15 (s, 6H), 1.31 (s, 9H) ; 13C NMR (100.6 MHz, 
CDCl3) hC 168.2, 152.9, 131.9, 125.4, 117.7, 87.0, 80.8, 80.1, 34.9, 31.1, 20.7; IR (cm -1) ちmax 
2968, 2240, 1766, 1242; MS m/z  (ESI),  for  C17H24NO4 [M+NH4] calc. 306.1700, found 
306.1692, error 2.70 ppm. 
3-Phenylprop-2-yne-1,1-diyl bis(2,2-Dimethylpropanoate) (187i) 
 
The starting material 3-phenylpropiolaldehyde (186a, 2.0 g, 15 mmol, 100 mol%) and pivalic 
anhydride (2.8 g, 15 mmol, 100 mol%) gave the title compound as a thick yellow oil (2.2 g, 7.0 
mmol, 46%). Rf = 0.83 (9:1 petrol ether:Et2O); 1H NMR (400 MHz, CDCl3) hH 7.52-7.49 (m, 
2H), 7.48 (s, 1H), 7.40-4.31 (m, 3H), 1.24 (s, 18H); 13C NMR (67.9 MHz, CDCl3) hC 175.7, 
132.1, 129.3, 128.3, 121.1, 86.3, 81.9, 80.3, 38.8, 26.8; IR (cm -1) ちmax 3011, 2241, 1751, 1492; 
MS m/z (ESI) for C19H24NaO4 [M+Na] calc. 339.1567, found 339.1565, error 0.60 ppm. 
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3-Phenylprop-2-yne-1,1-diyl Dibenzoate (187j) 
 
The starting material 3-phenylpropiolaldehyde (186a, 2.0 g, 15 mmol, 100 mol%) and benzoic 
anhydride (3.4 g, 15 mmol, 100 mol%) gave the title compound as a colourless solid (1.0 g, 2.9 
mmol, 20%). Purification by crystallization from EtOAc/petroleum ether. Rf = 0.60 (9:1 
petroleum ether:Et2O); M.p. 111-112 °C; 1H NMR (400 MHz, CDCl3) hH 8.16-8.13 (m, 4H), 
8.04 (s, 1H), 7.63-7.54 (m, 4H), 7.49-7.45 (m, 4H), 7.39-7.32 (m, 3H); 13C NMR (67.9 MHz, 
CDCl3) hC 163.9, 133.8, 132.2, 130.2, 129.5, 128.6, 128.5, 128.4, 120.9, 87.1, 81.7, 81.1; IR 
(cm -1)  ちmax 3066, 2244, 1744, 1272, MS m/z  (ESI)  for  C23H16NaO4 [M+Na] calc. 379.0941, 
found 379.0942, error 0.30 ppm. 
3-Phenylprop-2-yne-1,1-diyl d-diacetate (d-187a) 
O
O
CD3
CD3
O O
O
H
D3C
O
O CD3
O
FeCl3 (10 mol%)
CH2Cl2, r.t. 5 h
 
The starting material 3-phenylpropiolaldehyde (186a, 1 g, 7.7 mmol, 100 mol%) and d-acetic 
anhydride (0.72 ml, 7.7 mmol, 100 mol%) gave the title compound as yellow oil (1.0 g, 4.2 
mmol, 55%). Rf = 0.23 (9:1 petroleum ether:Et2O); 1H NMR (400 MHz, CDCl3) hH 7.52-7.49 
(m, 2H), 7.49 (s, 1H), 7.40-7.31 (m, 3H), 2.13 (quintet, 0.03H, J =  2.0  Hz,  CD3); 13C NMR 
(100.6 MHz, CDCl3) hC 169.2, 132.1, 129.5, 128.4, 120.8, 86.7, 81.5, 79.9, 20.0 (t, CD3, J = 
20.1 Hz); IR  (cm -1)  ちmax 3045, 2241, 1763, 1493, 1249; MS m/z  (ESI),  for  C13H6D6NaO4 
[M+Na] calc. 261.1004, found 261.0997, error 2.70 ppm. 
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3-Phenylprop-2-yn-1-ol: general procedure towards propargylic alcohols (189a) 
 
To phenylacetylene (6.6 ml, 60 mmol, 100 mol%) in THF (30 ml) at -78 °C was added slowly 
n-BuLi (2M, 30 ml, 60 mmol, 100 mol%). After 30 min (temperature usually around -50 °C) 
paraformaldehyde (5.4 g, 180 mmol, 300 mol%) was added in three portions and the reaction 
was left to warm up to room temperature overnight. The mixture was diluted with Et2O and 
quenched with saturated aqueous NH4Cl solution. The aqueous phase was extracted three times 
with Et2O and the  combined organic  layers  were  washed with  brine,  then  dried  with  MgSO4 
and concentrated in vacuo. Further purification was not always needed for the next reaction 
step but the product can be purified by flash column chromatography (10:1 petrol ether:Et2O). 
The product was obtained as a yellow oil (7.1 g, 54 mmol, 90%). Rf = 0.31 (4:1 petroleum 
ether:EtOAc); 1H NMR (400 MHz, CDCl3) hH 7.45-7.43 (m, 2H), 7.33-7.31 (m, 3H), 4.50 (s, 
2H), 1.80 (bs, 1H); 13C NMR (67.9 MHz, CDCl3)  hC 131.8, 131.7, 128.5, 128.3, 87.2, 85.7, 
51.6; IR (cm -1) ちmax 3606, 3403, 1490, 3006, 2872, 1443, 1383, 1031, 1021; MS m/z (EI) for 
C9H8O calc. 132.0575, found 132.0570, error 0.65 ppm. The NMR in the literature corresponds 
to the experimental data [182]. 
3-p-Tolylprop-2-yn-1-ol (189b) 
 
The starting material 4-ethynyltoluene (1.0 g, 8.6 mmol, 100 mol%) gave the title compound as 
a clear oil (0.89 g, 6.1 mmol, 71%). Rf = 0.44 (4:1 petroleum ether:EtOAc); 1H NMR (400 
MHz, CDCl3) hH 7.34-7.32 (m, 2H), 7.12-7.10 (m, 2H), 4.49 (s, 2H), 2.34 (s, 3H), 1.88 (bs, 
1H); 13C NMR (67.9 MHz, CDCl3)  hC 138.6, 131.5, 129.0, 119.4, 86.0, 85.8, 51.6, 21.4; IR 
(cm -1) ちmax 3607, 3407, 3004, 2924, 2871, 2237, 1731, 1510, 1382, 1025, 820; MS m/z (EI) 
for C10H10O1Na [M+Na] calc. for 169.0629, found 169.0624, error 2.71 ppm. The NMR data in 
literature corresponds to experimental data [183]. 
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3-m-Tolylprop-2-yn-1-ol (189c) 
 
The starting material m-tolylacetylene (1.0 g, 8.6 mmol, 100 mol%) gave the title compound as 
a yellow oil (1.2 g, 8.5 mmol, 99%). Rf = 0.21 (4:1 petroleum ether:EtOAc); 1H NMR (400 
MHz, CDCl3) hH 7.27-7.13 (m, 4H), 4.49 (s, 2H), 2.32 (s, 3H), 1.70 (bs, 1H); 13C NMR (67.9 
MHz, CDCl3)  hC 138.0, 132.3, 129.4, 128.7, 128.2, 122.3, 86.8, 85.9, 51.7, 21.2; IR (cm -1) 
ちmax 3601, 2254, 1381, 909, 651; MS m/z  (EI)  calc.  for  C10H10O 146.0726, found 146.0726, 
error 0.10 ppm. 
3-(4-Methoxyphenyl)prop-2-yn -1-ol (189d) 
 
The starting material 4-ethynylanisole (1.0 g, 7.6 mmol, 100 mol%) gave the title compound as 
a yellow solid (0.88 g, 5.4 mmol, 71%) and recovered starting material (0.25 g, 1.9 mmol, 
25%). Rf = 0.30 (4:1 petroleum ether:EtOAc); M.p. 61-62 °C; 1H NMR (400 MHz, CDCl3) hH 
7.38-7.36 (m, 2H), 6.84-6.83 (m, 2H), 4.48 (s, 2H), 3.81 (s, 2H), 2.17 (bs, 1H); 13C NMR (67.9 
MHz, CDCl3) hC 159.7, 133.2, 114.6, 113.9, 85.8, 85.6, 55.3, 51.7; IR (cm -1) ちmax 3688, 3605, 
3002, 2937, 2840, 2234, 1607, 1509, 1248, 1034, 833; MS m/z (EI), for C10H10O2Na [M+Na] 
calc. 185.0578, found 185.1. The Mp [184] and NMR [185] data in the literature correspond to 
the experimental data. 
3-Cyclohexenylprop-2-yn-1-ol (189e) 
 
The starting material 1-ethynylcyclohexene (2.0 g, 19 mmol, 100 mol%) gave the title 
compound as a clear oil (1.7 g, 12 mmol, 66%). Rf = 0.25 (4:1 petroleum ether:EtOAc); 1H 
NMR (400 MHz, CDCl3) hH"h 6.13-6.11 (m, 1H), 4.37 (d, 2H, J = 4.81 Hz), 2.13-2.07 (m, 4H), 
1.66-1.54 (m, 5H); 13C NMR (67.9 MHz, CDCl3) hC 135.5, 120.1, 87.6, 84.5, 51.7, 29.1, 25.6, 
22.2, 21.4; IR (cm -1) ちmax 3600, 3156, 2254, 1467, 1381, 910, 651; MS m/z (EI), for C9H12O 
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calc. 136.0883, found 136.0883, error 0.10 ppm. The NMR data in the literature corresponds to 
the experimental data [186]. 
5-Phenylpent-2-yn-1-ol (189f) 
 
The starting material 4-phenyl-1-butyne (1.0 g, 7.7 mmol, 100 mol%) gave the title compound 
as a clear oil (0.77 g, 4.8 mmol, 63%) and recovered starting material (0.38 g, 2.9 mmol, 37%). 
Rf = 0.39 (4:1 petroleum ether:EtOAc); 1H NMR (400 MHz, CDCl3)  hH 7.32-7.28 (m, 2H), 
7.24-7.20 (m, 3H), 4.23 (t, 2H, J = 2.4 Hz), 2.84 (t, 2H, J = 7.6 Hz), 2.52 (tt, 2H, J = 2.4, 7.6 
Hz), 1.72 (bs, 1H); 13C NMR (67.9 MHz, CDCl3) hC 140.5, 128.4 (2C), 126.3, 87.9, 85.7, 51.3, 
34.9, 20.9; IR (cm -1) ちmax 3611, 3387, 3065, 3007, 2931, 2868, 2223, 1496, 1453, 1384, 1007; 
MS m/z  (EI)  for  C11H12O1Na [M+Na] calc. 183.0786, found 183.0780, error 1.32 ppm. The 
NMR data in literature correspond to experimental data [187]. 
3-(Phenanthren-9-yl)prop-2-yn-1-ol (189g) 
 
The starting material 9-ethynylphenanthrene (0.88 g, 4.3 mmol, 100 mol%) gave the title 
compound as a yellow solid (0.65 g, 2.8 mmol, 64%) and recovered starting material (0.29 g, 
1.4 mmol, 34%). Rf = 0.27 (4:1 petroleum ether:EtOAc); M.p. 126-127 °C; 1H NMR (400 
MHz, CDCl3) hH 8.69-8.63 (m, 2H), 8.44-8.42 (m, 1H), 7.99 (s, 1H), 7.84-7.81 (m, 1H), 7.69-
7.64 (m, 3H), 7.61-7.59 (m, 1H), 4.69 (s,2H), 2.07 (bs, 1H); 13C NMR (67.9 MHz, CDCl3) hC 
132.2, 131.0, 130.9, 130.3, 130.0, 128.5, 127.5, 127.1, 127.0, 126.9, 126.8, 122.7, 122.5, 118.9, 
91.7, 83.9, 51.8; IR (cm -1) ちmax 3029, 3017, 2253, 1230, 1224, 1207, 802; MS m/z (ESI) for 
C17H12O1Na [M+Na] calc. 255.0780, found 255.0784, error 1.40 ppm. 
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3-Phenylpenta-1,2-dienyl Acetate: Method 1 to the synthesis of allenyl acetates via 
cuprate mediated SN2’ nucleophilic substitution (190b) 
 
CuI (0.62 g, 3.3 mmol, 250 mol%) and LiBr (0.28 g, 3.3 mmol, 250 mol%) were dried briefly 
in a Schlenck tube under vacuum with a heat gun. The mixture was cooled to room temperature 
and flushed with argon, cooled to 挑10 ºC and THF (25 ml) was added. EtMgBr (1 M  in 
MTBE, 3.2 ml, 3.2 mmol, 240 mol%) was added slowly and after 10 min 3-phenylprop-2-yne-
1,1-diyl diacetate (187a, 0.3 g, 1.3 mmol, 100 mol%) was added in THF (5 ml). After 30 min 
the reaction was quenched with a saturated aqueous NH4Cl/NH3 solution (prepared by adding 
10 ml of NH3 to 500 ml of saturated aqueous NH4Cl solution) and left to stir 2-3 min at 挑10 °C. 
The mixture was diluted with Et2O (150 ml) and the organic fraction was extracted and washed 
with NH4Cl/NH3 solution 3-4 times or until the aqueous phase was not blue. The organic phase 
was then washed with saturated aqueous NaCl solution, dried with MgSO4 and concentrated in 
vacuo. The crude product was purified by flash column chromatography (30:1 pentane:Et2O) 
and product was obtained as a yellow oil (0.23 g, 1.1 mmol, 88%). Compound data as 
described in method 2. 
3-Phenylpenta-1,2-dienyl Acetate: Method 2 to the synthesis of allenyl acetates via nickel 
catalyzed SN2’ nucleophilic substitution (190b) 
 
Solid Ni(acac)2 (TOXIC!) (6.4 mg, 0.025 mmol, 5 mol%) and (±)-NOBIN (10 mg, 0.035 
mmol, 7 mol%) were charged in a Schlenck tube and Et2O (5 ml) added. The reaction mixture 
was cooled to +4 °C and after 10 min ZnEt2 (1 M in hexanes, 2.5 ml, 2.5 mmol, 500 mol%) 
was added. After another 10 min 187a (0.116 g, 0.5 mmol, 100 mol%) was added in Et2O (5 
ml) over 1 h via a syringe pump. After 3 h the reaction was quenched with saturated aqueous 
NH4Cl solution and the aqueous layer was extracted three times with Et2O. The combined 
organics were washed with saturated aqueous NaCl solution, dried over MgSO4 and 
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concentated in vacuo. The residue was purified by flash column chromatography (30:1 
pentane:Et2O) and the title compound was obtained as a yellow oil (0.063 g, 0.31 mmol, 62%). 
Rf = 0.78 (4:1 petroleum ether:EtOAc); 1H NMR (400 MHz, CDCl3) hH 7.73 (t, 1H, J = 2.6 
Hz), 7.48-7.45 (m, 2H), 7.37-7.27 (m, 3H), 2.65-2.51 (m, 2H), 2.17 (s, 3H), 1.18 (t, 3H, J = 7.8 
Hz); 13C NMR (67.9 MHz, CDCl3) hC 192.5, 168.7, 135.7, 128.4, 128.0, 126.6, 121.8, 113.4, 
24.3, 20.9, 12.2; IR (cm -1)  ちmax 3010, 1750, 1372, 1240; MS m/z  (ESI)  for  C13H14O2Na 
[M+Na] calc. 225.0886, found 225.0893, error 2.90 ppm. 
Copper-catalyzed synthesis of allenyl acetate 190b in toluene 
 
CuBr•SMe2 (8.8 mg, 0.043 mmol, 10 mol%) and PCy3 (12.1 mg, 0.043 mmol, 10 mol%) were 
charged in a Schlenk tube and toluene (5 ml) was added at r.t and the mixture was cooled down 
to 挑20 °C. Diacetate (187a, 100 mg, 0.43 mmol, 100 mol%) was added in CH2Cl2 (1 ml) 
followed by addition of EtMgBr (2 M, 0.26 ml, 0.52 mmol, 120 mol%) over 30 minutes. The 
reaction was let to stir at 挑20 °C for 2 hours before quenching the reaction by addition of 
saturated aqueous NH4Cl solution. The aqueous phase was extracted with CH2Cl2 and the 
combined organic layers were concentrated on a rotary evaporator to give 3-phenylpenta-1,2-
dienyl acetate (190b, 24 mg, 0.12 mmol, 28%) and 1-Phenylpent-1-yn-3-ol (197, 5.5 mg, 0.03 
mmol, 8%). 
1-Phenylpent-1-yn-3-ol (197); Rf = 0.80 (4:1 petroleum ether:EtOAc); 1H NMR (400 MHz, 
CDCl3) hH 7.45-7.42 (m, 2H), 7.31-7.28 (m, 3H), 4.55 (t, 1H, J = 7.2 Hz), 2.30 (bs, 1H, OH), 
1.87-1.79 (m, 2H), 1.08 (t, 3H, J = 7.6 Hz); 13C NMR (67.9 MHz, CDCl3) hC 131.6, 128.3, 
128.2, 122.6, 90.0, 84.8, 64.1, 30.9, 9.5; IR compound was not pure enough for analysis; MS 
m/z  (EI)  for  C11H12O calc. 160.0888, found 160.0891, error 1.7 ppm. The NMR data in the 
literature correspond to the experimental data [188]. 
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Copper-catalyzed synthesis of allenyl acetate 190b in toluene 
 
Same procedure as above with mTHF as solvent gave 3-phenylpenta-1,2-dienyl acetate (190b, 
10.3 mg, 0.05 mmol, 12%), penta-1,2-dien-3-ylbenzene (195, 9.3 mg, 0.06 mmol, 15%) and 
hepta-3,4-dien-3-ylbenzene (196, 2.2 mg, 0.01 mmol, 3%). 
Penta-1,2-dien-3-ylbenzene (195); Yellow oil, Rf = 0.95 (4:1 petroleum ether:EtOAc); 1H 
NMR (400 MHz, CDCl3) hH 7.40-7.15 (m, 5H), 5.07 (t, 2H, J = 3.6 Hz), 2.44-2.37 (m, 2H), 
1.13 (m, 3H); 13C NMR (67.9 MHz, CDCl3) hC 208.4, 136.5, 128.3, 126.5, 128.9, (106.7), 78.7 
(CH2), 22.4, 12.5 sample contained impurities in the NMR spectra; IR compound was not pure 
enough for analysis; MS m/z (EI) for C11H12 calc. 144.0939, found 144.0925, error 9.8 ppm. 
The NMR data in the literature correspond to the experimental data [189]. 
Hepta-3,4-dien-3-ylbenzene (196); Yellow oil, Rf = 0.95 (4:1 petroleum ether:EtOAc); 1H 
NMR (400 MHz, CDCl3) hH 7.44-7.17 (m, 5H), 5.64-5.60 (m, 1H), 2.46-2.42 (m, 2H), 2.19-
2.11 (m, 2H), 1.15 (t, 3H, J = 6.8 Hz), 1.08 (t, 3H, J = 6.8 Hz); 13C NMR (67.9 MHz, CDCl3) 
hC 203.1, (128.2, 126.3, 125.7, 96.8, 22.8, 22.3, 13.5, 12.6) sample contained impurities in the 
NMR spectra; IR compound was not pure enough for analysis; MS m/z (EI) for C13H16 calc. 
172.1252, found 172. 1259, error 4.3 ppm. 
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3-Phenylbuta-1,2-dienyl Acetate (190a) 
 
Using method 1, the starting material 3-phenylprop-2-yne-1,1-diyl diacetate (187a, 0.23 g, 1.0 
mmol, 100 mol%) and MeMgBr (0.8 ml, 3 M, 2.4 mmol, 240 mol%) gave the title compound 
as a yellow oil (0.056 g, 0.30 mmol, 30%). Rf = 0.84 (4:1 petroleum ether:EtOAc); 1H NMR 
(400 MHz, CDCl3) hH 7.63 (q, 1H, J = 2.0 Hz), 7.50-7.47 (m, 2H), 7.38-7.26 (m, 3H), 2.25 (d, 
3H, J = 2.0 Hz), 2.17 (s, 3H); 13C NMR (67.9 MHz, CDCl3)  hC 193.1, 168.7, 135.7, 128.4, 
128.1, 126.4, 114.7, 111.2, 20.9, 18.4; IR (cm -1)  ちmax 3156, 2253, 1748, 1466, 1373, 1098, 
906; MS m/z (ESI) for C12H12O2Na [M+Na] calc. 211.0730, found 211.0737, error 3.50 ppm. 
3-Phenylhepta-1,2-dienyl Acetate (190c) 
 
Using method 1, the starting material 3-phenylprop-2-yne-1,1-diyl diacetate (187a, 0.23 g, 1.0 
mmol, 100 mol%) with n-BuMgCl (1.2 ml, 2 M, 2.4 mmol, 240 mol%) gave the title 
compound as a yellow oil (0.15 g, 0.65 mmol, 65%). Rf = 0.84 (4:1 petroleum ether:EtOAc); 
1H NMR (400 MHz, CDCl3) hH 7.69 (t, 1H, J = 1.8 Hz), 7.48-7.45 (m, 2H), 7.36-7.27 (m, 3H), 
2.63-2.49 (m, 2H), 2.17 (s, 3H), 1.60-1.53 (m, 2H), 1.47-1.38 (m, 2H), 0.94 (t, 3H, J = 7.6 Hz); 
13C NMR (67.9 MHz, CDCl3) hC 192.8, 168.8, 135.7, 128.5, 128.0, 126.7, 120.1, 112.7, 31.0, 
29.9, 22.4, 21.0, 13.9; IR (cm -1) ちmax 3156, 2254, 1747, 1467, 1381, 1097, 907; MS m/z (ESI) 
for C15H18O2Na [M+Na] calc. 253.1199, found 253.1199, error 0.10 ppm. 
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3-Phenylpenta-1,2-dienyl Pivalate (190d) 
 
Using method 1, the starting material 3-phenylprop-2-yne-1,1-diyl bis(2,2-
dimethylpropanoate) (187i, 0.63 g, 2.0 mmol, 100 mol%) gave the title compound as a yellow 
oil (0.38 g, 1.6 mmol, 78%). Rf = 0.85 (9:1 petroleum ether:Et2O); 1H NMR (400 MHz, 
CDCl3) hH 7.71 (t, 1H, J = 1.8 Hz), 7.49-7.46 (m, 2H), 7.36-7.25 (m, 3H), 2.67-2.49 (m, 2H), 
1.26 (s, 9H), 1.17 (t, 3H, J = 6.3 Hz); 13C NMR (67.9 MHz, CDCl3) hC 192.8, 176.4, 135.9, 
128.4, 127.9, 126.6, 121.3, 113.7, 39.1, 27.1, 24.3, 12.3; IR (cm -1)  ちmax 2974, 1964, 1736, 
1277, 1134, MS m/z (ESI) for C16H20NaO2 [M+Na] calc. 267.1356, found 267.1342, error 5.00 
ppm. 
3-Phenylpenta-1,2-dienyl Benzoate (190e) 
 
Using method 1, the starting material 3-phenylprop-2-yne-1,1-diyl dibenzoate (187j, 0.71 g, 
2.0 mmol, 100 mol%) gave the title compound as a yellow oil (0.39 g, 1.5 mmol, 74%). Rf = 
0.75 (9:1 petroleum ether: Et2O); 1H NMR (400 MHz, CDCl3) hH 8.13-8.11 (m, 2H), 7.99 (t, 
1H, J = 2.2 Hz), 7.61-7.44 (m, 6H), 7.38-7.27 (m, 2H), 2.72-2.54 (m, 2H), 1.22 (t, 3H, J = 7.0 
Hz), 13C NMR (67.9 MHz, CDCl3)  hC 193.1, 164.4, 135.7, 133.4, 130.0, 129.4, 128.5 (2C), 
128.1, 126.7, 121.9, 113.8, 30.9, 24.3, 12.3; IR (cm -1)  ちmax 3065, 2973, 2935, 1966, 1725, 
1266; MS m/z (ESI) for C18H16NaO2 [M+Na] calc. 287.1043, found 287.1037, error 1.90 ppm.  
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3-p-Tolylpenta-1,2-dienyl Acetate (190f) 
 
Using method 1, the starting material 3-p-tolylprop-2-yne-1,1-diyl diacetate (187b, 0.49 g, 2.0 
mmol, 100 mol%) gave the title compound as a yellow oil (0.35 g, 1.6 mmol, 81%). Rf = 0.51 
(20:1 petroleum ether:EtOAc); 1H NMR (400 MHz, CDCl3) hH 7.71 (t, 3H, J = 1.9 Hz), 7.38-
7.35 (m, 2H), 7.16-7.14 (m, 2H), 2.63-2.49 (m, 2H), 2.35 (s, 3H), 2.17 (s, 3H), 1.17 (t, 3H, J = 
6.1 Hz); 13C NMR (67.9 MHz, CDCl3)  hC 191.9, 168.8, 138.0, 132.7, 129.2, 126.5, 121.7, 
113.2, 24.3, 21.2, 21.0, 12.3; IR (cm -1) ちmax 2253, 1746, 1466, 1380, 1097, 906, 651; MS m/z 
(ESI) for C14H16O2Na [M+Na] calc. 239.1043, found 239.1041, error 0.60 ppm. 
3-m-Tolylpenta-1,2-dienyl Acetate (190g) 
 
Using method 1, the starting material 3-m-tolylprop-2-yne-1,1-diyl diacetate (187c, 0.1 g, 0.41 
mmol, 100 mol%) gave the title compound as a yellow oil (46 mg, 0.21 mmol, 46%). Rf = 0.5 
(20:1 petroleum ether:EtOAc); 1H NMR (400 MHz, CDCl3) hH 7.73-7.72 (m, 1H), 7.28-7.23 
(m, 3H), 7.10-7.08 (m, 1H), 2.64-2.54 (m, 2H), 2.36 (s, 3H), 2.18 (s, 3H), 1.17 (t, 3H, J = 7.2 
Hz); 13C NMR (67.9 MHz, CDCl3) hC 192.3, 168.7, 138.0, 135.6, 128.8, 128.3, 127.3, 123.6, 
121.9, 113.2, 24.4, 21.4, 21.0, 12.3; IR (cm -1) ちmax 2969, 1957, 1755, 1603, 1368, 1208; MS 
m/z (ESI) for C14H16O2Na [M+Na] calc. 239.1043, found 239.1048, error 2.30 ppm. 
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3-Cyclohexenylpenta-1,2-dienyl Acetate (190h) 
 
Using method 1, the starting material 3-cyclohexenylprop-2-yne-1,1-diyl diacetate (187e, 0.16 
g, 0.7 mmol, 100 mol%) gave the title compound as a yellow oil (0.10 g, 0.47 mmol, 67%). Rf 
= 0.66 (20:1 petroleum ether:EtOAc); 1H NMR (400 MHz, CDCl3)  hH 7.55-7.54 (m, 1H), 
5.98-5.96 (m, 1H), 2.36-2.28 (m, 2H), 2.16-2.09 (m, 4H), 2.14 (s, 3H), 1.66-1.57 (m, 4H), 1.06 
(t, 3H, J = 7.2 Hz); 13C NMR (67.9 MHz, CDCl3) hC 191.5, 168.8, 132.5, 125.9, 123.6, 113.1, 
27.2, 26.0, 22.7 (2C), 22.2, 21.0, 12.3; IR (cm -1) ちmax 2931, 1952, 1754, 1368; MS m/z (ESI) 
for  C13H18O2Na [M+Na] calc. 229.1199, found 229.1202, error 1.30 ppm; Anal. calc. for 
C13H18O2 C, 76.0; H, 8.8, found C, 76.2; H, 8.9%. 
3-Ethyl-5-phenylpenta-1,2-dienyl Acetate (190i) 
 
Using method 1, the starting material 5-phenylpent-2-yne-1,1-diyl diacetate (187f, 0.20 g, 0.77 
mmol, 100 mol%) gave the title compound as a clear oil (83 mg, 0.36 mmol, 51%). Rf = 0.37 
(20:1 petroleum ether:EtOAc); 1H NMR (400 MHz, CDCl3)  hH 7.43 (m, app. q, 1H, J = 2.0 
Hz), 7.30-7.27 (m, 2H), 7.20-7.17 (m, 3H), 2.79-2.75 (m, 2H), 2.47-2.30 (m, 2H), 2.14 (s, 3H), 
2.13-2.04 (m, 2H), 1.04 (t, 3H, J = 7.9 Hz); 13C NMR (67.9 MHz, CDCl3) hC 188.7, 168.8, 
141.7, 128.4, 128.3, 125.9, 122.2, 112.3, 35.5, 33.7, 27.2, 21.0, 11.9; IR (cm -1)  ちmax 2254, 
1741, 1466, 1380, 912, 651; MS m/z (ESI) for C15H19O2 [M+H] calc. 231.1380, found 
231.1375, error 2.00 ppm. 
  
151 
 
3-(Phenanthren-9-yl)penta-1,2-dienyl Acetate (190j) 
 
Using method 1, the starting material 3-(phenanthren-9-yl)prop-2-yne-1,1-diyl diacetate (187g, 
0.14 g, 0.41 mol, 100 mol%) with EtMgBr (0.33 ml, 3 M, 0.98 mmol, 240 mol%) gave the title 
compound as a colourless solid (0.064 g, 0.21 mmol, 51%) which can be recrystallized from 
isopropyl alcohol to give colourless needles. Rf = 0.81 (4:1 petroleum ether:EtOAc); M.p. 79-
80 °C; 1H NMR (400 MHz, CDCl3) hH 8.75-8.67 (m, 2H), 8.17-8.15 (m, 1H), 7.89-7.87 (m, 
1H), 7.70-7.60 (m, 6H), 2.68-2.63 (m, 2H), 2.17 (s, 3H), 1.22 (t, 3H, J = 7.6 Hz); 13C NMR 
(67.9 MHz, CDCl3) hC 192.5, 168.5, 134.6, 131.3, 130.7, 129.9, 128.6, 126.8 (2C), 126.6 (2C), 
126.0, 125.9, 123.0, 122.5, 120.6, 111.6, 29.1, 21.0, 12.3; IR (cm -1)  ちmax 3072, 3004, 2975, 
2935, 2360, 1974, 1743, 1370, 1240, 1067, 1045; MS m/z (ESI) for C21H22NO2 [M+NH4] calc. 
320.1645, found 320.1638, error 2.30 ppm. 
 
Crystal data for 190j.  C21H18O2, M = 302.35, monoclinic, a = 8.380(2), b = 7.611(2), c = 
24.952(7) Å, く = 94.366(5)º, U = 1586.8(7) Å3, T = 150(2) K, space group P21/c (No. 14), Z = 
4, µ(Mo-Kg) = 0.080 mm-1, 2789 unique reflections measured, corrected for absorption (Rint 
0.070) and used in all calculations. The H atoms in the methyl group centred on C7 are 
disordered by rotation about the C6—C7 bond: this was modelled by two orientations, the 
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occupancies of which refined to 0.52(4) and 0.48(4). Final R1 [2139 F"œ 4j(F)] = 0.0670 and 
wR(all F2) was 0.158.  
3-(4-t-Butylphenyl)penta-1,2-dienyl Acetate (190k) 
 
Using method 1, the starting material 3-(4-tert-butylphenyl)prop-2-yne-1,1-diyl diacetate 
(187h, 0.5 g, 1.7 mmol, 100 mol%) gave the title compound as a clear oil ( 0.24 g, 0.92 mmol, 
53%). Rf = 0.82 (4:1 petroleum ether: Et2O); 1H NMR (400 MHz, CDCl3)  hH 7.71-7.70 (m, 
1H), 7.42-7.36 (m, 4H), 2.65-2.53 (m, 2H), 2.16 (s, 3H), 1.32 (s, 9H), 1.18 (t, 3H, J = 8 Hz); 
13C NMR (100.6 MHz, CDCl3) hC 192.2, 168.8, 151.2, 132.8, 126.2, 125.4, 121.6, 113.2, 34.6, 
31.2, 24.2, 21.0, 12.3; IR (cm -1)  ちmax 2968, 2254, 1745, 1369, 1048; MS m/z (ESI), for 
C17H22NaO2 [M+Na] calc. 281.1512, found 281.1504, error 2.90 ppm. 
General procedure for the kinetic resolution of allenyl acetates: (S)-3-Phenylpenta-1,2-
dienyl Acetate and (E)- And (Z)-3-phenylpent-2-enal (E/Z)-(192) 
 
To rac-3-phenylpenta-1,2-dienyl acetate [(±)-190b (105 mg, 0.52 mmol, 100 mol%)] was 
added THF (0.2 ml) and phosphate buffer (15 ml, pH = 7.4) at r.t. with vigorous stirring. 
Lipase from Burcholderia cepacia (PS Amano SD) (400 mg) was added with vigorous stirring 
in small portions. After 2 hours the reaction mixture was extracted five times with Et2O and the 
combined organics were concentrated on a rotary evaporator. The residue was purified by flash 
column chromatography (30:1 pentane:Et2O) which gave the title compound (S)-190b (32 mg, 
0.16 mmol, 31%, ee 88%) with [g]D = +83.9 (c = 0.65 in CHCl3, d = 0.25) and a 1:1 mixture of 
(E)- and (Z)- 3-phenylpent-2-enals 192 (55 mg, 0.34 mmol, 65%). 
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The two enantiomers of (S)-190b can be separated with GC column octakis(2,6-di-O-methyl-3-
O-pentyl)-け-cyclodextrin program 40 °C–150 °C 1 °C/min, which gave the two enantiomers 
with retention times of (85.08/85.59 min).  
 
Byproducts of the kinetic resolution of 190b were obtained as 1:1 mixture of isomers. (E)- And 
(Z)- aldehydes could not be separated with flash column chromatography. Rf = 0.50 (9:1 
petroleum ether:Et2O); 1H NMR (400 MHz, CDCl3) hH 10.20 (d, 1H, J = 8.0 Hz)E, 9.49 (d, 
1H, J = 8.0 Hz)Z, 7.55-7.28 (m, 5+5H), 6.29 (d, 1H, J = 8.0 Hz)E, 6.14 (dt, 1H, J
 
= 8.0, 2.0 
Hz)Z, 3.10 (q, 2H, J = 7.6 Hz)E, 2.64 (qd, 2H, J
 
= 7.6, 2.0 Hz)Z, 1.22 (t, 3H, J = 7.6 Hz)E, 1.14 
(t, 3H, J = 7.6 Hz)Z; 13C NMR (67.9 MHz, CDCl3) hC 193.8, 191.0, 167.9, 164.6, 129.9, 128.9, 
128.8, 128.5, 128.4, 128.2, 128.0, 127.5, 127.4, 127.0, 126.8, 126.6, 32.7, 23.3, 15.0, 12.0; IR 
(cm -1) ちmax 1752, 1663, MS m/z (EI) for C11H12NaO [M+Na] calc. 183.0780, found 183.0788, 
error 4.4 ppm. 1H NMR of the Z-isomer in the literature corresponds to the experimental data 
and was used for the assignment of the isomers [190].  
(S)-3-p-Tolylpenta-1,2-dienyl acetate (S)-(190f) and (E)- and (Z)-3-p-tolylpent-2-enal 
(E/Z)-(193) 
 
The rac-3-p-tolylpenta-1,2-dienyl acetate [(±)-190f (0.13 g, 0.61 mmol, 100 mol%)] and PS 
Amano SD (0.53 g) gave after 1 hour the title compound (S)-190f (33 mg, 0.15 mmol, 25%, ee 
45%) with [g]D = +43.2 (c = 0.61 in CH3Cl, d = 0.25) and a 1:1 mixture of (E)- and (Z)-3-p-
tolylpent-2-enals 193 (59 mg, 0.34 mmol, 56%).  
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The two enantiomers of (S)-3-p-tolylpenta-1,2-dienyl acetate were separated with GC column 
octakis(2,6-di-O-methyl-3-O-pentyl)-け-cyclodextrin, program 40 °C-150 °C 0.5 °C/min which 
gave the two enantiomers with retention times of (91.20/91.93 min).  
 
Byproducts of the kinetic resolution of 3-p-tolylpenta-1,2-dienyl acetate 190f.  (E)- And (Z)- 
aldehydes could not be separated with flash column chromatography and they were assigned 
according to aldehydes (E/Z)-(192). Rf = 0.50 (9:1 petroleum ether:Et2O); 1H NMR (400 MHz, 
CDCl3) hH 10.15 (d, 1H, J = 7.8 Hz)E, 9.47 (d, 1H, J = 8.0 Hz)Z, 7.43-7.04 (m, 5+5H), 6.26 (d, 
1H, J = 7.8 Hz)E, 6.09 (dt, 1H, J
 
=8.0, 1.4 Hz)Z, 3.05 (q, 2H, J = 7.6 Hz)E, 2.59 (qd, 2H, J
 
= 
7.2, 1.4 Hz)Z, 2.39 (s, 3+3H), 1.18 (t, 3H, J = 7.6 Hz)E, 1.09 (t, 3H, J = 7.2 Hz)Z; 13C NMR 
(67.9 MHz, CDCl3)  hC 194.0, 191.0, 140.0, 139.0, 134.9, 129.5, 129.0, 128.5, 127.2, 126.6, 
126.2, 32.6, 23.1, 21.2, 15.1, 12.1; IR (cm -1)  ちmax 1751, 1661, MS m/z  (EI)  for  C12H14NaO 
[M+Na] calc. 197.0937, found 197.0947, error 4.9 ppm. 
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(R)-O-2'-Hydroxy-1,1'-binaphthyl-2-yl Diethylcarbamothioate (230): General procedure 
to the synthesis of catbamothioate ligands 
 
To (R)-BINOL (0.63 g, 2.2 mmol, 100 mol%) in a Schlenk tube at r.t. was added CH2Cl2 (25 
ml). Triethylamine (0.35 ml, 2.53 mmol, 115 mol%) and DMAP (67 mg, 0.55 mmol, 25 mol%) 
were added followed by the addition of diethylthiocarbamoyl chloride (0.38 g, 2.53 mmol, 115 
mol%). The reaction was stirred at +25 °C waterbath for 3 days. The mixture was quenched 
with saturated aqueous NH4Cl solution and washed 3 times with 1 M HCl and once with 
saturated aqueous NaCl solution. The organic fractions were dried over Na2SO4 and 
concentrated in vacuo to provide a yellow foam. This was purified by flash column 
chromatography (CH2Cl2 with 2% EtOH) which gave a yellow thick oil. The oil was stirred 
with petroleum ether overnight and the colourless solid that formed was filtrated. The title 
compound was obtained as a colourless solid (0.34 g, 0.85 mmol, 39%). M.p. 123-124°C 
(literature 142-143°C); Rf = 0.37 (4:1 petroleum ether:EtOAc); 1H NMR (400 MHz, CDCl3) 
hH 8.09 (d, 1H, J = 8.8 Hz), 7.99 (d, 1H, J = 8.4 Hz), 7.89 (d, 1H, J = 9.2 Hz), 7.86-7.84 (m, 
1H), 7.54-7.50 (m, 1H), 7.46 (d, 1H, J = 8.8 Hz), 7.38-7.24 (m, 5H), 7.14-7.12 (m, 1H), 5.96 
(s, 1H, OH), 3.74-3.59 (m, 2H), 3.21 (sextet, 1H, J = 6.8 Hz), 2.90 (sextet, 1H, J = 7.2 Hz), 
1.09 (t, 3H, J = 6.8 Hz), 0.50 (t, 3H, J = 7.2 Hz); 13C NMR (100.6 MHz, CDCl3) hC 186.3, 
152.2, 151.2, 133.8, 133.6, 132.1, 130.0, 129.9, 129.1, 128.2, 127.9, 127.2, 126.5, 126.2, 125.8, 
124.6, 124.1, 123.4, 123.0, 119.4, 115.0, 48.0, 43.6, 12.1, 11.5; IR (cm -1)  ちmax 3355, 3063, 
2985, 2938, 1621, 1598, 1520 (S=C strong), 1433, 1286, 1241, 1162; MS m/z (ESI Positive), 
for C25H23NNaO2S [M+Na] calc. 424.1342, found 424.1346, error 1.10 ppm; [g]D = +332.0 (c 
= 0.97 in CHCl3). The NMR data in the literature corresponds to the experimental data [191]. 
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(R)-O-2'-Hydroxy-1,1'-binaphthyl-2-yl Methyl(phenyl)carbamothioate (231) 
 
(R)-BINOL (0.63 g, 2.2 mmol, 100 mol%) and N-methyl-N-phenylthiocarbamoyl chloride 
(0.47 g, 2.53 mmol, 115 mol%) gave the title compound as a grey powder (20 mg, 0.046 
mmol, 2%), which contained minor impurities even after purification. M.p. 82-83 °C; Rf = 
0.37 (4:1 petroleum ether:EtOAc); 1H NMR (400 MHz, CDCl3)  hH 8.03-7.93 (m, 5H), 7.52-
7.32 (m, 4H), 7.07-6.98 (m, 3H), 6.80-6.76 (m, 3H), 6.22-6.20 (m, 2H), 5.71 (s, 1H), 3.52 (s, 
3H); 13C NMR (100.6 MHz, CDCl3) hC 187.3, 151.9, 151.2, 142.1, 134.0, 133.5, 132.1, 130.2, 
130.0, 129.9, 129.0, 128.7, 128.2, 127.8, 127.3, 127.1, 126.6, 126.3, 125.7, 124.81, 124.77, 
123.7, 123.6, 123.0, 119.2, 114.9, 44.6; IR (cm -1) ちmax 3692, 2928, 2855, 2338, 1600, 1494, 
1386, 1181; MS m/z  (ESI  Positive),  for  C28H21NNaO2S [M+Na] calc. 458.1185, found 
458.1189, error 0.80 ppm; [g]D = +136.9 (c = 0.43 in CHCl3). 
N,N'-(3-Phenylprop-2-yne-1,1-diyl)diacetamide (232) 
O
H
NH
HN
O
O
H2SO4 (10 mol%)
MeCN, r.t. 18 h
186a 232
O
NH2 (2 equiv)
57% yield
 
3-Phenylpropiolaldehyde (186a, 0.65 g, 5 mmol, 100 mol%) was dissolved in MeCN (11 ml) 
at r.t. and the flask was flushed with argon. Acetamide (0.59 g, 10 mmol, 200 mol%) and 
H2SO4 (0.05 g, 0.5 mmol, 10 mol%) were added and the reaction was stirred vigorously for 2 
days. Solids formed in the reaction and these were collected by filtration, washed well with 
MeCN and dried in vacuo. Product 232 was obtained as a colourless solid (0.66 g, 2.9 mmol, 
57%). M.p. 230-232 °C; 1H NMR (400 MHz, CD3OD) hH 7.46-7.43 (m, 2H), 7.37-7.32 (m, 
3H), 6.50 (s, 1H), 1.96 (s, 6H), NH was not visible in 1H spectrum; 13C NMR (67.9 MHz, 
CD3OD) hC 172.0, 132.8, 129.9, 129.5, 123.4, 86.0, 83.6, 47.1, 22.4; IR (cm -1)  ちmax 3687, 
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3444, 3291, 3012, 1671, 1646, 1443, 1240, MS m/z (ESI) for C13H14N2NaO2 calc. 253.0947, 
found 253.0955, error 3.10 ppm. 
 (3,3)-Dimethoxyprop-1-ynyl)benzene (233) 
 
To 3-phenylpropiolaldehyde (186a, 2.0 g, 15.4 mmol, 100 mol%) in MeOH (15.5 ml) at r.t. 
were added trimethoxymethane (1.7 ml, 15.4 mmol, 100 mol%) and p-TsOH (0.29 g, 1.54 
mmol, 10 mol%) and the reaction mixture was heated up to +60 °C for 3 hours. The mixture 
was cooled to r.t. and the solvents were evaporated. The residue was distilled to give the title 
compound as a clear oil (1.3 g, 7.6 mmol, 50%). 1H NMR (400 MHz, CDCl3) hH 7.50-7.47 (m, 
2H), 7.34-7.32 (m, 3H), 5.38 (s, 1H), 3.40 (s, 6H); 13C NMR (67.9 MHz, CDCl3)  hC 132.0, 
129.0, 128.4, 121.7, 93.6, 85.9, 83.5, 52.7; IR (cm -1) ちmax 3621, 3464, 3010, 2976, 2833, 2227, 
1490, 1445, 1360, 1250, 1107, 1052; MS m/z  (EI),  for  C11H12NaO2 [M+Na] calc. 199.0730, 
found 199.0731, error 0.80 ppm. 
(E)-3-oxo-3-Phenylprop-1-enyl Acetate (238): General procedure for the Meyer-Schuster 
reaction of diacetates 187 
 
To 3-phenylprop-2-yne-1,1-diyl diacetate (187a, 50 mg, 0.22 mmol, 100 mol%) in CH2Cl2 (20 
ml) at r.t. were added Au(IPr)Cl (2.3 mg, 0.004 mmol, 2 mol%) and AgOTf (1.0 mg, 0.004 
mmol, 2 mol%). After 1 h 30 min the reaction mixture was filtered through a pad of Celite with 
a CH2Cl2 wash and concentrated in vacuo. The residue was purified by flash column 
chromatography (4:1 petroleum ether:Et2O), which gave the title compound as a white solid 
(12 mg, 0.062 mmol, 28%). M.p. 57-58°C; Rf = 0.29 (4:1 petroleum ether:Et2O); 1H NMR 
(400 MHz, CDCl3) hH 8.40 (d, 1H, J = 12.4 Hz), 7.92-7.89 (m, 2H), 7.59-7.46 (m, 3H), 6.79 (d, 
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1H, J = 12.4 Hz), 2.26 (s, 3H); 13C NMR (100.6 MHz, CDCl3) hC 190.4, 166.9, 150.2, 137.8, 
133.0, 128.6, 128.3, 109.9, 20.6; IR (cm -1)  ちmax 3011, 2360, 1776, 1674, 1615, 1191, 1135; 
MS m/z (EI), for C11H10NaO3 [M+Na] calc. 213.0522, found 213.0521, error 0.6 ppm. 
 (E)-3-oxo-3-Phenylprop-1-enyl d3-acetate (d-238) 
 
The starting material 3-phenylprop-2-yne-1,1-diyl d-diacetate (d-187a, 50 mg, 0.21 mmol, 100 
mol%) with 2 h reaction time gave the title compound as a white solid (12 mg, 0.063 mmol, 
33%). Rf = 0.29 (4:1 petroleum ether:Et2O); 1H NMR (400 MHz, CDCl3) hH 8.40 (d, 1H, J = 
12.4 Hz), 7.92-7.89 (m, 2H), 7.60-7.46 (m, 3H), 6.79 (d, 1H, J = 12.4 Hz), 2.23 (quintet, 
0.04H, CD3, J = 2.4 Hz); 13C NMR (100.6 MHz, CDCl3) hC 190.4, 166.9, 150.2, 137.8, 133.0, 
128.6, 128.3, 109.9, 20.0 (t, CD3, J = 20.1 Hz); IR (cm -1) ちmax 3156, 2902, 2254, 1770, 1675, 
910; MS m/z (EI), for C11H7D3NaO3 [M+Na] calc. 216.0710, found 216.0705, error 2.4 ppm. 
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6.4 Gold-catalyzed synthesis of indenes 
3-Ethyl-1H-inden-1-yl Acetate: general procedure for the gold-catalyzed cyclization of 
allenic acetates (292a) 
 
To 3-phenylpenta-1,2-dienyl acetate (190b, 140 mg, 0.64 mmol, 100 mol%) in CH2Cl2 (10 ml) 
at r.t. were added Au(IPr)Cl (9.2 mg, 0.013 mmol, 2.0 mol%) and AgOTf (2.8 mg, 0.013 
mmol, 2.0 mol%) under air. After 10 min the reaction mixture was filtrated through  a pad of 
silica gel with a CH2Cl2 wash and product, 3-ethyl-1H-inden-1-yl acetate 292a, was obtained 
as yellow oil (140 mg mg, 0.64 mmol, 99%). The product did not need to be purified but it 
could be subjected to flash column chromatography (30:1 pentane:Et2O). Rf = 0.64 (9:1 
petroleum ether:Et2O); 1H NMR (400 MHz, CDCl3) hH 7.44-7.43 (m, 1H, Ar-H), 7.34-7.30 (m, 
1H, Ar-H), 7.25-7.19 (m, 2H, Ar-H), 6.20-6.18 (m, 1H, C1-H), 6.06-6.05 (m, 1H, C2-H), 2.54-
2.47 (m, 2H, C12-H), 2.15 (s, 3H, C11-H), 1.27 (t, 3H, J = 7.6 Hz, C13-H); 13C NMR (67.9 
MHz, CDCl3) hC 171.6  (C10), 149.8 (C3), 144.0 (C8), 142.7 (C9), 128.7, 126.3 (C2), 125.8, 
124.1, 119.3, 77.2 (C1), 21.2 (C11), 20.7 (C12), 11.6 (C13); IR (cm -1) ちmax 2973, 1732, 1372, 
1241, MS m/z (ESI) for C13H14NaO2 [M+Na] calc. 225.0886, found 225.0884, error 1.10 ppm. 
The GC trace of the title compound with column octakis(2,6-di-O-methyl-3-O-pentyl)-け-
cyclodextrin and temperature gradient program 60 °C-150 °C 2 °C/min gave retention times 
for the enantiomers of (50.86/51.01 min). 
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Following the cyclization of 190b by gas chromatography 
 
 
Table 29 
Time (min) GC yield 292a (%) Ee of 190b (%) 
0 0 70.8 
1 9.0 67.0 
2 14.2 61.8 
5 26.1 53.7 
10 48.1 32.2 
20 76.1 0 
30 84.0 0 
40 85.5 0 
50 85.5 0 
60 85.5 0 
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3-Methyl-1H-inden-1-yl Acetate (292b) 
 
The starting material 3-phenylbuta-1,2-dienyl acetate (190a, 80 mg, 0.42 mmol, 100 mol%) 
gave the title compound as a yellow oil (51 mg, 0.27 mmol, 64%). Rf = 0.69 (9:1 petroleum 
ether:Et2O);1H NMR (400 MHz, CDCl3) hH 7.43-7.41 (m, 1H), 7.33-7.31 (m, 1H), 7.24-7.22 
(m, 2H), 6.19-6.18 (m, 1H), 6.07-6.05 (m, 1H), 2.14 (s, 3H), 2.12 (d, 3H, J = 1.6 Hz); 13C 
NMR (100.6 MHz, CDCl3) hC 171.5, 133.5, 143.8, 142.5, 128.8, 127.9, 126.2, 124.0, 119.3, 
76.7, 21.2, 13.0; IR (cm -1) ちmax 3011, 1732, 1626, 1372, 1244; MS m/z (EI) for C12H12NaO2 
[M+Na] calc. 211.0730, found 211.0723, error 3.10 ppm. The NMR data in the literature 
correspond to the experimental data [192]. 
3-Butyl-1H-inden-1-yl Acetate (292c) 
 
The starting material 3-phenylhepta-1,2-dienyl acetate (190c, 0.36 g, 1.6 mmol, 100%)  gave 
the title compound as a clear oil (0.33 g, 1.4 mmol, 92%). Rf = 0.68 (4:1 petroleum 
ether:Et2O); 1H NMR (400 MHz, CDCl3) hH 7.44-7.19 (m, 4H), 6.18-6.17 (m, 1H), 6.05-6.04 
(m, 1H), 2.50-2.46 (m, 2H), 2.14 (s, 3H), 1.69-1.62 (m, 2H), 1.46-1.61 (m, 2H), 0.96 (t, 3H, J 
= 7.2 Hz); 13C NMR (100.6 MHz, CDCl3) hC 171.6, 148.3, 144.1, 142.7, 128.7, 126.6, 126.2, 
124.1, 119.4, 76.7, 29.5, 27.2, 22.6, 21.2, 13.9; IR (cm -1) ちmax 3012, 2960, 2361, 1732, 1372, 
1243; MS m/z (ESI), for C15H18NaO2 [M+Na] calc. 253.1199, found 253.1198, error 0.50 ppm. 
The NMR data in the literature correspond to the experimental data [167]. 
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3-Ethyl-1H-inden-1-yl Benzoate (292d) 
 
The starting material 3-phenylpenta-1,2-dienyl benzoate (190e, 92 mg, 0.35 mmol, 100 mol%) 
gave the title compound as a yellow oil (68.7 mg, 0.26 mmol, 82%). Rf = 0.68 (9:1 petroleum 
ether:Et2O);1H NMR (400 MHz, CDCl3) hH 8.09-8.07 (m, 2H), 7.58-7.50 (m, 2H), 7.45-7.41 
(m, 1H), 7.37-3.21 (m, 4H), 6.44-6.42 (m, 1H), 6.19-6.17 (m, 1H), 2.58-2.51 (m, 2H), 1.30 (t, 
3H, J = 7.4 Hz); 13C NMR (100.6 MHz, CDCl3) hC 167.1, 149.8, 144.1, 142.9, 133.0, 130.1, 
129.8, 128.7, 128.3, 126.2, 126.1, 124.2, 119.3, 77.1, 20.7, 11.7; IR (cm -1) ちmax 2973, 1713, 
1452, 1268; MS m/z (ESI) for C18H16NaO2 [M+Na] calc. 287.1043, found 287.1038, error 1.50 
ppm. 
3-Ethyl-1H-inden-1-yl Pivalate (292e) 
 
The starting material 3-phenylpenta-1,2-dienyl pivalate (190d, 0.15 g, 0.61 mmol, 100%) gave 
the title compound as a clear oil (0.14 g, 0.59 mmol, 96%). Rf = 0.87 (9:1 petroleum 
ether:Et2O); 1H NMR (400 MHz, CDCl3) hH 7.38-7.18 (m, 4H), 6.19-6.17 (m, 1H), 6.04-6.03 
(m, 1H), 2.54-2.50 (m, 2H), 1.28 (t, 3H, J = 7.2 Hz), 1.24 (s, 9H); 13C NMR (100.6 MHz, 
CDCl3) hC 179.1, 149.4, 144.0, 143.2, 128.5, 126.3 (2C), 123.8, 119.3, 76.5, 39.0, 27.2, 20.7, 
11.7; IR (cm -1) ちmax 2973, 2934, 2254, 1719, 1159; MS m/z (ESI), for C16H20NaO2 [M+Na] 
calc. 267.1356, found 267.1344, error 4.20 ppm. 
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6-t-Butyl-3-ethyl-1H-inden-1-yl Acetate (292f) 
 
The starting material 3-(4-t-butylphenyl)penta-1,2-dienyl acetate (190k, 0.18 g, 0.68 mmol, 
100 %) gave the title compound as a clear oil (0.17 g, 0.65 mmol, 97%). Rf = 0.77 (4:1 
petroleum ether:Et2O); 1H NMR (400 MHz, CDCl3) hH 7.48-7.47 (m, 1H), 7.37-7.34 (m, 1H), 
7.18-7.16 (m, 1H), 6.19-6.18 (m, 1H), 6.02-6.00 (m, 1H), 2.52-2.46 (m, 2H), 2.16 (s, 3H), 1.33 
(s, 9H), 1.26 (t, 3H, J = 7.6 Hz); 13C NMR (100.6 MHz, CDCl3) hC 171.6, 149.7, 142.6, 141.4, 
125.5 (2C), 125.3, 121.4, 118.8, 76.7, 34.8, 31.5, 21.3, 20.7, 11.7; IR (cm -1) ちmax 3011, 2970, 
1731, 1602, 1243; MS m/z (ESI), for C17H22NaO2  [M+Na] calc. 281.1512, found 281.1501, 
error 4.00 ppm. 
3-Ethyl-6-methyl-1H-inden-1-yl Acetate (292g) 
 
The starting material 3-p-tolylpenta-1,2-dienyl acetate (190f, 0.17 g, 0.79 mmol, 100 mol%) 
gave the title compound as clear oil (0.12 g, 0.55 mmol, 70%). Rf = 0.49 (9:1 petroleum 
ether:Et2O); 1H NMR (400 MHz, CDCl3) hH 7.26-7.25 (m, 1H), 7.13-7.12 (m, 2H), 6.17-6.16 
(m, 1H), 6.00-5.97 (m, 1H), 2.50-2.47 (m, 2H), 2.36 (s, 3H), 2.14 (s, 3H), 1.26 (t, 3H, J = 7.2 
Hz); 13C NMR (100.6 MHz, CDCl3) hC 171.6, 149.8, 143.0, 141.3, 136.2, 129.2, 125.2, 124.9, 
119.1, 76.7, 21.4, 21.2, 20.7, 11.7; IR (cm -1)  ちmax 3011, 2972, 1732, 1372, 1243; MS m/z 
(ESI), for C14H16NaO2 [M+Na] calc. 239.1043, found 239.1042, error 0.30 ppm. 
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3-Ethyl-5-methyl-1H-inden-1-yl Acetate and 3-ethyl-7-methyl-1H-inden-1-yl Acetate 
(292h mixture of isomers) 
 
The starting material 3-m-tolylpenta-1,2-dienyl acetate (190g, 0.24 g, 1.1 mmol, 100 mol%) 
gave the title compounds as a clear oil and inseparable mixture of isomers (0.22 g, 1.0 mmol, 
92%). Rf = 0.50 (9:1 petroleum ether:Et2O); The isomers could not be identified so they are 
named as A and B (A:B 2:1) 1H NMR (400 MHz, CDCl3) hH 7.31 (d, 1H, J = 7.6 Hz)A, 7.23 
(d, 1H, J = 8.0 Hz)B, 7.09-7.01 (m, 2+2H)A/B, 6.25-6.23 (m, 1H)B, 6.16-6.15 (m, 1H)A, 6.08-
6.06 (m, 1H)B, 6.04-6.03 (m, 1H)A, 2.52-2.46 (m, 2+2H)A/B, 2.38 (s, 3H)A, 2.31 (s, 3H)B, 
2.14 (s, 3H)B, 2.13 (s, 3H)A, 1.27 (t, 3H, J = 7.2 Hz)A, 1.25 (t, 3H, J = 7.6 Hz)B; 13C NMR 
(100.6 MHz, CDCl3) hC 171.6 (A), 171.3 (B), 149.8, 144.2, 144.1, 140.0, 139.8, 138.7, 134.2, 
129.0, 128.1, 126.8, 126.1, 125.6, 123.9, 120.3, 117.1, 76.5 (A), 76.3 (B), 21.6, 21.2, 21.0, 
20.7, 20.6, 17.9, 11.7 (2C) ; IR (cm -1) ちmax 3011, 2972, 1732, 1372, 1243; MS m/z (ESI), for 
C14H16NaO2 [M+Na] calc. 239.1043, found 239.1042, error 0.10 ppm. 
3-Phenylpenta-1,3-dienyl Acetate (1E/Z, 3E/Z) (294) 
 
A  mixture  of  two  isomers  was  obtained  as  product.  As  the  compound  is  not  known  in  the  
literature, it could not be distigued whether the final products were isomers of C1 E/Z or C3 
E/Z. 
3-Phenylpenta-1,2-dienyl acetate (190b, 0.1 g, 0.49 mmol, 100 mol%) was dissolved in CH2Cl2 
(5 ml) at r.t. and AgOTf (6.3 mg, 0.024 mmol, 5 mol%) was added. The reaction was stirred 30 
minutes at room temperature, then filtered through a pad of silica with a CH2Cl2 wash and 
concentrated in vacuo. The crude product was purified by flash column chromatography (9:1 
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petroleum ether: Et2O) to give the product as a mixture of two isomers as a yellow oil (37 mg, 
0.18 mmol, 37%). Rf = 0.54 (9:1 petroleum ether:Et2O); 1H NMR (400 MHz, CDCl3) hH 7.38-
7.17 (m, 10 H)A/B, 7.13 (d, 1H, J = 12.4 Hz)A, 6.82 (d, 1H, J = 12.8 Hz)B, 6.52 (d, 1H, J = 
12.4)A, 6.25 (d, 1H, J = 12.8 Hz)B, 5.75 (q, 1H, J = 6.8 Hz)B, 5.58 (q, 1H, J = 6.8 Hz)A, 2.13 
(s, 3H)A, 2.08 (s, 3H)B, 1.86 (d, 3H, J = 6.8 Hz)A, 1.56 (d, 3H, J =  6.8  Hz)B;  13C NMR 
(100.6 MHz, CDCl3) hC 167.9, 167.8, 141.5, 139.2, 137.7, 137.4, 137.0, 136.3, 129.2, 128.8, 
128.5, 128.4, 128.2, 128.0, 127.3, 127.1, 127.0, 126.6, 120.2, 112.6, 30.9, 20.7, 14.8, 14.1; IR 
(cm -1)  ちmax 3156, 2903, 2254, 1794, 1752, 1466 1373, 1103, 919; MS m/z (ESI), for 
C13H14NaO2 [M+Na] calc. 225.0886, found 225.0884, error 0.80 ppm. The GC trace of the title 
compound with the column octakis(2,6-di-O-methyl-3-O-pentyl)-け-cyclodextrin and 
temperature gradient program 60 °C-150 °C 2 °C/min gave retention times for the isomers of 
(47.84/50.38 min). 
3-Phenyl-1-(trimethylsilyl)pent-1-yn-3-ol (296) 
 
Trimethylsilylacetylene (8.3 ml, 60 mmol, 100 mol%) was dissolved in THF (200 ml) and 
cooled to -60 °C. A solution of n-BuLi (1.6 M, 37.5 ml, 60 mmol, 100 mol%) was added 
slowly. After 30 min propiophenone (8 g, 60 mmol, 100 mol%) was added to the reaction 
mixture and the reaction was left to warm to room temperature overnight. The reaction was 
quenched with the addition of a saturated aqueous NH4Cl solution. After separating the phases, 
the aqueous phase was re-extracted with Et2O. The combined organic fractions were washed 
with saturated aqueous NaCl solution, dried with MgSO4 and concentrated in vacuo. This 
procedure gave the title compound as a 3:1 inseparable mixture of product and starting material 
as a yellow oil (12.3 g). This mixture was used directly in the next step. Rf = 0.76 (4:1 
petroleum ether:EtOAc); 1H NMR (400 MHz, CDCl3)  hH 7.53-7.50 (m, 2H), 7.28-7.16 (m, 
3H), 2.27 (s, 1H), 1.94-1.76 (m, 2H), 0.85 (t, 3H, J = 7.60 Hz), 0.13 (s, 9H); 13C NMR (100.6 
MHz, CDCl3) hC 144.3, 128.1, 127.6, 125.5, 107.6, 90.7, 74.2, 38.3, 9.1, -0.1; IR (cm -1) ちmax 
3589, 2971, 2254; MS m/z (ESI), for C14H20NaOSi [M+Na] calc. 255.1176, found 255.1169, 
error 2.60 ppm. The NMR data in the literature correspond to the experimental data [193]. 
166 
 
4-Methyl-3-phenyl-1-(trimethylsilyl)pent-1-yn-3-ol (296b) 
 
The starting material 2-methyl-1-phenylpropan-1-one (1.0 g, 6.7 mmol, 100 mol%) gave the 
title compound as a clear oil (1.3 g, 5.2 mmol, 78%). Rf = 0.86 (4:1 petroleum ether:Et2O); 1H 
NMR (400 MHz, CDCl3) hH 7.62-7.59 (m, 2H), 7.37-7.26 (m, 3H), 2.30 (s, 1H), 2.08 (septet, 
1H, J = 6.4 Hz), 1.07 (d, 3H, J = 6.4 Hz), 0.80 (d, 3H, J = 6.4 Hz), 0.23 (s, 9H); 13C NMR 
(100.6 MHz, CDCl3) hC 143.6, 127.8, 127.6, 126.1, 106.6, 91.5, 77.4, 40.3, 18.0, 17.4, 0.0; IR 
(cm -1) ちmax 3593, 2167, 1251; MS m/z (ESI), for C15H22NaOSi [M+Na] calc. 269.1332, found 
269.1332, error 0.10 ppm. 
2-(4-Methoxyphenyl)-4-(trimethylsilyl)but-3-yn-2-ol (296c) 
 
The starting material 4’-methoxyacetophenone (1.0 g, 6.7 mmol, 100 mol%) gave the title 
compound as a colourless solid (1.0 g, 4.1 mmol, 61%). M.p. 62-63 °C; Rf = 0.70 (4:1 
petroleum ether:Et2O); 1H NMR (400 MHz, CDCl3) hH 7.59-7.57 (m, 2H), 6.90-6.88 (m, 2H), 
3.82 (s, 3H), 2.17 (s, 1H), 1.74 (s, 3H), 0.21 (s, 9H); 13C NMR (100.6 MHz, CDCl3) hC 159.1, 
137.6, 126.3, 113.5, 109.0, 89.1, 69.8, 55.3, 33.2, 0.1; IR (cm -1) ちmax 3588, 2168, 1611, 1510, 
1251, 846; MS m/z (EI), for C14H20NaO2Si [M+Na] calc. 271.1125, found 271.1122, error 1.00 
ppm. 
3-Phenylpent-1-yn-3-ol (297) 
 
Crude 3-phenyl-1-(trimethylsilyl)pent-1-yn-3-ol 296 (as 3:1 mixture of starting material and 
propiophenone) (12.2 g, 53 mmol [calc. for MW of 296], 100 mol%) was dissolved in MeOH 
(100 ml) and freshly ground K2CO3 (14.5 g, 105 mmol, 200 mol%) was added. The reaction 
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was stirred at room temperature overnight and then quenched by addition of 100 ml water, 
followed by extraction to CH2Cl2. The organic layer was dried over MgSO4 and concentrated 
in vacuo. Purification by flash column chromatography gave the title compound as a clear oil 
(6.1 g, 38 mmol, 64% over 2 steps). Rf = 0.65 (4:1 petroleum ether:EtOAc); 1H NMR (400 
MHz, CDCl3) hH 7.64-7.62 (m, 2H), 7.39-7.26 (m, 3H), 2.69 (s, 1H), 2.37 (s, 1H), 2.04-1.90 
(m, 2H), 0.97 (t, 3H, J = 7.2 Hz); 13C NMR (100.6 MHz, CDCl3)  hC 143.9, 128.2, 127.8, 
125.4, 86.0, 74.1, 73.8, 38.2, 8.9; IR (cm -1) ちmax 3590, 3306, 2976, 1449, 1327; MS m/z (EI), 
for  C11H12O [M] calc. 160.0888, found 160.1885, error 1.90 ppm. The GC trace of the title 
compound with column octakis(2,6-di-O-methyl-3-O-pentyl)-け-cyclodextrin and the 
temperature gradient program 60 °C-150 °C 2 °C/min gave retention times for the enantiomers 
of (45.86/46.49 min). 
1-d-3-Phenylpent-1-yn-3-ol (d-297) 
 
The starting material 3-phenylpent-1-yn-3-ol (297, 1.0 g, 6.24 mmol 100 mol%) was dissolved 
in dry THF (50 ml) and n-BuLi (1.6 M in hexanes, 8.0 ml, 12.8 mmol, 205 mol%) was added 
slowly at -60 °C. After 30 min the reaction was taken out of the cold bath and D2O (1 ml) was 
added while the reaction was kept under argon atmosphere. The reaction mixture was diluted 
with Et2O  and  washed  once  with  brine.  The  organic  layer  was  dried  on  Mg2SO4 and 
concentrated in vacuo. The product (1.0 g, 6.16 mmol, 99%) was obtained as a clear oil and did 
not need further purification. The product was >98% isotopically pure based on 1H NMR 
spectroscopy. Rf = 0.65 (4:1 petroleum ether:EtOAc); 1H NMR (400 MHz, CDCl3)  hH 7.64-
7.61 (m, 2H), 7.39-7.28 (m, 3H), 2.69 (s, 0.01 H), 2.36 (s, 1H), 2.06-1.83 (m, 2H), 0.97 (t, 3H, 
J = 7.2 Hz); 13C NMR (100.6 MHz, CDCl3)  hC 143.9, 128.2, 127.8, 125.4, 85.6, 73.8, 38.2, 
8.9, CD could not be seen; IR (cm -1) ちmax 3590, 3011, 2595, 1978, 1492, 1449, 1327; MS m/z 
(EI), for C11H11DO [M] calc. 161.0951, found 161.0955, error 2.50 ppm. 
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4-Methyl-3-phenylpent-1-yn-3-ol (297b) 
  
The starting material 4-methyl-3-phenyl-1-(trimethylsilyl)pent-1-yn-3-ol (296b, 1.2 g, 4.9 
mmol, 100 mol%) gave the title compound as a clear oil (0.7 g, 4.0 mmol, 82%). Rf = 0.76 (4:1 
petroleum ether:Et2O); 1H NMR (400 MHz, CDCl3) hH 7.63-7.60 (m, 2H), 7.38-7.26 (m, 3H), 
2.69 (s, 1H), 2.36 (s, 1H), 2.12 (septet, 1H, J = 6.8 Hz), 1.08 (d, 3H, J = 6.8 Hz), 0.84 (d, 3H, J 
= 6.8 Hz); 13C NMR (100.6 MHz, CDCl3) hC 143.3, 127.9, 127.7, 126.0, 84.9, 74.9, 40.1, 17.8, 
17.3, one quaternary carbon was not visible in 13C spectrum; IR (cm -1) ちmax 3593, 3306, 2970, 
1682, 1448, 1014; MS m/z (EI), for C12H14O [M] calc. 174.1045, found 174.1040, error 2.90 
ppm. The NMR data in literature correspond to this experimental data [194]. 
2-(4-Methoxyphenyl)but-3-yn-2-ol (297c) 
 
The starting material 2-(4-methoxyphenyl)-4-(trimethylsilyl)but-3-yn-2-ol (296c, 1.0 g, 4.0 
mmol, 100 mol%) gave the title compound as a clear oil (0.59 g, 3.3 mmol, 83%). Rf = 0.39 
(4:1 petroleum ether:Et2O); 1H NMR (400 MHz, CDCl3) hH 7.60-7.57 (m, 2H), 6.91-6.87 (m, 
2H), 3.81 (s, 3H), 2.67 (s, 1H), 2.38 (s, 1H), 1.78 (s, 3H); 13C NMR (100.6 MHz, CDCl3) hC 
159.2, 137.2, 126.2, 113.6, 87.4, 72.9, 69.5, 55.3, 33.0; IR (cm -1) ちmax 3589, 3306, 3011, 2840, 
2555, 1610, 1510, 1253; MS m/z (EI), for C11H12O2 [M] calc. 176.0837, found 176.0833, error 
2.30 ppm. The NMR data in literature correspond to this experimental data [195]. 
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3-Phenylpent-1-yn-3-yl Acetate (298a) 
 
The starting material 3-phenylpent-1-yn-3-ol (297, 6.1 g, 38 mmol, 100 mol%) was dissolved 
in CH2Cl2 (300 ml) at r.t. and dimethylaminopyridine (2.3 g, 19 mmol, 50 mol%) and 
triethylamine (10.6 ml, 76 mmol, 200 mol%) were added. Acetic anhydride (7.2 ml, 76 mmol, 
200 mol%) was added slowly and the reaction left to stir overnight. The mixture was 
concentrated in vacuo to an oil. Purification of the residue by flash column chromatography 
(9:1 petroleum ether:Et2O) gave the title compound as a clear oil (6.6 g, 32 mmol, 85%). Rf = 
0.72 (4:1 petroleum ether:EtOAc); 1H NMR (400 MHz, CDCl3)  hH 7.53-7.51 (m, 2H), 7.36-
7.26 (m, 3H), 2.82 (s, 1H), 2.23-2.16 (m,1H), 2.08 (s, 3H), 2.01-1.95 (m, 1H), 0.94 (t, 3H, J = 
7.6 Hz); 13C NMR (100.6 MHz, CDCl3) hC 168.6, 140.9, 128.2, 127.8, 125.2, 81.7, 79.3, 76.4, 
37.4, 21.7, 8.5; IR (cm -1) ちmax 3306, 2980, 2117, 1743, 1242; MS m/z (ESI), for C13H14NaO2 
[M+Na] calc. 225.0886, found 225.0876, error 4.30 ppm. The GC trace of the title compound 
with column octakis(2,6-di-O-methyl-3-O-pentyl)-け-cyclodextrin and the temperature gradient 
program 60 °C-150 °C 2 °C/min gave retention times for the enantiomers of (44.06/44.29 min). 
1-d-3-Phenylpent-1-yn-3-yl Acetate (d-298) 
 
The starting material 1-d-3-phenylpent-1-yn-3-ol d-297 (0.9 g, 5.6 mmol, 100 mol%) gave the 
title compound as a clear oil (1.0 g, 4.9 mmol, 89%) with 81% isotopic purity. Rf = 0.72 (4:1 
petroleum ether:EtOAc); 1H NMR (400 MHz, CDCl3)  hH 7.53-7.51 (m, 2H), 7.37-7.28 (m, 
3H), 2.82 (s, 0.19H), 2.21-2.14 (m, 1H), 2.08 (s, 3H), 2.02-1.95 (m, 1H), 0.94 (t, 3H, J = 7.2 
Hz); 13C NMR (100.6 MHz, CDCl3)  hC 168.6, 140.9, 128.2, 127.8, 125.2, 79.3, 76.4, 37.4, 
21.7, 8.5, CD could not be seen; IR (cm -1)  ちmax 3306, 3010, 2596, 1984, 1743, 1493, 1369, 
1242; MS m/z  (ESI),  for  C13H13DNaO2 [M+Na] calc. 226.0949, found 226.0942, error 3.00 
ppm. 
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Kinetic resolution of 3-Phenylpent-1-yn-3-yl Acetate (298a) 
 
To 3-phenylpent-1-yn-3-yl acetate 298a (0.50 g, 2.5 mmol, 100 %) in phosphate buffer 
solution (20 ml) was added lipase A from Candida Antarctica (1.0 g on solid support) with 
vigorous stirring at r. t. After 18 hours the products were extracted with Et2O (5 x 20 ml) and 
the combined organics concentrated in vacuo. Purification by flash column chromatography 
gave (R)-alcohol and (S)- acetate as products: (S)-298a (0.25 g, 1.2 mmol, 48%); ee 57 %; [g]D 
= -33.9 (c = 0.86, CHCl3), and (R)-297 (0.13 g, 0.81 mmol, 32%); ee 90 %;  [g]D = -0.93 (c = 
0.60, CHCl3). 
3-phenylpent-1-yn-3-yl acetate (298a) 
 
 
3-phenylpent-1-yn-3-ol (297) 
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4-Methyl-3-phenylpent-1-yn-3-yl Acetate (298b) 
 
The starting material 4-methyl-3-phenylpent-1-yn-3-ol 297b (0.59 g, 3.4 mmol, 100 mol%) 
gave the title compound as a yellow solid containing a mixture of starting material and product 
(20% starting material remaining) (0.54 g, 2.5 mmol, 74%). Rf = 0.76 (4:1 petroleum ether: 
Et2O); M.p. 39-40 °C; 1H NMR (400 MHz, CDCl3) hH 7.52-7.49 (m, 2H), 7.35-7.25 (m, 3H), 
2.80 (s, 1H), 2.27-2.21 (septet, 1H, J = 6.4 Hz), 2.06 (s, 3H), 1.18 (d, 3H, J = 6.4 Hz), 0.72 (d, 
3H, J =  6.4  Hz);  13C NMR (100.6 MHz, CDCl3)  hC 168.5, 140.4, 128.0, 127.7, 125.6, 85.5, 
79.9, 76.3, 53.4, 40.0, 21.7, 17.8, 16.9; IR (cm -1) ちmax 3306, 3011, 2338, 1743, 1242; MS m/z 
(ESI), for C14H16NaO2 [M+Na] calc. 239.1043, found 239.1038, error 2.10 ppm. NOTE: In this 
reaction the Rf values of starting material and product are identical.  
Products from gold-catalyzed transformation of 3-phenylpent-1-yn-3-yl acetate 298a: 
 
To 3-phenylpent-1-yn-3-yl acetate (298b, 130 mg, 0.65 mmol, 100 mol%) in CH2Cl2 (10 ml) at 
r.t. were added Au(IPr)Cl (9.2 mg, 0.013 mmol, 2.0 mol%) and AgOTf (2.8 mg, 0.013 mmol, 
2.0 mol%). After 10 min the reaction mixture was filtrated through a pad of silica gel with a 
CH2Cl2 wash  and  the  solvents  were  evaporated  on  a  rotary  evaporator.  Purification  of  the  
residue by column chromatography (30:1 pentane:Et2O) gave 1-ethyl-1H-inden-2-yl acetate 
(299a, 51 mg, 0.25 mmol, 39%), 3-Ethyl-1H-inden-1-yl acetate (292a, 14 mg, 0.07 mmol, 
11%) and Z-or E-pent-3-en-1-yn-3-ylbenzene (300, 23 mg, 0.16 mmol, 25%). 
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1-Ethyl-1H-inden-2-yl acetate (299a) 
Clear oil, Rf = 0.28 (30:1 petroleum ether:Et2O); 1H NMR (400 MHz, CDCl3) hH 7.31-7.22 (m, 
3H), 7.16-7.12 (m, 1H), 6.65-6.64 (m, 1H), 3.62-3.59 (m, 1H), 2.27 (s, 3H), 1.96-1.83 (m, 2H), 
0.76 (t, 3H, J = 7.2 Hz); 13C NMR (100.6 MHz, CDCl3) hC 168.1, 158.0, 142.5, 141.0, 126.7, 
124.3, 122.6, 121.0, 114.3, 49.0, 22.4, 21.3, 9.3; IR (cm -1) ちmax 2969, 1761, 1601, 1463, 1192; 
MS m/z (ESI), for C13H14NaO2 [M+Na] calc. 225.0886, found 225.0890, error 1.70 ppm. The 
GC  trace  of  the  title  compound  with  column  octakis(2,6-di-O-methyl-3-O-pentyl)-け-
cyclodextrin and the temperature gradient program 60 °C-150 °C 2 °C/min gave retention 
times for the enantiomers of (49.12/49.41 min). 
 (Z)- Or (E)-pent-3-en-1-yn-3-ylbenzene (300) 
Yellow oil, Rf = 0.75 (20:1 petroleum ether:Et2O); 1H NMR (400 MHz, CDCl3) hH 7.61-7.58 
(m, 2H), 7.36-7.24 (m, 3H), 6.56 (qd, 1H, J = 6.8, 0.8 Hz), 3.37 (s, 1H), 2.10 (d, 3H, J = 6.8 
Hz); 13C NMR (100.6 MHz, CDCl3)  hC 137.8, 134.8, 128.3, 127.5, 125.8, 123.6, 83.3, 80.8, 
16.9; IR (cm -1) ちmax 3306, 3009, 2914, 1711, 1598, 1495, 1440, 1363; MS m/z (EI), for C11H10 
[M] calc. 142.0783, found 142.0777, error 4.20 ppm. The GC trace of the title compound with 
column octakis(2,6-di-O-methyl-3-O-pentyl)-け-cyclodextrin and the temperature gradient 
program 60 °C-150 °C 2 °C/min gave a single retention time of (32.28 min). 
 (E)-1-Ethylidene-1H-indene (302) 
 
Full data for the elimination product could not be obtained as it co-elutes in column 
chromatography with pent-3-en-1-yn-3-ylbenzene 300 and  both  have  the  same  mass  so  the  
structure is tentatively assigned as 302. Rf = 0.75 (20:1 petroleum ether: Et2O); partial 1H 
NMR (400 MHz, CDCl3) hH 6.91-6.89 (m, 1H), 6.83-6.82 (m, 1H), 6.73-6.67 (m, 1H), 2.20 (d, 
3H, J = 7.2 Hz); The GC trace of the title compound with column octakis(2,6-di-O-methyl-3-
O-pentyl)-け-cyclodextrin and the temperature gradient program 60 °C-150 °C 2 °C/min gave a 
single retention time of (32.28 min). The NMR data in literature is in accord with the 
experimental data [196]. 
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The  following  NMR  data  in  Figures  7-10  are  taken  from  the  gold  catalyzed  reaction  of  3-
phenylpent-1-yn-3-yl acetate 298a after 1min, 8min, 30min and 2 hours and it can be seen how 
3-ethyl-1H-inden-1-yl acetate 292a disappears slowly and is replaced by another compound 
tentatively assigned as 302 based on its NMR data. 
 
 
Figure 7: 2 min reaction time 
 
Figure 8: 8 min reaction time 
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Figure 9: 30 min reaction time 
 
Figure 10: 2 h reaction time 
Gold-catalyzed cycloisomerization of deuterium labeled 1-d-3-phenylpent-1-yn-3-yl 
acetate d-298 
 
Using the same procedure as with the synthesis of indenes 292a-h the gold-catalyzed 
cycloisomerization of 1-d-3-phenylpent-1-yn-3-yl acetate (d-298, 0.5 g, 2.5 mmol, 100 mol%) 
gave 3-d-1-Ethyl-1H-inden-2-yl acetate (d-299a, clear oil, 96 mg, 0.47 mmol, 19%) with 80% 
isotopic purity and 3-Ethyl-1-d-inden-1-yl acetate (d-292a, clear oil, 62 mg, 0.31 mmol, 12%) 
with 80% isotopic purity. 
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3-d-1-Ethyl-1H-inden-2-yl acetate d-299a; Rf = 0.28 (30:1 petroleum ether:Et2O); 1H NMR 
(400 MHz, CDCl3)  hH 7.32-7.21 (m, 3H), 7.17-7.13 (m, 1H), 6.65-6.64 (m, 0.2H), 3.62-3.59 
(m, 1H), 2.27 (s, 3H), 2.00-1.82 (m, 2H), 0.76 (t, 3H, J = 7.6 Hz); 13C NMR (100.6 MHz, 
CDCl3) hC 168.0, 157.9, 142.5, 141.0, 128.4, 126.7, 124.3, 122.6, 120.9, 48.9, 22.4, 21.3, 9.3; 
IR (cm -1) ちmax 2969, 1762, 1599, 1567, 1461, 1371, 1192; MS m/z (ESI), for C13H13DNaO2 
[M+Na] calc. 226.0949, found 226.0944, error 2.00 ppm. 
3-Ethyl-1-d-inden-1-yl acetate (d-292a); Rf = 0.64 (9:1 petroleum ether:Et2O); 1H NMR (400 
MHz, CDCl3)  hH 7.44-7.15 (m, 4H), 6.20-6.19 (m, 0.2H), 6.06-6.05 (m, 1H), 2.54-2.48 (m, 
2H), 2.15 (s, 3H), 1.28 (t, 3H, J = 7.6 Hz); 13C NMR (100.6 MHz, CDCl3)  hC 171.6, 149.9, 
144.1, 142.7, 128.8, 126.3, 126.2, 125.8, 119.3, 77.2, 12.2, 20.7, 11.6; IR (cm -1)  ちmax 3011, 
2972, 1731, 1431, 1371, 1242; MS m/z (ESI), for C13H13DNaO2 [M+Na] calc. 226.0949, found 
226.0945, error 1.70 ppm. 
1-Phenylpent-2-yn-1-ol (303) 
 
1-Butyne (~1.2 ml, 18.9 mmol, 100 mol%) was condensed in a Schlenk tube under argon at -78 
°C. Freshly distilled THF (20 ml) was cooled to -78 °C and added slowly to the butyne. A cold 
solution of n-BuLi (11.8 ml, 1 M in hexanes, 18.9 mmol, 100 mol%) was added dropwise and 
after 30 min benzaldehyde (1.9 ml, 18.9 mmol, 100 mol%) was added and the reaction was left 
to warm to room temperature overnight. The mixture was quenched with saturated aqueous 
NH4Cl and the aqueous layer was re-extracted twice with Et2O. The combined organic layers 
were washed with saturated aqueous NaCl solution and dried over Mg2SO4. The crude product 
was concentrated in vacuo and purified by flash column chromatography (9:1 petroleum 
ether:Et2O). The title compound was obtained as a clear oil (2.79 g, 17.4 mmol, 92%). Rf = 
0.69 (4:1 petroleum ether:EtOAc); 1H NMR (400 MHz, CDCl3)  hH 7.56-7.53 (m, 2H), 7.40-
7.30 (m, 3H), 5.45 (dt, 1H, J = 6.0, 2.0 Hz), 2.29 (qd, 2H, J = 7.6, 2.0 Hz), 2.10 (d, 2H, J = 6.0 
Hz, OH), 1.18 (t, 3H, J = 7.6 Hz); 13C NMR (100.6 MHz, CDCl3)  hC 141.2, 128.5, 128.2, 
126.6, 89.0, 79.3, 64.8, 13.7, 12.5; IR (cm -1) ちmax 3593, 3066, 3011, 2981, 2230, 1603, 1494, 
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1374, 991; MS m/z  (EI),  for  C11H12NaO [M+Na] calc. 183.0780, found 183.0783, error 1.6 
ppm. The NMR data in the literature correspond to the experimental data [197]. 
1-Phenylpent-2-ynyl acetate (304) 
 
The same procedure was used as with tertiary propargylic acetate 298a. The starting material 
1-phenylpent-2-yn-1-ol 303 (2.0 g, 12.5 mmol, 100 mol%) gave the title compound as a clear 
oil (2.5g, 12.5 mmol, 99%). Rf = 0.87 (4:1 petroleum ether:EtOAc); 1H NMR (400 MHz, 
CDCl3) hH 7.53-7.50 (m, 2H), 7.40-7.32 (m, 3H), 6.46 (t, 1H, J = 2.0 Hz), 2.29 (qd, 2H, J = 
7.6, 2.0 Hz), 2.10 (s, 3H), 1.17 (t, 3H, J = 7.6 Hz); 13C NMR (100.6 MHz, CDCl3) hC 169.9, 
137.7, 128.7, 128.5, 127.7, 89.6, 76.0, 66.0, 21.2, 13.5, 12.5; IR (cm -1) ちmax 3011, 2982, 2941, 
2238, 1734, 1371, 1242; MS m/z  (ESI  positive),  for  C13H14NaO2 [M+Na] calc. 225.0886, 
found 225.0879, error 3.00 ppm. The GC trace of the title compound with column octakis(2,6-
di-O-methyl-3-O-pentyl)-け-cyclodextrin and the temperature gradient program 60 °C-150 °C 2 
°C/min gave retention times for the enantiomers of (46.75/47.13 min). 
Gold-catalyzed isomerization of 1-phenylpent-2-ynyl acetate 304 with long reaction time 
and AgBF4 as cocatalyst 
 
The starting material 1-phenylpent-2-ynyl acetate (304, 0.2 g, 0.99 mmol, 100 mol%) was 
dissolved in CH2Cl2 (10ml) at r.t. and Au(IPr)Cl (12 mg, 0.02 mmol, 2 mol%) and AgBF4 (5.1 
mg, 0.02 mmol, 2 mol%) were added. After 15 min the reaction was quenched by filtration 
through a pad of silica to give a product mixture of 1-ethyl-1H-inden-1-yl acetate (306, 0.11 g, 
0.57 mmol, 54%) and (E)-1-phenylpent-1-en-3-one 305 18%. 
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1-Ethyl-1H-inden-1-yl acetate (306); Rf = 0.50 (9:1 petroleum ether:Et2O); 1H NMR (400 
MHz, CDCl3) hH 7.35-7.33 (m, 1H), 7.27-7.16 (m, 3H), 6.73 (dd, 1H, J = 6.0, 0.8 Hz), 6.54 (d, 
1H, J = 6.0 Hz), 2.30-2.21 (m, 1H), 2.04-1.95 (m, 1H), 2.01 (s, 3H), 0.79 (t, 3H, J = 7.2 Hz); 
13C NMR (100.6 MHz, CDCl3)  hC 169.9, 145.3, 142.3, 137.3, 132.4, 128.5, 126.1, 122.0, 
121.6, 91.2, 28.7, 21.8, 8.4; IR (cm -1) ちmax 2977, 2254, 1735, 1464, 1251, 909; MS m/z (ESI 
Positive), for C13H14NaO2 [M+Na] calc. 225.0886, found 225.0884, error 1.10 ppm. The GC 
trace of the title compound with column octakis(2,6-di-O-methyl-3-O-pentyl)-け-cyclodextrin 
and the temperature gradient program 60 °C-150 °C 2 °C/min gave a single retention time of 
(43.80 min). 
Gold-catalyzed isomerization of 1-phenylpent-2-ynyl acetate with short reaction time and 
AgOTf as cocatalyst 
 
The starting material 1-Phenylpent-2-ynyl acetate (304, 0.2 g, 0.99 mmol, 100 mol%) was 
dissolved in CH2Cl2 (10ml) at r.t. and Au(IPr)Cl (12 mg, 0.02 mmol, 2 mol%) and AgOTf (5.1 
mg, 0.02 mmol, 2 mol%) were added. After 15 min the reaction was quenched by elution 
through a pad of silica to give product mixture of 1-phenylpenta-1,2-dien-3-yl acetate (307, 
clear oil, 0.11 g, 0.56 mmol, 57%) and (E)-1-phenylpent-1-en-3-one (305, 52 mg, 0.33 mmol,  
33%). 
1-Phenylpenta-1,2-dien-3-yl acetate (307); Rf = 0.58 (9:1 petroleum ether:Et2O); 1H NMR 
(400 MHz, CDCl3) hH 7.44-7.42 (m, 2H), 7.35-7.31 (m, 2H), 7.27-7.23 (m, 1H), 6.62 (t, 1H, J 
= 3.2 Hz), 2.40-2.33 (m, 2H), 2.15 (s, 3H), 1.07 (t, 3H, J = 7.6 Hz); 13C NMR (100.6 MHz, 
CDCl3) hC 196.3, 168.7, 133.9, 128.6, 128.4, 128.0, 127.8, 105.1, 25.0, 21.0, 10.7; IR (cm -1) 
ちmax 3011, 2977, 2939, 2880, 2337, 1963, 1747, 1331, 1241; MS m/z  (EI),  for  C13H14NaO2 
[M+Na] calc. 225.0886, found 225.0887, error 0.50 ppm. The GC trace of the title compound 
with column octakis(2,6-di-O-methyl-3-O-pentyl)-け-cyclodextrin and the temperature gradient 
program 60 °C-150 °C 2 °C/min gave retention times for the enantiomers of (49.29/49.83 min). 
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(E)-1-Phenylpent-1-en-3-one (305); Rf = 0.39 (9:1 petroleum ether:Et2O); 1H NMR (400 
MHz, CDCl3) hH 7.56 (d, 1H, J = 16.8 Hz), 7.56-7.54 (m, 2H), 7.41-7.39 (m, 3H), 6.75 (d, 1H, 
J = 16.8 Hz), 2.71 (q, 2H, J = 7.2 Hz), 1.18 (t, 3H, J = 7.2 Hz); 13C NMR (100.6 MHz, CDCl3) 
hC 200.9, 142.2, 134.6, 130.3, 128.9, 128.2, 126.0, 34.0, 8.2; IR (cm -1) ちmax 3011, 2982, 2941, 
1749, 1688, 1662, 1610, 1578, 1191; MS m/z  (ESI  Positive),  for  C11H12NaO [M+Na] calc. 
183.0780, found 183.0777, error 2.00 ppm. The NMR data in the literature correspond to this 
experimental data [198]. 
3-Ethyl-3-phenylcycloprop-1-enyl Acetate (309) 
 
Tentatively assumed as the intermediate in the gold-catalyzed cycloisomerization of 298a. As 
this compound could not be isolated, only NMR from the reaction mixture could be obtained 
and the compounds in the reaction mixture overlap with some of the NMR signals of putative 
309. Following NMR data could be assigned for the intermediate: 1H NMR (400 MHz, CDCl3) 
hH 7.44-7.42 (m, 1H), 2.58-2.53 and 2.35-2.30 (2 x m, 2H, CH2"g to  asym. center), 1.92 (s, 
3H), 0.61 (t, 3H, J = 7.6 Hz); 13C NMR (100.6 MHz, CDCl3) hC 204.1, 169.8, 76.7, 26.8, 7.0. 
3-Ethyl-2,3-diphenylcycloprop-1-enyl Acetate (312) 
 
CuI (0.92 g, 4.9 mmol, 250 mol%) and LiBr (0.42 g, 4.9 mmol, 250 mol%) were dried briefly 
under vacuum with a heat gun. The reaction flask was flushed with argon and THF (40 ml) was 
added. The reaction was cooled to -10 °C and EtMgBr (1 M in MTBE, 4.7 ml, 4.7 mmol, 240 
mol%) was added followed by the addition of 2,3-diphenylcycloprop-2-enone (0.4 g, 1.9 
mmol, 100 mol) in three portions. After 1 h 30 min Ac2O (0.4 ml, 4.2 mmol, 218 mol%) was 
added and the reaction was warmed to r.t. for 30 min. The reaction was quenched with 
saturated aqueous NH4Cl/NH3 solution (prepared by adding 10 ml of 35% NH3 to 500 ml of 
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saturated NH4Cl solution) and the organic layer was washed 3-4 times with the quench solution 
until the aqueous layer was no longer blue. The combined aqueous layers were re-extracted 
once with Et2O and then the combined organic layers were washed with saturated aqueous 
NaCl solution and dried over Mg2SO4 and concentrated in vacuo. Purification by flash column 
chromatography (30:1-20:1 petroleum ether:Et2O) gave the title compound as a yellow oil (47 
mg, 0.17 mmol, 9%). Rf = 0.35 (9:1 petroleum ether:Et2O); 1H NMR (400 MHz, CDCl3) hH 
7.59-7.56 (m, 2H), 7.41-7.24 (m, 8H), 2.37-2.31 (m, 2H, CH2"g to asym. center), 2.31 (s, 3H), 
0.91 (t, 3H, J = 7.6 Hz); 13C NMR (100.6 MHz, CDCl3) hC 207.9, 166.3, 145.4, 129.3, 128.5, 
128.1, 127.8, 126.7, 125.8, 92.5, 40.6, 26.7, 20.8, 11.6; IR (cm -1) ちmax 3062, 3011, 2967, 2932, 
2875, 1863, 1774, 1685, 1598, 1184; MS m/z (ESI Positive), for C19H18NaO2 [M+Na] calc. 
301.1199, found 301.1209, error 3.20 ppm.  
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6.4.1 Example of GC calibration for screening reaction conditions 
Many of the reactions where several catalytic conditions were screened were followed on gas 
chromatography. Here is given one example of how the GC was calibrated in the case of the 
SN2’ reaction of propargylic diacetates. 
OAc
OAc
OAc
[cat]
R-M
 
Calibration plot was made for starting material (SM) and for the product (PR). First two 
standard solutions were prepared: 
Solution 1 (SM): 0.26 g (1.13 mmol) of 3-phenylprop-2-yne-1,1-diyl diacetate 187a in 10 ml 
of 2-Me-THF 
Solution 2 (PR): 0.26 g (1.31 mmol) of 3-phenylpenta-1,2-dienyl acetate 190b in 10 ml of 2-
Me-THF 
Five samples were made containing both solutions (Table 30). 
Table 30 
sample V(sol 1) n (SM) V(sol 2) n (PR) 
1 2 ml 0.225 mmol 0.1 ml 0.013 mmol 
2 1 ml 0.113 mmol 0.25 ml 0.033 mmol 
3 0.5 ml 0.056 mmol 0.5 ml 0.065 mmol 
4 0.25 ml 0.028 mmol 1 ml 0.131 mmol 
5 0.1 ml 0.013 mmol 2 ml 0.262 mmol 
Samples were prepared according to the following procedure: To 5 ml of 2-Me-THF was 
added the volumes of solutions 1 and 2 and this mixture was ‘quenched’ with saturated 
aqueous NH4Cl containing 2% of ammonia. To the organic layer was added 50 たl of tridecane 
and organic layer was dried over MgSO4 and used in GC analysis. 
 
These concentrations were chosen because the carousel test reactions were run with 50 mg 
(0.22 mmol) 3-phenylprop-2-yne-1,1-diyl diacetate as starting material. This means that the 
amount of product and starting material in the reaction mixture always falls to the calibration 
curve and no extrapolation is needed. Also the same amount (50 たl) of tridecane is always used 
in each test reaction. When the amount of a reaction component (in mmol) is plotted against 
the ration of the reaction component and internal standard, the calibration gave the following 
linear plots (Figure 11): 
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Figure 11 
From this plot the amount (in mmol) of the reaction component can be calculated in an 
unknown sample according to following equation: 
Equation 4 
unkISarea
unkSMarea
xncurvecalibratiokunkSMn SM )(
)()()( ?
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